
<html lang="en"     class="pb-page"  data-request-id="4216a985-a1ba-4772-998b-c2a0884a408a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm501207r;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain" /></meta><meta name="dc.Creator" content="Yu  Lan" /></meta><meta name="dc.Creator" content="Yin  Chen" /></meta><meta name="dc.Creator" content="Xudong  Cao" /></meta><meta name="dc.Creator" content="Juecheng  Zhang" /></meta><meta name="dc.Creator" content="Jie  Wang" /></meta><meta name="dc.Creator" content="Xiangqing  Xu" /></meta><meta name="dc.Creator" content="Yinli  Qiu" /></meta><meta name="dc.Creator" content="Tan  Zhang" /></meta><meta name="dc.Creator" content="Xin  Liu" /></meta><meta name="dc.Creator" content="Bi-Feng  Liu" /></meta><meta name="dc.Creator" content="Guisen  Zhang" /></meta><meta name="dc.Description" content="The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article..." /></meta><meta name="Description" content="The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 4, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501207r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501207r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501207r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501207r" /></link>
        
    
    

<title>Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501207r" /></meta><meta property="og:title" content="Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0021.jpeg" /></meta><meta property="og:description" content="The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in σ-1 and σ-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropathic pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501207r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501207r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501207r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501207r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501207r&amp;href=/doi/10.1021/jm501207r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10404-10423</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501112q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5010336" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Lan">Yu Lan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yin++Chen">Yin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xudong++Cao">Xudong Cao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juecheng++Zhang">Juecheng Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Wang">Jie Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiangqing++Xu">Xiangqing Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yinli++Qiu">Yinli Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tan++Zhang">Tan Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Liu">Xin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bi-Feng++Liu">Bi-Feng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guisen++Zhang">Guisen Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Jiangsu Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86-27-87792235. Fax: +86-27-87792170. E-mail: <a href="/cdn-cgi/l/email-protection#e780949d8f868980a78a868e8bc98f929493c9828392c98489"><span class="__cf_email__" data-cfemail="1671656c7e777871567b777f7a387e63656238737263387578">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501207r&amp;href=/doi/10.1021%2Fjm501207r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10404–10423</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 24, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 August 2014</li><li><span class="item_label"><b>Published</b> online</span>4 December 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501207r" title="DOI URL">https://doi.org/10.1021/jm501207r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10404%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYu%2BLan%252C%2BYin%2BChen%252C%2BXudong%2BCao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D24%26contentID%3Djm501207r%26title%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BSigma-1%2BReceptor%2BAntagonists%2BBased%2Bon%2BPyrimidine%2BScaffold%2BAs%2BAgents%2Bfor%2BTreating%2BNeuropathic%2BPain%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10423%26publicationDate%3DDecember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501207r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1915</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501207r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Yin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xudong&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Juecheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xiangqing&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Yinli&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Tan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bi-Feng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guisen&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;10404-10423&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501207r&quot;},&quot;abstract&quot;:&quot;The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in σ-1 and σ-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropa&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501207r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501207r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501207r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501207r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501207r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501207r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501207r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501207r&amp;href=/doi/10.1021/jm501207r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501207r" /></input><a href="/doi/pdf/10.1021/jm501207r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501207r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501207r%26sid%3Dliteratum%253Aachs%26pmid%3D25420090%26genre%3Darticle%26aulast%3DLan%26date%3D2014%26atitle%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BSigma-1%2BReceptor%2BAntagonists%2BBased%2Bon%2BPyrimidine%2BScaffold%2BAs%2BAgents%2Bfor%2BTreating%2BNeuropathic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D24%26spage%3D10404%26epage%3D10423%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jmcmar.2014.57.issue-24/20141226/jmcmar.2014.57.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ<sub>1</sub>R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in σ-1 and σ-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>137</b>), which exhibited a high binding affinity to σ<sub>1</sub>R receptor (<i>K</i><sub>i</sub> σ<sub>1</sub> = 1.06 nM) and good σ-1/2 selectivity (1344-fold). In in vivo tests, compound <b>137</b> exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound <b>137</b> may constitute a novel class of drugs for the treatment of neuropathic pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuropathic pain is widely recognized as one of the most difficult clinical syndromes, which affects 8% of the population and is considerably costly for the health care system and devastating to the people who experience it.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Although progress has been made from basic science and clinical research and preclinical neuropathic pain models have facilitated identification of several promising targets, innovations in the field of pain in recent years are lacking. Available therapies often provide incomplete pain relief and treatment-related side effects are common; thus neuropathic pain management remains a challenge.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Various guidelines have been established for the pharmacological management of neuropathic pain.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Although differing in detail, the guidelines are generally consistent.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Medications recommended as first-line treatments for neuropathic pain include antidepressants (such as tricyclic antidepressants, TCA, and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel α<sub>2</sub>-δ ligands (gabapentin and prebagalin), and topical lidocaine. These medications are very effective in reducing pain in several neuropathic pain disorders, but treatment may be compromised and outweighed by its side effects. Opioid analgesics can alleviate nociceptive and neuropathic pain with a mean decrease in pain intensity, comparable with TCA and gabapentin/pregabalin. Regarding their long-term safety, opioid-induced hyperalgesia and the risk of addiction relative to the first-line medications, opioid analgesics are recommended typically for patients who have not responded to first-line medications. Several medications are generally used as third-line treatments because of weak efficacy, discrepant results, or safety concerns, including anticonvulsants, NMDA receptor antagonists, and topical capsaicin. Thus, neuropathic pain analgesics with novel mechanisms of action that improve the efficacy of existing therapies and reduce unwanted effects are needed.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a></div><div class="NLM_p">The sigma receptors (σR) were first discovered in 1976<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and mischaracterized originally as a new class of opioid receptors. Later, sigma receptors were confused with the PCP/NMDA glutamate receptor complex because of nonselective ligands.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Currently, sigma receptors are considered unique proteins without homology to opioid receptors or other mammalian proteins.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Pharmacological studies and biochemical analyses have identified two distinct subtypes of sigma receptor, termed the sigma-1 (σ<sub>1</sub>) and sigma-2 (σ<sub>2</sub>) receptors.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The σ<sub>1</sub>R has been purified and cloned and encodes a protein of 223 amino acids with a molecular weight of ∼24 kDa.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Investigations have suggested that the σ<sub>1</sub>R plays an important role in central nervous system (CNS) function.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This protein acts as a unique ligand-regulated molecular chaperone that modulates the activity of different proteins such as <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic (NMDA)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> receptors and several ion channels.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> The σ<sub>2</sub>R has not been characterized as well as the σ<sub>1</sub>R, and cloning of the σ<sub>2</sub>R has not been reported. Recently, the σ<sub>2</sub>R was shown to be involved in cellular proliferation and cell death, and radiolabeled ligands acting on σ<sub>2</sub>R have been used for tumor imaging techniques (i.e., positron emission tomography, PET). Numerous studies suggest that the σ<sub>2</sub>R is an excellent biomarker and a promising therapeutic target for the treatment of cancer.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Due to their different pharmacological functions, selectivity between the σ<sub>1</sub>R and σ<sub>2</sub>R is desirable.</div><div class="NLM_p">To date, selective σ<sub>1</sub>R ligands have not been introduced to the market, but many of the compounds have been tested in clinical studies as antidepressants,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> antipsychotics,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> treatments for drug abuse,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and learning/memory enhancers.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Moreover, numerous groups have studied the potential role of the σ<sub>1</sub>R in pain management, especially neuropathic pain.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Since the 1990s, the σ<sub>1</sub>R has been known to modulate opioid analgesia,<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> and recently, the relationship between the μ-opioid and σ<sub>1</sub>R was shown to involve a direct physical interaction.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Treatment with σ<sub>1</sub>R antagonists or σ<sub>1</sub>R antisense oligodeoxynucleotides enhanced the antinociceptive effect induced by morphine and other μ-opioid receptor agonists in the acute nociceptive test, while σ<sub>1</sub>R agonists reduced the analgesic response elicited by opioids.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> The σ<sub>1</sub>R also plays a nociceptive role in the absence of opioids, as shown in studies using σ<sub>1</sub>R knockout mice and certain behavioral models involving pain sensitization pathways. Mice lacking σ<sub>1</sub>R were unable to develop completely the two phases of formalin-induced paw licking/biting behavior<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and showed no mechanical hypersensitivity following capsaicin sensitization.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In an animal model of neuropathic pain, cold and mechanical hypersensitivity were strongly attenuated in σ<sub>1</sub>R knockout mice treated with paclitaxel<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or exposed to partial sciatic nerve ligation.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Pharmacological antagonism of the σ<sub>1</sub>R produced similar results. Haloperidol and its metabolites I and II, which have an affinity for the σ<sub>1</sub>R, inhibited formalin-induced pain<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and capsaicin-induced sensitization in wild-type mice.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The recently described σ<sub>1</sub>R antagonists, S1RA, with high affinity to σ-1 receptors (<i>K</i><sub>i</sub> = 17 nM) and excellent selectivity ratio (σ<sub>2</sub>/σ<sub>1</sub> > 550), are currently undergoing phase II clinical trials for treatment of neuropathic pain<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative σ<sub>1</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our interest has focused on the development of novel ligands with high affinity to the σ<sub>1</sub>R and selectivity over the σ<sub>2</sub>R subtype.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Using a three-dimensional (3D) pharmacophore model of σ<sub>1</sub>R antagonists and virtual screening program, we identified a new series of compounds based on pyrimidine scaffold. Herein, we report the synthesis and investigated the behavior of pyrimidine derivatives as novel and potent antineuropathic analgesics. The compounds were subjected to preliminary pharmacological evaluation to determine their affinities to the σ<sub>1</sub>R and σ<sub>2</sub>R. Their structure–activity relationships (SARs) for the σ<sub>1</sub>R and σ<sub>2</sub>R were associated with variation in the basic amino moieties and substituents on the pyrimidine scaffold. Among the derivatives prepared, compound <b>137</b> exhibited a high binding affinity to σ<sub>1</sub>R (<i>K</i><sub>i</sub> σ<sub>1</sub> = 1.06 nM), good σ<sub>1</sub>R/σ<sub>2</sub>R selectivity (1344-fold), and was identified as a σ<sub>1</sub>R antagonist. Weak affinity to hERG channels indicated that compound <b>137</b> had a low incidence of cardiac toxicity. In addition, compound <b>137</b> inhibited dose-dependent antinociceptive effects in the mouse formalin-induced pain model and rat chronic constriction injury (CCI) model. Motor impairments were not found in rotarod tests at analgesic doses, and acceptable pharmacokinetic properties were observed. On the basis of these properties, compound <b>137</b> may be considered a novel class of drugs for the treatment of neuropathic pain.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Molecular Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As the lack of three-dimensional protein structure of a σ<sub>1</sub> receptor,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> the main focus of current efforts toward the development of a new σ<sub>1</sub>R ligand is concentrated on structure-based ligand design. In this work, Discovery Studio 2.5 software (DS) was utilized to build and validate pharmacophore model. 3D pharmacophore hypotheses were built based on a set of known diverse σ<sub>1</sub>R antagonists. The best pharmacophore model, which identified compounds with an associated correlation coefficient of 0.94027 between the experimental and estimated <i>K</i><sub>i</sub> value, consisted of four pharmacophoric feature: HBA (green), Hydrophob_aromatic (blue), Hydrophobic (light blue), and PosIonizable (red), as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A. Detailed information about 3D pharmacophore model generation can be found in the <a class="ref internalNav" href="#notes-2" aria-label="Support Information">Support Information</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) The 3D-QSAR pharmacophore model of σ-1R antagonist. The model is constituted with four pharmacophore features: HBA, green; Hydrophob_aromatic, blue; Hydrophobic, light blue; and PosIonizable, red. (B) The virtual screening result and molecular design of pyrimidine scaffold by this 3D-QSAR model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the preliminary founding of virtual screening by this 3D pharmacophore model and analysis of hits identification, we got the pyrimidine scaffold and design a series of compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). In detail, the chemical structures of these pyrimidine derivatives were designed according to the following rationale: we changed the distance between the pyrimidine ring and basic amino moiety (carbon chain linker) to validate the requirement of the pharmacophoric model, tested various basic amino moieties to fit the PosIonizable and Hydrophobic feature (NR<sub>1</sub>R<sub>2</sub>), took different substitution on the 4- and 5-positions of the pyrimidine ring (R<sub>3</sub> and R<sub>4</sub>), and replaced the 2-phenyl goup of pyrimidine by an aromatic ring or small alkyl group (R<sub>5</sub>) to find the best conformational fitting to the receptor.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the new compounds was accomplished using different routes, as shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>n</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) HNR<sub>1</sub>R<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux;</p></p></figure><div class="NLM_p">As depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, phenyl aminoalkoxypyrimidine derivatives <b>8</b> and <b>14</b>–<b>34</b> were obtained using two alternative procedures. The key intermediate 6-methyl-2-phenylpyrimidin-4-ol <b>7</b> was prepared using a one-step procedure from benzimidamide <b>5</b>, which was cyclized with a moderate yield of ethyl 3-oxobutanoate <b>6</b>. Depending on the substitution pattern, the final compounds <b>8</b> and <b>14</b>–<b>34</b> were prepared using method A or the two-step procedure, method B (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In method A, <b>7</b> was reacted with commercially available chloroalkylamine under a basic condition to obtain a good yield of compound <b>8</b>. Method B involved standard alkylation with 1,<i>n</i>-dibromoalkanes to produce <b>9</b>–<b>13</b>, and reaction with the corresponding amines under mild basic conditions resulted in moderate yields of the final compounds <b>14</b>–<b>34</b>. The general synthetic methods for phenyl aminoalkoxypyrimidine derivatives <b>8</b> and <b>14</b>–<b>34</b> (methods A and B) are described in the <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>8</b>, <b>14</b>–<b>18</b>, <b>36</b>, and <b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>1</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>2</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (σ<sub>2</sub>/σ<sub>1</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">36.3 ± 4.8<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">949 ± 65</td><td class="colsep0 rowsep0" align="char" char=".">26.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="center">95.2 ± 7.6</td><td class="colsep0 rowsep0" align="center">1072 ± 82</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>5</sub></td><td class="colsep0 rowsep0" align="center">389 ± 63</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>6</sub></td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH═CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">116 ± 9.4</td><td class="colsep0 rowsep0" align="center">1451 ± 82</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">422 ± 73</td><td class="colsep0 rowsep0" align="center">1924 ± 107</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CHOHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">486 ± 85</td><td class="colsep0 rowsep0" align="center">1644 ± 124</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ-1 receptors.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">The values are means ± SEM of three experiments performed in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptors of Compounds <b>14</b> and <b>19</b>–<b>34</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0015.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ-1 receptors.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">The values are means ± SEM of three experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">Elongated analogues <b>36</b> and <b>38</b> were obtained starting from 6-methyl-2-phenylpyrimidin-4-ol <b>7</b>, as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Alkylation of <b>7</b> with 1-bromo-2-(bromoethoxy)ethane under basic conditions produced the monosubstituted <b>35</b>, which was reacted with morpholine to afforded compound <b>36</b>. Hydroxyl derivative <b>38</b> was prepared by treatment of <b>7</b> with 2-(chloromethyl)oxirane under basic conditions, followed by ring-opening with morpholine.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) Br(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, KI, acetone, reflux; (II) morpholine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (III) 2-(cholomethyl)oxirane, K<sub>2</sub>CO<sub>3</sub>, KI, acetone, reflux; (IV) morpholine, MeOH, reflux.</p></p></figure><div class="NLM_p">The route depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> was used for the preparation of substituted pyrimidine scaffold compounds <b>69</b>–<b>78</b> and <b>79</b>–<b>88</b>. The intermediates <b>49</b>–<b>58</b> were obtained using the cyclization procedure with benzimidamide <b>5</b>, which was reacted with various substituted ethyl 3-oxobutanoates <b>39</b>–<b>48</b>, depending on the substitution pattern of the final pyrimidine. Next, standard alkylation with 1,3-dibromopropane was conducted to produce <b>59</b>–<b>68</b>, and then reaction with the piperidine or pyrrodine afforded the final compounds <b>69</b>–<b>78</b> and <b>79</b>–<b>88</b>, respectively, with moderate yields (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>19</b>, <b>31</b>, and <b>69</b>–<b>88</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0017.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">n</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> σ<sub>1</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>2</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (σ<sub>2</sub>/σ<sub>1</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">11.8 ± 2.6<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">1051 ± 87</td><td class="colsep0 rowsep0" align="char" char=".">89.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">20.5 ± 3.3</td><td class="colsep0 rowsep0" align="center">1141 ± 97</td><td class="colsep0 rowsep0" align="char" char=".">55.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">34.9 ± 6.1</td><td class="colsep0 rowsep0" align="center">1456 ± 127</td><td class="colsep0 rowsep0" align="char" char=".">41.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">188 ± 25</td><td class="colsep0 rowsep0" align="center">1836 ± 232</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">19.3 ± 4.6</td><td class="colsep0 rowsep0" align="center">892 ± 77</td><td class="colsep0 rowsep0" align="char" char=".">46.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">27.6 ± 5.9</td><td class="colsep0 rowsep0" align="center">1327 ± 101</td><td class="colsep0 rowsep0" align="char" char=".">48.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">253 ± 46</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">966 ± 92</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">9.51 ± 1.3</td><td class="colsep0 rowsep0" align="center">1221 ± 104</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">3.75 ± 0.4</td><td class="colsep0 rowsep0" align="center">1361 ± 119</td><td class="colsep0 rowsep0" align="char" char=".">363</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">2.33 ± 0.6</td><td class="colsep0 rowsep0" align="center">1649 ± 119</td><td class="colsep0 rowsep0" align="char" char=".">708</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">13.6 ± 3.1</td><td class="colsep0 rowsep0" align="center">1253 ± 78</td><td class="colsep0 rowsep0" align="char" char=".">92.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">22.4 ± 4.1</td><td class="colsep0 rowsep0" align="center">1429 ± 133</td><td class="colsep0 rowsep0" align="char" char=".">63.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">38.9 ± 7.6</td><td class="colsep0 rowsep0" align="center">1396 ± 121</td><td class="colsep0 rowsep0" align="char" char=".">35.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">218 ± 55</td><td class="colsep0 rowsep0" align="center">1092 ± 172</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">19.3 ± 4.6</td><td class="colsep0 rowsep0" align="center">892 ± 77</td><td class="colsep0 rowsep0" align="char" char=".">46.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">27.6 ± 5.9</td><td class="colsep0 rowsep0" align="center">1327 ± 101</td><td class="colsep0 rowsep0" align="char" char=".">48.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">278 ± 51</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">735 ± 108</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH3</td><td class="colsep0 rowsep0" align="char" char="±">11.4 ± 1.2</td><td class="colsep0 rowsep0" align="center">1279 ± 173</td><td class="colsep0 rowsep0" align="char" char=".">112</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">3.51 ± 0.7</td><td class="colsep0 rowsep0" align="center">1194 ± 97</td><td class="colsep0 rowsep0" align="char" char=".">340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">4.02 ± 0.6</td><td class="colsep0 rowsep0" align="center">1684 ± 131</td><td class="colsep0 rowsep0" align="char" char=".">419</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block sigma-1 receptors.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">The values are means ± SEM of three experiments performed in duplicate.</p></div></div></div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><div class="NLM_p">6,7-Dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidines <b>94</b>–<b>95</b> and 5,6,7,8-tetrahydroquinazoline <b>97</b>–<b>98</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were prepared by reaction of <b>5</b> with ethyl 2-oxocyclopentanecarboxylate or 2-oxocyclohexanecarboxylate to obtain intermediates <b>91</b> and <b>92</b>, which were subsequently alkylated with 1,3-dibromopropane and reacted with piperidine or pyrrolidine, under conditions similar to those used for substituted pyrimidine derivatives.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>94</b>–<b>95</b>, <b>97</b>, and <b>98</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0018.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0019.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block sigma-1 receptors.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">The values are means ± SEM of three experiments performed in duplicate.</p></div></div><div></div></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><div class="NLM_p">The syntheses of the 2-substituted 5-chloro-4-methyl-6-aminoalkoxy pyrimidine derivatives <b>132</b>–<b>142</b> were accomplished by the corresponding aryl- or alkyl- amidine <b>99</b>–<b>109</b> that were reacted with ethyl 2-chloro-3-oxobutanoate <b>48</b>, followed by alkylation with 1,3-dibromopropane and reaction with piperidine (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The nonsubstituted 5-chloro-4-methyl-6-aminoalkoxy pyrimidine, intermediate <b>118</b>, which is soluble in water, was purified using flash chromatography.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Affinities for the σ<sub>1</sub> and σ<sub>2</sub> Receptor of Compounds <b>78</b> and <b>132</b>–<b>142</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0020.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> σ<sub>1</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>2</sub> (nM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (σ<sub>2</sub>/σ<sub>1</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char="±">2.33 ± 0.6<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">1649 ± 119</td><td class="colsep0 rowsep0" align="char" char=".">708</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>132</b></td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="char" char="±">1.96 ± 0.7</td><td class="colsep0 rowsep0" align="center">1554 ± 92</td><td class="colsep0 rowsep0" align="char" char=".">792</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>133</b></td><td class="colsep0 rowsep0" align="left">4-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">3.88 ± 1.0</td><td class="colsep0 rowsep0" align="center">1288 ± 76</td><td class="colsep0 rowsep0" align="char" char=".">332</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>134</b></td><td class="colsep0 rowsep0" align="left">4-(trifluoromethyl)phenyl</td><td class="colsep0 rowsep0" align="char" char="±">4.42 ± 1.4</td><td class="colsep0 rowsep0" align="center">1776 ± 135</td><td class="colsep0 rowsep0" align="char" char=".">402</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>135</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">1.14 ± 0.2</td><td class="colsep0 rowsep0" align="center">1329 ± 202</td><td class="colsep0 rowsep0" align="char" char=".">1165</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>136</b></td><td class="colsep0 rowsep0" align="left">3,4-difluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">0.97 ± 0.l</td><td class="colsep0 rowsep0" align="center">943 ± 156</td><td class="colsep0 rowsep0" align="char" char=".">973</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>137</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">1.06 ± 0.2</td><td class="colsep0 rowsep0" align="center">1425 ± 139</td><td class="colsep0 rowsep0" align="char" char=".">1344</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>138</b></td><td class="colsep0 rowsep0" align="left">3,4-dichlorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">89.8 ± 13</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>139</b></td><td class="colsep0 rowsep0" align="left">2-naphthyl</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 19</td><td class="colsep0 rowsep0" align="center">>2000</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>140</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">187 ± 14</td><td class="colsep0 rowsep0" align="center">1104 ± 88</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>141</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">58.8 ± 7.2</td><td class="colsep0 rowsep0" align="center">1081 ± 63</td><td class="colsep0 rowsep0" align="char" char=".">18.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>142</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="char" char="±">39.5 ± 6.8</td><td class="colsep0 rowsep0" align="center">1328 ± 104</td><td class="colsep0 rowsep0" align="char" char=".">33.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-(+)-pentazocine.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Affinities were determined in guinea pig brain using [<sup>3</sup>H]-DTG in the presence of (+)-SKF-10047 to block σ-1 receptors.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">The values are means ± SEM of three experiments performed in duplicate.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships</h3><div class="NLM_p">The design of the new series of pyrimidines derivatives was based on the known pharmacophoric features of σ<sub>1</sub>R ligands. As recently summarized by Glennon et al., σ<sub>1</sub>R inhibitors should contain a basic amino group and no less than two hydrophobic regions at specified distances, 2.5–3.9 and 6–10 Å from the amino group<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Compounds of the general structure (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) were designed in which the pyrimidine acted as an important scaffold and various groups added according to these pharmacophoric requirements; some variations were also considered.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glennon’s pharmacophoric σ<sub>1</sub> receptor model (A) and general structure of the new pyrimidine derivative (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Effect of the Distance between the Pyrimidine Ring and the Basic Amino Moiety</h4><div class="NLM_p">In this study, our initial focus was to investigate the effect of different chain lengths on affinities to σ<sub>1</sub>R and σ<sub>2</sub>R (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compounds <b>8</b>, <b>14</b>–<b>34</b>, <b>36</b>, and <b>38</b>). The morpholine group was used because of its frequent appearance in σ<sub>1</sub>R ligands, such as S1RA. At position 2 of the pyrimidine ring, a simple nonsubstituted phenyl was selected to meet the requirement of the pharmacophoric model.</div><div class="NLM_p last">Initially, the two-carbon linker compound <b>8</b> was prepared but did not activate either receptor; apparently the linker was too short. Increasing the linker with only one carbon atom (<b>14</b>) demonstrated binding affinity and selectivity for the σ<sub>1</sub>R over the σ<sub>2</sub>R (<i>K</i><sub>i</sub> σ<sub>1</sub> = 36.3 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 949 nM). Further elongation of the straight carbon linker between the pyrimidine scaffold and morpholine moiety provided derivatives <b>15</b>–<b>16</b>, which had lower σ<sub>1</sub>R and σ<sub>2</sub>R affinities than their propylene counterparts. Derivatives of a six-atom spacer, compound <b>17</b>, did not bind either receptor, suggesting the distance was too large for the binding site. Compared to compound <b>15</b>, replacing the single bond with a trans double bond (<b>18</b>) did not promote affinity to the σ<sub>1</sub>/σ<sub>2</sub> receptor. A five-atom linker with an intercalated oxygen atom (<b>36</b>) maintained the potency for both receptors as compound <b>16</b>. The introduction of a hydroxyl group in the linker (<b>38</b>) resulted in decreased potency for both receptors, suggesting that polar groups are not preferred in this region. Taken together, the data indicated that the distance between the pyrimidine and basic amino group affected significantly the potency of both receptors; three-carbon chain length (<b>14</b>) was the most preferred and so was further investigated.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effect of the Basic Amino Moiety for Different Amino Groups</h4><div class="NLM_p">After determining the scaffold of the phenyl pyrimidine derivatives, the effect of various basic amino moieties was investigated by synthesizing variations of compound <b>14</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, we selected piperidine, 4-methylpiperidine, 3,5-dimethylpiperidine, and 2,2,6,6-tetramethylpiperidine (compounds <b>19</b>–<b>22</b>) to replace the morpholine moiety. The substitution of morpholine with piperidine analogues resulted in compound <b>19</b>, which showed significantly improved σ<sub>1</sub>R binding affinity and selectivity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 11.8 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1051 nM). The improvement was possibly due to the greater hydrophobicity of the piperidine moiety, which was closer in similarity to Glennon’s pharmacophoric σ<sub>1</sub>R model.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Increasing the hydrophobic ability of piperidinyl by adding a methyl group on the ring (<b>20</b>–<b>21</b>) did not enhance the receptor’s binding affinity, which suggested that the space in this region was limited. The compound with 2,2,6,6-tetramethylpiperidine (<b>22</b>) showed weak affinity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 377 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> > 2000 nM) to both receptors, mainly because the four methyls formed a strong steric hindrance around the N atom, affecting the ligand–receptor interaction. Substituting the oxygen atom of the morpholino with a hydroxyl group or carbonyl group (<b>23</b>–<b>24</b>) decreased greatly the affinity to both the σ<sub>1</sub>R and σ<sub>2</sub>R, which suggested the polar groups were not conducive to σ<sub>1</sub>R or σ<sub>2</sub>R binding in this position.</div><div class="NLM_p">Changing the oxygen atom in the morpholino group to a N atom produced the piperazine derivative, compound <b>25</b>, which showed a weak receptor affinity (<i>K</i><sub>i</sub> σ<sub>1</sub> = 151 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1212 nM) and may be due to the hydrophilic property of piperazine. Substituting the hydrogen in piperazine with small alkyl groups improved the hydrophobic property and resulted in the potent and selective compounds <b>26</b>–<b>27</b> and in the larger diazepane derivative, compound <b>28</b> (<i>K</i><sub>i</sub> σ<sub>1</sub> = 18.7 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1295 nM). However, substituting with large groups, such as <i>t</i>-butyloxycarboryl (<b>29</b>) or phenyl (<b>30</b>), was not tolerated by either the σ<sub>1</sub>R or σ<sub>2</sub>R.</div><div class="NLM_p last">Smaller pyrrolidine analogues showed good potency and maintained the selectivity (<b>27</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 13.6 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1253 nM). Open-chain amines (<b>32</b>–<b>34</b>) retained some activity (albeit less than compounds <b>19</b> and <b>31</b>) and exhibited lower selectivity.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Effects of Substitution on the 4- and 5-Positions of the Pyrimidine Ring</h4><div class="NLM_p">The piperidinyl and pyrrolidinyl groups emerged as the best two amino moieties in receptor binding affinity and selectivity, and the three-carbon linker was selected as the proper distance to match the pharmacophoric requirement. Thus, compounds <b>19</b> and <b>31</b> were selected for further investigation of the SAR.</div><div class="NLM_p">We first explored the effects of replacing the methyl (R<sub>3</sub>) with other substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <b>69</b>–<b>75</b>, <b>79</b>–<b>85</b>). The affinities of compounds <b>69</b>–<b>70</b> and <b>79</b>–<b>80</b> vs compounds <b>19</b> and <b>31</b> to σ<sub>1</sub>R and σ<sub>2</sub>R decreased as a result of the additional group size or hydrophobicity. The substitution of a methyl group with isopropyl (<b>71</b>, <b>81</b>), cyclopropyl (<b>74</b>, <b>84</b>), and phenyl (<b>75</b>, <b>85</b>) groups produced a significant decrease in the affinities for the receptors, which confirmed the above-stated conclusion. On the basis of these results, the modification of the group in the 4-position (R<sub>3</sub>) of the pyrimidine produced analogues in the following order of σ<sub>1</sub>R affinities: methyl > ethyl > isopropyl > <i>n</i>-propyl > cyclopropyl > phenyl. The electron-withdrawing groups, methyloxyl (<b>72</b>, <b>82</b>) and trifluoromethyl (<b>73</b>, <b>83</b>), showed good potency for the σ<sub>1</sub>R, but weaker selectivity than the methyl group.</div><div class="NLM_p">Introduction to the 5-position (R<sub>4</sub>) in the pyrimidine scaffold with a small group (<b>76</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 9.51 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1221 nM; <b>86</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 11.4 nM and <i>K</i><sub>i</sub> σ<sub>2</sub> = 1279 nM) led to good affinity for the σ<sub>1</sub>R and maintained selectivity to the σ<sub>2</sub>R. Therefore, we continued the investigation by introducing other substituents at this position. Introducing halogens such as fluorine (<b>77</b>, <b>87</b>) and chlorine (<b>78</b>, <b>88</b>) showed moderate affinities to the σ<sub>1</sub>R and increased selectivity to the σ<sub>2</sub>R. Notably, compound <b>78</b>, with chlorine in the 5-position of the pyrimidine and piperidinyl basic moiety, showed significantly higher binding affinity to σ<sub>1</sub>R (<i>K</i><sub>i</sub> σ<sub>1</sub> = 2.33 nM) and σ<sub>1</sub>/σ<sub>2</sub> selectivity (708-fold) compared with pyrrodinyl analogues (<b>88</b>). Fluorosubstituted analogue <b>77</b> showed less selectivity (363-fold), possibly due to the hydrogen bonding effect of the fluorine atom, which was not preferred in this position.</div><div class="NLM_p last">To better explain the SAR of substitution on the pyrimidine ring, ring derivatives connecting the 4- or 5-positions were prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) as 6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidines (<b>94</b>–<b>95</b>) and 5,6,7,8-tetrahydroquinazolins (<b>97</b>–<b>98</b>), respectively. The binding affinities of these compounds showed the five-membered ring on pyrimidine could maintain the affinity to the σ<sub>1</sub>R and preferential selectivity with the piperidinyl moiety (<b>94</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 44.2 nM, <i>K</i><sub>i</sub> σ<sub>2</sub> = 1626 nM). A six-membered ring in the same position resulted in loss of activity, possibly due to the larger ring size hindering receptor binding.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Effect of Replacing the Phenyl Group on the 2-Position of the Pyrimidine Ring (<b>78</b>) with Another Aromatic Ring</h4><div class="NLM_p last">Compound <b>78</b> exhibited significant affinity to the σ<sub>1</sub>R and σ<sub>1</sub>/σ<sub>2</sub> selectivity and was thus used for further investigation of the effect of various aromatic rings (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>132</b>–<b>142</b>). The nature of the aromatic group on the 2-position was important for activity and selection. Either introducing an electron-donating group (methyl) or electron-withdrawing group (methoxyl and trifluoromethyl) would increase activity, but halogens, such as fluorine (<b>135</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 1.14 nM, <i>K</i><sub>i</sub> σ<sub>2</sub> = 1329 nM) and chlorine (<b>137</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 1.06 nM, <i>K</i><sub>i</sub> σ<sub>2</sub> = 1425 nM), showed high affinity to σ<sub>1</sub>R and good selectivity to σ<sub>2</sub>R. The 3,4-difluorophenyl (<b>136</b>) group maintained the receptor-binding profile, but 3,4-dichlorophenyl (<b>138</b>) and 2-naphthyl (<b>139</b>) were not conducive to σ<sub>1</sub> or σ<sub>2</sub> receptor binding in this position. Replacing the aromatic group at the 2-position with hydrogen (<b>140</b>) or a small alkyl such as methyl (<b>141</b>) resulted in a marked reduction in potency. Cyclopropyl (<b>142</b>, <i>K</i><sub>i</sub> σ<sub>1</sub> = 39.5 nM, <i>K</i><sub>i</sub> σ<sub>2</sub> = 1328 nM) only maintained partial potency and selectivity, thus suggesting the importance of an aromatic ring in this position.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Human Ether-a-go-go-Related Gene (hERG) KC Channel</h3><div class="NLM_p">Human ether-a-go-go-related gene (hERG) channel blockade is an important predictor of cardiac toxicity. The compounds with <i>K</i><sub>i</sub> σ<sub>1</sub> < 5 nM and selectivity >400-fold were subjected to a hERG patch-clamp assay<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. In this experiment, a cutoff value of IC<sub>50</sub> > 5 μM was used.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Additional Data for Compounds Complying with <i>K</i><sub>i</sub> σ<sub>1</sub> < 5 nmol and Selectivity >400-Fold</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">hERGIC<sub>50</sub> (μmol)</th><th class="colsep0 rowsep0" align="center">LD<sub>50</sub> (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="center">439.5 (361.0–534.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="char" char=".">3.76</td><td class="colsep0 rowsep0" align="center">>2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>132</b></td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="center">1684.2 (1500.4–1892.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>134</b></td><td class="colsep0 rowsep0" align="char" char=".">2.61</td><td class="colsep0 rowsep0" align="center">377.3 (298.8–476.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>135</b></td><td class="colsep0 rowsep0" align="char" char=".">1.54</td><td class="colsep0 rowsep0" align="center">884.5 (755.7–1162.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>136</b></td><td class="colsep0 rowsep0" align="char" char=".">1.40</td><td class="colsep0 rowsep0" align="center">584.8 (455.7–750.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>137</b></td><td class="colsep0 rowsep0" align="char" char=".">6.98</td><td class="colsep0 rowsep0" align="center">>2000</td></tr></tbody></table></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Acute Toxicity</h3><div class="NLM_p last">After considering the above-mentioned results, the compounds that exhibited high affinity to σ<sub>1</sub>R and good selectivity to σ<sub>2</sub>R, with low affinity for hERG, were assayed for acute toxicity. The acute toxicities of compounds were evaluated in terms of LD<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>137</b> showed a good profile even at the highest dose tested (LD<sub>50</sub> > 2000 mg/kg).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Functional Profile of σ<sub>1</sub> Receptor</h3><div class="NLM_p last">The phenytoin-media shift on σ<sub>1</sub>R ligand affinity and FRET based biosensor of σ<sub>1</sub>R ligand were mainly used to categorize compounds into agonists and antagonists recently.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In these work, the functional activity of compounds with high σ<sub>1</sub> receptor binding affinity and selectivity to the σ<sub>1</sub>R over the σ<sub>2</sub>R was evaluated using phenytoin, a low-potency allosteric modulator of the σ<sub>1</sub> receptor. Phenytoin shifts σ<sub>1</sub>R agonists to significantly higher affinities (<i>K</i><sub>i</sub> ratios without phenytoin vs with phenytoin >1), while σ<sub>1</sub>R antagonists show no effect or a very little effect on lowering the affinity values (<i>K</i><sub>i</sub> ratios without phenytoin vs with phenytoin ≤1). Compound <b>137</b> produced a small shift, lowering the affinity when incubated in the presence of phenytoin (<i>K</i><sub>i</sub> ratios without phenytoin vs with phenytoin = 0.87), which exhibited antagonist properties on the σ<sub>1</sub> receptor.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Formalin-Induced Nociceptive Behavior</h3><div class="NLM_p">Because of the marked effects on the σ<sub>1</sub>R and σ<sub>2</sub>R with its antagonist property and good safety profile, compound <b>137</b> was selected as a promising candidate and subjected to further pharmacological evaluation.</div><div class="NLM_p">Recent research showed that σ<sub>1</sub>R antagonists could reduce both phases of formalin-induced paw licking/biting behavior in mice.<a onclick="showRef(event, 'ref44 ref49'); return false;" href="javascript:void(0);" class="ref ref44 ref49">(44, 49)</a> As a classic model of acute and chronic pain, the formalin test was performed to evaluate the antinociceptive effect of selected compounds. Intraplantar injection of formalin solution into the hind paw produces a biphasic pain response, a brief, acute phase that indicates direct effects on pain receptors (phase I), followed by a longer-lasting tonic phase that reflects inflammation (phase II). The time spent licking or biting the paw after injection was measured as an indicator of the pain response in mice. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, pretreatment with compound <b>137</b> (80 mg/kg, ip) inhibited pain responses to a similar degree as S1RA, reducing licking and biting time to 12.65 ± 5.07 s in phase I and 37.41 ± 8.89 s in phase II. S1RA at the same dose reduced licking and biting time to 10.65 ± 3.94 and 33.16 ± 7.28 s during phase I and II, respectively; the vehicle had no effect relative to treatment with formalin alone. To better characterize the antinociceptive effects of <b>137</b>, a wide range of doses was tested (20–160 mg/kg). Compound <b>62</b> produced dose dependent antinociception in both phases; the ED<sub>50</sub> values were 48.36 ± 5.11 and 42.15 ± 3.96 mg/kg for phases I and II, respectively.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antinociceptive effect of S1RA and compound <b>137</b> in phase I (0–5 min) and phase II (15–45 min) of the mice formalin test at the dose of 80 mg/kg. Each column and vertical line represents mean ± SEM of the values obtained in at least 10 animals. Statistically significant differences: <sup>##</sup><i>p</i> < 0.01 vs vehicle; ** <i>p</i> < 0.01 vs vehicle + formalin (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> CCI Model</h3><div class="NLM_p">Compound <b>137</b> was evaluated in a representative and frequently used model of neuropathic pain, the CCI model in rats. Chronic constriction injury results in the development of allodynia-like behavior, hyperalgesia, and spontaneous pain-like behavior, which are normally maximal 10–14 days after surgery.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> CCI rats exhibited signs of allodynia to mechanical stimulation and hyperalgesia to thermal stimulation, which were used as outcome measures of neuropathic pain. Mechanical allodynia was quantified by measuring the hind paw withdrawal response to von Frey hair stimulation, while thermal (heat) hyperalgesia was assessed using a plantar test by measuring hind paw withdrawal latency in response to radiant heat.</div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, compound <b>137</b> dose-dependently inhibited mechanical allodynia and thermal hypersensitivity, both in single dose treatment (day 15) and repeated dose treatment (day 18), while sham operated rats did not induce significant changes in mechanical and thermal sensitivity respect to rats before surgery (basal). The ED<sub>50</sub> values of single dose treatment on mechanical allodynia and thermal hypersensitivity were 58.25 ± 6.04 and 47.23 ± 3.87 mg/kg, respectively. In repeated dose treatment, the ED<sub>50</sub> values of mechanical allodynia and thermal hypersensitivity were 61.82 ± 6.15 and 50.21 ± 5.07 mg/kg, respectively.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antinociceptive effects of compound <b>137</b> on the expression of neuropathic pain in CCI and sham operated rats. Date obtained from 10 rats per group and expressed as mean ± SEM pressure threshold (g) evoking paw withdrawal or latency (s) to paw withdrawal. Statistically significant differences between the rats before surgery (basal) and surgery groups: * <i>p</i> < 0.05, ** <i>p</i> < 0.01 VS basal; <sup>#</sup><i>p</i> < 0.05; <sup>##</sup><i>p</i> < 0.01 vs vehicle treatment on day 14 (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Motor Coordination: Rotarod Test</h3><div class="NLM_p">To investigate the possibility that the observed efficacy of compound <b>137</b> could interfere with motor coordination and thus with the response of mice in the nociceptive and neuropathic pain-related behavioral tests, motor performance was measured in the rotarod test.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, no significant effect of compound <b>137</b> at an analgesic dose was observed and no treatment-related adverse effects were found. In contrast, an analgesic dose of pregabalin induced obvious motor impairment.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0008.jpeg" id="GRAPHIC-d1002e3524-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response effect of compound <b>137</b> and pregabalin on motor coordination (rotarod test). Date obtained from 8–10 mice per group and expressed as mean ± SEM latency (s) to fall down from rod. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01 vs vehicle (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacokinetic Properties of Compound <b>137</b></h3><div class="NLM_p">The evaluated pharmacokinetic properties of compound <b>137</b> included the in vitro and in vivo efficacy and the degree of safety, as characterized in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Plasma Pharmacokinetic Data Following the Administration of Compound <b>137</b> in Rats (<i>n</i> = 8/Group)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–24h</sub> (ng × h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–inf</sub> (ng × h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv 16</td><td class="colsep0 rowsep0" align="char" char=".">7261.45</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">10.57</td><td class="colsep0 rowsep0" align="char" char=".">3295.31</td><td class="colsep0 rowsep0" align="char" char=".">3686.17</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po 320</td><td class="colsep0 rowsep0" align="char" char=".">17394.90</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">3.81</td><td class="colsep0 rowsep0" align="char" char=".">54672.61</td><td class="colsep0 rowsep0" align="char" char=".">55393.45</td><td class="colsep0 rowsep0" align="char" char=".">75.1</td></tr></tbody></table></div></div><div class="NLM_p last">Intravenous administration of compound <b>137</b> to rats (16 mg/kg, <i>n</i> = 8) resulted in detectable plasma levels, with a half-life (<i>t</i><sub>1/2</sub>) of 10.57 h. Oral administration of compound <b>137</b> to rats (320 mg/kg, <i>n</i> = 8) resulted in a <i>t</i><sub>1/2</sub> of 3.81 h. The area under the curve (AUC) value of compound <b>137</b> was 3295.31 ng × h/mL after intravenous administration vs 54672.61 ng × h/mL after oral administration. After oral administration of 320 mg/mL, compound <b>137</b> achieved a peak concentration of 17394.90 ng/mL; the <i>T</i><sub>max</sub> value was 0.5 h. The bioavailability of compound <b>137</b> was 75.1%. These encouraging preclinical data suggested that compound <b>137</b> possessed desirable drug-like human pharmacokinetic properties.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Selectivity Profile of Compound <b>137</b></h3><div class="NLM_p last">To assess the interaction of compound <b>137</b> with other receptors or ion channels, a selectivity profile for additional receptors (such as μ-opioid, serotoninergic, H<sub>3</sub>, cannabinoid, NMDA receptors, et. al) and ion channels (voltage-gated sodium channel Nav 1.7 and TRPV-1 protein) that implicated in pain was performed. Compound <b>137</b> showed no significant affinity (% inhibition at 1 μM < 50%) to these targets, as shown in <a class="ref internalNav" href="#notes-2" aria-label="part S2 in Support Information">part S2 in Support Information</a>.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A detailed structure–activity relationship investigation of pyrimidine scaffold derivatives has shown that several factors influence the binding affinity of these compounds to σ<sub>1</sub> and σ<sub>2</sub> receptors.</div><div class="NLM_p">Pyrimidine scaffold was crucial for activity, and a basic amine was necessary matching the known σ<sub>1</sub>R pharmacophoric model. A straight three-carbon chain alkyl between the pyrimidine ring and the amino moiety was preferred over other linkers. The substitution on the 4-position (R<sub>3</sub>) with a small alkyl group was preferred, and methyl was the favored substituent. The introduction of a halogen (chloro) on the 5-position (R<sub>4</sub>) showed moderate affinities to σ<sub>1</sub>R and increased selectivity to σ<sub>2</sub>R. An aromatic group on the 2-position of the pyrimidine ring was essential for activity, and 4-chlorophenyl was favored.</div><div class="NLM_p last">From the SAR study, a series of 2-arylpyrimides were synthesized, several of which were shown to be potent and selective σ<sub>1</sub>R ligands. The most promising compound, <b>137</b>, showed high affinity to σ<sub>1</sub> receptor, low affinity to σ<sub>2</sub> and hERG channels, and was identified as a σ<sub>1</sub>R antagonist. Compound <b>137</b> exerted clear dose-dependent analgesic effects on the mice formalin-induced pain model and antinociception on both mechanical allodynia and thermal hypersensitivity in the rat CCI model. Moreover, compound <b>137</b> exhibited good safety, acceptable pharmacokinetic properties, and good selective profile to other specific targets that have been implicated in pain. Thus, compound <b>137</b> may facilitate the development of a novel class of drugs for the treatment of neuropathic pain. Further studies of compound <b>137</b> and evaluation of these series of derivatives are currently underway in our laboratory and will be reported in due course.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p">Melting points were determined in open capillary tubes and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance III 600 spectrometer at 600 MHz (<sup>1</sup>H) and 150 MHz (<sup>13</sup>C) using CDCl<sub>3</sub> as solvent. Chemical shifts are given in δ values (ppm), using tetramethylsilane (TMS) as the internal standard; coupling constants (<i>J</i>) are given in Hz. Signal multiplicities are characterized as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad signal). Commercial reagents and solvents were all of analytical grade or of chemical purity (>99%). Analytical thin layer chromatography (TLC) was performed on silica gel GF254. Column chromatographic purification was carried out using silica gel. Purity analysis was carried out by LC-MS analysis using an Agilent 1200 system. The HPLC conditions are as follows: column, ZORBAX BP-C18 5.0 μm × 150 mm × 4.6 mm I.D. (Agilent, USA); mobile phase, 30 mmol of NH<sub>4</sub>COOH (Roe Scientific Inc., USA) aq/acetonitrile (Merck Company, Germany), 30/70; flow rate, 1.0 mL/min; column temperature, 40 °C. Compound purity is determined by high performance liquid chromatography (HPLC), and all final test compounds display purity higher than 95% as determined by this method.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Methyl-2-phenylpyrimidin-4-ol (<b>7</b>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></h4><div class="NLM_p last">To a suspension of benzimidamide hydrochloride (<b>5</b>, 50 mmol) and ethyl 3-oxobutanoate (<b>6</b>, 55 mmol) in MeOH (200 mL) was added <i>t</i>-BuOK (10 mmol) portionwise with stirring at 0 °C for 30 min. The resulting mixture was heated to reflux for 4 h and then cooled down to room temperature. After that, ice–water (200 mL) was added and neutralized with citric acid. The precipitate thus formed was filtered and washed with water. The crude residue obtained was recrystallized from <i>i</i>-PrOH to give 6-methyl-2-phenylpyrimidin-4-ol, <b>7</b>, as a white solid (6.8 g, 73.0%), mp 220–222 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.65 (s, 1H), 8.22–8.10 (m, 2H), 7.67–7.50 (m, 3H), 6.30 (s, 1H), 2.40 (s, 3H).</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Procedures for the Synthesis of 6-Methyl-2-phenylpyrimidinyl Derivatives (<b>8</b> and <b>14</b>–<b>34</b>)</h4><div id="sec6_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Method A: 4-(2-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)ethyl)morpholine (<b>8</b>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h5><div class="NLM_p last">To a suspension of <b>7</b> (10 mmol) and 4-(2-chloroethyl) morpholine (10 mmol) in acetonitrile (100 mL), potassium carbonate (20 mmol) and a catalytic amount of potassium iodide (1% mol) were added. The resulting mixture was heated and refluxed for 6–8 h. The progress of the reaction was monitored by TLC. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 4-(2-((6-methyl-2-phenylpyrimidin-4-yl)oxy)ethyl)morpholine, <b>8</b>, as a pale-yellow oil (2.42 g, 80.9%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.40 (m, 2H), 7.48–7.41 (m, 3H), 6.48 (s, 1H), 4.61 (t, <i>J</i> = 5.8 Hz, 2H), 3.71 (t, <i>J</i> = 4.6 Hz, 4H), 2.81 (t, <i>J</i> = 5.8 Hz, 2H), 2.57–2.51 (m, 4H), 2.48 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 300.3 (calcd 300.2 for C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Method B: 4-(3-Bromopropoxy)-6-methyl-2-phenylpyrimidine (<b>9</b>)</h5><div class="NLM_p last">To a solution of <b>7</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 50/1) to yield 4-(3-bromopropoxy)-6-methyl-2-phenylpyrimidine, <b>9</b>, as a pale-yellow oil (1.92 g, 62.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.38 (m, 2H), 7.48–7.43 (m, 3H), 6.45 (s, 1H), 4.61 (t, <i>J</i> = 6.0 Hz, 2H), 3.57 (t, <i>J</i> = 6.5 Hz, 2H), 2.49 (s, 3H), 2.38–2.32 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 308.3 (calcd 308.2 for C<sub>14</sub>H<sub>15</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 4-(4-Bromobutoxy)-6-methyl-2-phenylpyrimidine (<b>10</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.03 g, 63.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.39 (m, 2H), 7.49–7.41 (m, 3H), 6.42 (s, 1H), 4.47 (t, <i>J</i> = 6.2 Hz, 2H), 3.46 (t, <i>J</i> = 6.6 Hz, 2H), 2.47 (s, 3H), 2.09–1.86 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 322.6 (calcd 322.2 for C<sub>15</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 4-((5-Bromopentyl)oxy)-6-methyl-2-phenylpyrimidine (<b>11</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.96 g, 58.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.37 (m, 2H), 7.49–7.38 (m, 3H), 6.41 (s, 1H), 4.43 (t, <i>J</i> = 6.6 Hz, 2H), 3.39 (t, <i>J</i> = 6.8 Hz, 2H), 2.46 (s, 3H), 1.95–1.73 (m, 4H), 1.67–1.51 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 336.4 (calcd 336.2 for C<sub>16</sub>H<sub>19</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4-((6-Bromohexyl)oxy)-6-methyl-2-phenylpyrimidine (<b>12</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.98 g, 56.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.36 (m, 2H), 7.53–7.40 (m, 3H), 6.45 (s, 1H), 4.47 (t, <i>J</i> = 6.6 Hz, 2H), 3.42 (t, <i>J</i> = 6.8 Hz, 2H), 2.49 (s, 3H), 1.95–1.76 (m, 4H), 1.60–1.43 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 350.1 (calcd 350.3 for C<sub>17</sub>H<sub>21</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>E</i>)-4-((4-Bromobut-2-en-1-yl)oxy)-6-methyl-2-phenylpyrimidine (<b>13</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.13 g, 67.0%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.35 (m, 2H), 7.50–7.40 (m, 3H), 6.45 (s, 1H), 6.16–5.94 (m, 2H), 4.98 (d, <i>J</i> = 5.3 Hz, 2H), 3.95 (d, <i>J</i> = 7.1 Hz, 2H), 2.47 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 320.3 (calcd 320.2 for C<sub>15</sub>H<sub>15</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-(3-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)propyl)morpholine (<b>14</b>)</h5><div class="NLM_p last">To a suspension of <b>9</b> (5 mmol) and morpholine (5.5 mmol) in acetonitrile (100 mL), cesium carbonate (10 mmol) was added, and the resulting mixture was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product was purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 4-(3-((6-methyl-2-phenylpyrimidin-4-yl)oxy)propyl)morpholine, <b>14</b>, as a pale-yellow oil (1.43 g, 91.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.41 (m, 2H), 7.45–7.40 (m, 3H), 6.44 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 3.71 (t, <i>J</i> = 4.6 Hz, 4H), 2.57–2.39 (m, 9H), 2.05–1.94 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 314.6 (calcd 314.4 for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4-(4-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)butyl)morpholine (<b>15</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.48 g, 90.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.41 (m, 2H), 7.46–7.41 (m, 3H), 6.44 (s, 1H), 4.49 (t, <i>J</i> = 6.5 Hz, 2H), 3.70 (t, <i>J</i> = 4.6 Hz, 4H), 2.48 (s, 3H), 2.45–2.38 (m, 6H), 1.88–1.80 (m, 2H), 1.71–1.63 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 328.8 (calcd 328.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-(5-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)pentyl)morpholine (<b>16</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.50 g, 88.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.38 (m, 2H), 7.46–7.40 (m, 3H), 6.45 (s, 1H), 4.48 (t, <i>J</i> = 6.6 Hz, 2H), 3.71 (t, <i>J</i> = 4.5 Hz, 4H), 2.49 (s, 3H), 2.40–2.33 (m, 6H), 1.86–1.82 (m, 2H), 1.63–1.54 (m, 2H), 1.53–1.46 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 342.7 (calcd 342.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-(6-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)hexyl)morpholine (<b>17</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.58 g, 89.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.41 (m, 2H), 7.48–7.42 (m, 3H), 6.44 (s, 1H), 4.46 (t, <i>J</i> = 6.6 Hz, 2H), 3.71 (t, <i>J</i> = 4.6 Hz, 4H), 2.49 (s, 3H), 2.42–2.32 (m, 6H), 1.85–1.77 (m, 2H), 1.53–1.49 (m, 4H), 1.44–1.32 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 356.8 (calcd 356.5 for C<sub>21</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (<i>E</i>)-4-(4-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)but-2-en-1-yl)morpholine (<b>18</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.41 g, 86.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.39 (m, 2H), 7.49–7.42 (m, 3H), 6.46 (s, 1H), 5.97–5.83 (m, 2H), 4.98 (d, <i>J</i> = 4.2 Hz, 2H), 3.65 (t, <i>J</i> = 4.6 Hz, 4H), 3.01 (d, <i>J</i> = 4.9 Hz, 2H), 2.48 (s, 3H), 2.45–2.38 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 326.5 (calcd 326.4 for C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-Methyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>19</b>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h5><div class="NLM_p last">A yellow oil (1.42 g, 91.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.37 (m, 2H), 7.47–7.41 (m, 3H), 6.44 (s, 1H), 4.50 (t, <i>J</i> = 6.5 Hz, 2H), 2.53–2.34 (m, 9H), 2.04–1.96 (m, 2H), 1.64–1.55 (m, 4H), 1.46–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 312.6 (calcd 312.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-Methyl-6-(3-(4-methylpiperidin-1-yl)propoxy)-2-phenylpyrimidine (<b>20</b>)</h5><div class="NLM_p last">A yellow oil (1.40 g, 86.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.36 (m, 2H), 7.54–7.41 (m, 3H), 6.43 (s, 1H), 4.50 (t, <i>J</i> = 6.5 Hz, 2H), 2.93–2.85 (m, 2H), 2.51–2.45 (m, 5H), 2.05–1.96 (m, 2H), 1.95–1.87 (m, 2H), 1.62–1.58 (m, 2H), 1.39–1.30 (m, 1H), 1.28–1.21 (m, 2H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 326.6 (calcd 326.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-(3-(3,5-Dimethylpiperidin-1-yl)propoxy)-6-methyl-2-phenylpyrimidine (<b>21</b>)</h5><div class="NLM_p last">A yellow oil (1.42 g, 83.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.38 (m, 2H), 7.50–7.40 (m, 3H), 6.43 (s, 1H), 4.50 (t, <i>J</i> = 6.5 Hz, 2H), 2.89–2.83 (m, 2H), 2.53–2.42 (m, 5H), 2.07–1.96 (m, 2H), 1.75–1.61 (m, 4H), 1.42 (t, <i>J</i> = 10.9 Hz, 2H), 0.84 (d, <i>J</i> = 6.5 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 340.8 (calcd 340.5 for C<sub>21</sub>H<sub>29</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 4-Methyl-2-phenyl-6-(3-(2,2,6,6-tetramethylpiperidin-1-yl)propoxy)pyrimidine (<b>22</b>)</h5><div class="NLM_p last">A yellow oil (1.63 g, 88.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.41 (m, 2H), 7.53–7.42 (m, 3H), 6.44 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.53–2.42 (m, 5H), 2.07–1.96 (m, 2H), 1.66–1.48 (m, 4H), 1.49–1.33 (m, 2H), 0.76 (s, 12H). MS (ESI) <i>m</i>/<i>z</i> 368.3 (calcd 368.5 for C<sub>23</sub>H<sub>33</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 1-(3-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)propyl)piperidin-4-ol (<b>23</b>)</h5><div class="NLM_p last">A yellow oil (1.35 g, 82.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.38 (m, 2H), 7.48–7.43 (m, 3H), 6.45 (s, 1H), 4.50 (t, <i>J</i> = 6.4 Hz, 2H), 3.66 (s, 1H), 2.84–2.74 (m, 2H), 2.67–2.43 (m, 6H), 2.18–2.07 (m, 2H), 2.03–1.96 (m, 2H), 1.92–1.83 (m, 2H), 1.63–1.54 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 328.8 (calcd 328.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 1-(3-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)propyl)piperidin-4-one (<b>24</b>)</h5><div class="NLM_p last">A yellow oil (1.30 g, 80.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.38 (m, 2H), 7.47–7.43 (m, 3H), 6.46 (s, 1H), 4.56 (t, <i>J</i> = 6.4 Hz, 2H), 2.76 (t, <i>J</i> = 6.1 Hz, 4H), 2.63 (t, <i>J</i> = 7.2 Hz, 2H), 2.51–2.43 (m, 7H), 2.06–1.97 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 326.7 (calcd 326.4 for C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-Methyl-2-phenyl-6-(3-(piperazin-1-yl)propoxy)pyrimidine (<b>25</b>)</h5><div class="NLM_p last">A yellow oil (1.22 g, 78.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.38 (m, 2H), 7.50–7.42 (m, 3H), 6.44 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.94–2.08 (m, 14H), 2.03–1.97 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 313.6 (calcd 313.4 for C<sub>18</sub>H<sub>24</sub>N<sub>4</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 4-Methyl-6-(3-(4-methylpiperazin-1-yl)propoxy)-2-phenylpyrimidine (<b>26</b>)</h5><div class="NLM_p last">A yellow oil (1.47 g, 90.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.39 (m, 2H), 7.47–7.42 (m, 3H), 6.44 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.94–2.10 (m, 16H), 2.03–1.97 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 327.6 (calcd 327.4 for C<sub>19</sub>H<sub>26</sub>N<sub>4</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-(3-(4-Ethylpiperazin-1-yl)propoxy)-6-methyl-2-phenylpyrimidine (<b>27</b>)</h5><div class="NLM_p last">A yellow oil (1.48 g, 87.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.40 (m, 2H), 7.46–7.41 (m, 3H), 6.44 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.95–2.17 (m, 15H), 2.02–1.96 (m, 2H), 1.08 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 341.4 (calcd 341.5 for C<sub>20</sub>H<sub>28</sub>N<sub>4</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 1-Methyl-4-(3-((6-methyl-2-phenylpyrimidin-4-yl)oxy)propyl)-1,4-diazepane (<b>28</b>)</h5><div class="NLM_p last">A yellow oil (1.49 g, 87.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.40 (m, 2H), 7.48–7.43 (m, 3H), 6.45 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 2.85–2.28 (m, 15H), 2.02–1.94 (m, 2H), 1.86–1.80 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 341.7 (calcd 341.5 for C<sub>20</sub>H<sub>28</sub>N<sub>4</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 4-(3-(4-Boc-piperazin-1-yl)propoxy)-6-methyl-2-phenylpyrimidine (<b>29</b>)</h5><div class="NLM_p last">A yellow oil (1.75 g, 85.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.38 (m, 2H), 7.48–7.42 (m, 3H), 6.44 (s, 1H), 4.52 (t, <i>J</i> = 6.4 Hz, 2H), 3.44 (s, 4H), 2.57–2.46 (m, 5H), 2.46–2.24 (m, 4H), 2.02–1.97 (m, 2H), 1.46 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 413.7 (calcd 413.5 for C<sub>23</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 4-Methyl-2-phenyl-6-(3-(4-phenylpiperazin-1-yl)propoxy)pyrimidine (<b>30</b>)</h5><div class="NLM_p last">A yellow oil (1.71 g, 88.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.41 (m, 2H), 7.48–7.44 (m, 3H), 7.29–7.24 (m, 2H), 6.96–6.91 (m, 2H), 6.88–6.82 (m, 1H), 6.46 (s, 1H), 4.56 (t, <i>J</i> = 6.4 Hz, 2H), 3.28–3.15 (m, 4H), 2.68–2.62 (m, 4H), 2.61–2.56 (m, 2H), 2.49 (s, 3H), 2.08–2.02 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 389.2 (calcd 389.5 for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4-Methyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>31</b>)</h5><div class="NLM_p last">A pale-red oil (1.36 g, 91.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.40 (m, 2H), 7.46–7.43 (m, 3H), 6.45 (s, 1H), 4.53 (t, <i>J</i> = 6.5 Hz, 2H), 2.66–2.60 (m, 2H), 2.57–2.51 (m, 4H), 2.48 (s, 3H), 2.07–2.01 (m, 2H), 1.82–1.76 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 298.8 (calcd 289.4 for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>,<i>N</i>-Dimethyl-3-((6-methyl-2-phenylpyrimidin-4-yl)oxy)propan-1-amine (<b>32</b>)</h5><div class="NLM_p last">A yellow oil (1.05 g, 77.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.41 (m, 2H), 7.44–7.41 (m, 3H), 6.41 (s, 1H), 4.48 (t, <i>J</i> = 6.5 Hz, 2H), 2.46–2.40 (m, 5H), 2.23 (s, 6H), 1.99–1.91 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 272.6 (calcd 272.4 for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>,<i>N</i>-Diethyl-3-((6-methyl-2-phenylpyrimidin-4-yl)oxy)propan-1-amine (<b>33</b>)</h5><div class="NLM_p last">A yellow oil (1.13 g, 76.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.41 (m, 2H), 7.50–7.43 (m, 3H), 6.45 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.64–2.59 (m, 2H), 2.58–2.52 (m, 4H), 2.48 (s, 3H), 2.00–1.92 (m, 2H), 1.03 (t, <i>J</i> = 7.2 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 300.2 (calcd 300.4 for C<sub>18</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 3-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)-<i>N</i>,<i>N</i>-dipropylpropan-1-amine (<b>34</b>)</h5><div class="NLM_p last">A yellow oil (1.31 g, 80.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.38 (m, 2H), 7.48–7.43 (m, 3H), 6.45 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.63–2.57 (m, 2H), 2.49 (s, 3H), 2.42–2.36 (m, 4H), 1.99–1.91 (m, 2H), 1.51–1.41 (m, 4H), 0.87 (t, <i>J</i> = 7.4 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 328.5 (calcd 328.5 for C<sub>20</sub>H<sub>29</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div></div><div id="sec6_1_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(2-(2-Bromoethoxy)ethoxy)-6-methyl-2-phenylpyrimidine (<b>35</b>)</h4><div class="NLM_p last">To a solution of <b>7</b> (10 mmol) and 1-bromo-2-(2-bromoethoxy)ethane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol), and a catalytic amount of potassium iodide (1% mol) were added. The mixture was refluxed for 4–6 h, and the progress was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 100/1 to 50/1) to yield 4-(2-(2-bromoethoxy)ethoxy)-6-methyl-2-phenylpyrimidine, <b>35</b>, as a pale-yellow oil (1.85 g, 54.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.36 (m, 2H), 7.50–7.40 (m, 3H), 6.50 (s, 1H), 4.64 (t, <i>J</i> = 6.4 Hz, 2H), 3.88 (t, <i>J</i> = 6.3 Hz, 2H), 3.84 (t, <i>J</i> = 6.3 Hz, 2H), 3.47 (t, <i>J</i> = 6.3 Hz, 2H), 2.48 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 338.1 (calcd 338.2 for C<sub>15</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(2-(2-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)ethoxy)ethyl)morpholine (<b>36</b>)</h4><div class="NLM_p last">To a suspension of <b>35</b> (5 mmol) and morpholine (5.5 mmol) in acetonitrile (100 mL), cesium carbonate (10 mmol) was added and the resulting mixture was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 4-(2-(2-((6-methyl-2-phenylpyrimidin-4-yl)oxy)ethoxy)ethyl)morpholine, <b>36</b>, as a pale-yellow oil (1.49 g, 86.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.38 (m, 2H), 7.50–7.40 (m, 3H), 6.50 (s, 1H), 4.65 (t, <i>J</i> = 6.6 Hz, 2H), 3.88–3.79 (m, 2H), 3.72–3.66 (m, 6H), 2.62–2.56 (m, 2H), 2.49–2.39 (m, 7H). MS (ESI) <i>m</i>/<i>z</i> 344.7 (calcd 344.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-Methyl-6-(oxiran-2-ylmethoxy)-2-phenylpyrimidine (<b>37</b>)</h4><div class="NLM_p last">To a suspension of <b>7</b> (10 mmol) and 2-(chloromethyl)oxirane (11 mmol) in acetonitrile (100 mL), potassium carbonate (20 mmol) and a catalytic amount of potassium iodide (1% mol) were added. The resulting mixture was heated and refluxed for 4–6 h, and the progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 40/1) to yield 4-methyl-6-(oxiran-2-ylmethoxy)-2-phenylpyrimidine, <b>37</b>, as a pale-yellow oil (1.77 g, 71.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.24 (m, 2H), 7.43–7.33 (m, 3H), 6.44 (s, 1H), 4.82–4.14 (m, 2H), 3.40–3.22 (m, 1H), 2.91–2.60 (m, 2H), 2.42 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 243.5 (calcd 243.3 for C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-((6-Methyl-2-phenylpyrimidin-4-yl)oxy)-3-morpholinopropan-2-ol (<b>38</b>)</h4><div class="NLM_p last">A mixture of <b>37</b> and (5 mmol) and morpholine (5.5 mmol) in MeOH was stirred and heated to reflux for 6–8 h. The solvent was evaporated under reduced pressure, and the crude product was purified by means of chromatography (petroleum ether/EtOAc = 10/1 to EtOAc) to yield 1-((6-methyl-2-phenylpyrimidin-4-yl)oxy)-3-morpholinopropan-2-ol, <b>38</b>, as a yellow oil (0.83 g, 50.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.35 (m, 2H), 7.51–7.46 (m, 3H), 6.53 (s, 1H), 4.35–4.26 (m, 2H), 4.12–4.08 (m, 2H), 3.85–3.64 (m, 6H), 2.57–2.54 (m, 4H), 2.51 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 330.4 (calcd 330.4 for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> General Procedures for the Synthesis of 2-Phenylpyrimidinyl Derivatives (<b>49</b>–<b>58</b>).<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57 ref58 ref59">(53-59)</a></h4><div id="sec6_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 6-Ethyl-2-phenylpyrimidin-4-ol (<b>49</b>)</h5><div class="NLM_p last">To a suspension of benzimidamide hydrochloride (<b>5</b>, 50 mmol) and ethyl 3-oxopentanoate (<b>39</b>, 55 mmol) in MeOH (200 mL) was added <i>t</i>-BuOK (10 mmol) portionwise, with stirring, at 0 °C for 30 min. The resulting mixture was heated to reflux for 4 h and then cooled down to room temperature. After that, ice–water (200 mL) was added and neutralized with citric acid. The precipitate thus formed was filtered and washed with water. The crude residue obtained was recrystallized from <i>i</i>-PrOH to give 6-ethyl-2-phenylpyrimidin-4-ol, <b>49</b>, as a white solid (7.60 g, 75.9%), mp 166–168 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.15 (s, 1H), 8.33–8.12 (m, 2H), 7.63–7.45 (m, 3H), 6.31 (s, 1H), 2.67 (q, <i>J</i> = 7.5 Hz, 2H), 1.30 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec6_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 2-Phenyl-6-propylpyrimidin-4-ol (<b>50</b>)</h5><div class="NLM_p last">A white solid (8.20 g, 76.7%), mp 145–147 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.84 (s, 1H), 8.26–8.15 (m, 2H), 7.66–7.48 (m, 3H), 6.29 (s, 1H), 2.61 (t, <i>J</i> = 7.6 Hz, 2H), 1.86–1.73 (m, 2H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H).</div></div><div id="sec6_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 6-Isopropyl-2-phenylpyrimidin-4-ol (<b>51</b>)</h5><div class="NLM_p last">A white solid (8.37 g, 78.2%), mp 133–136 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.16 (s, 1H), 8.36–8.16 (m, 2H), 7.67–7.43 (m, 3H), 6.31 (s, 1H), 3.00–2.71 (m, 1H), 1.30 (d, <i>J</i> = 6.9 Hz, 6H).</div></div><div id="sec6_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 6-Methoxy-2-phenylpyrimidin-4-ol (<b>52</b>)</h5><div class="NLM_p last">A white solid (7.31 g, 72.3%), mp 112–115 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.24 (s, 1H), 8.38–8.12 (m, 2H), 7.67–7.49 (m, 3H), 6.59 (s, 1H), 3.52 (s, 3H).</div></div><div id="sec6_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 2-Phenyl-6-(trifluoromethyl)pyrimidin-4-ol (<b>53</b>)</h5><div class="NLM_p last">A white solid (9.46 g, 78.8%), mp 107–110 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.78 (s, 1H), 8.45–8.13 (m, 2H), 7.89–7.47 (m, 3H), 6.84 (s, 1H).</div></div><div id="sec6_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 6-Cyclopropyl-2-phenylpyrimidin-4-ol (<b>54</b>)</h5><div class="NLM_p last">A white solid (8.41 g, 79.2%), mp 181–183 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.93 (s, 1H), 8.39–8.02 (m, 2H), 7.65–7.42 (m, 3H), 6.33 (s, 1H), 2.00–1.74 (m, 1H), 1.35–1.13 (m, 2H), 1.08–0.86 (m, 2H).</div></div><div id="sec6_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 2,6-Diphenylpyrimidin-4-ol (<b>55</b>)</h5><div class="NLM_p last">A white solid (9.98 g, 80.4%), mp 285–288 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.50 (s, 1H), 8.28–8.20 (m, 2H), 8.17–8.09 (m, 2H), 7.68–7.45 (m, 6H), 6.89 (s, 1H).</div></div><div id="sec6_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 5,6-Dimethyl-2-phenylpyrimidin-4-ol (<b>56</b>)</h5><div class="NLM_p last">A white solid (7.44 g, 74.3%), mp 157–160 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.36 (s, 1H), 8.40–8.14 (m, 2H), 7.65–7.40 (m, 3H), 2.41 (s, 3H), 2.13 (s, 3H).</div></div><div id="sec6_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 5-Fluoro-6-methyl-2-phenylpyrimidin-4-ol (<b>57</b>)</h5><div class="NLM_p last">A white solid (7.18 g, 70.3%), mp 148–151 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.13 (s, 1H), 8.34–7.97 (m, 2H), 7.67–7.44 (m, 3H), 2.43 (s, 3H).</div></div><div id="sec6_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 5-Chloro-6-methyl-2-phenylpyrimidin-4-ol (<b>58</b>)</h5><div class="NLM_p last">A white solid (7.88 g, 71.4%), mp 166–169 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.86 (s, 1H), 8.27–7.95 (m, 2H), 7.70–7.37 (m, 2H), 2.55 (s, 3H).</div></div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> General Procedures for the Synthesis of 2-Phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine Derivatives (<b>59</b>–<b>78</b>)</h4><div id="sec6_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 4-(3-Bromopropoxy)-6-ethyl-2-phenylpyrimidine (<b>59</b>)</h5><div class="NLM_p last">To a solution of <b>49</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 50/1) to yield 4-(3-bromopropoxy)-6-ethyl-2-phenylpyrimidine, <b>59</b>, as a pale-yellow oil (1.95 g, 60.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.49–8.40 (m, 2H), 7.49–7.43 (m, 3H), 6.46 (s, 1H), 4.62 (t, <i>J</i> = 6.0 Hz, 2H), 3.58 (t, <i>J</i> = 6.5 Hz, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.42–2.31 (m, 2H), 1.33 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 322.4 (calcd 322.2 for C<sub>15</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 4-(3-Bromopropoxy)-2-phenyl-6-propylpyrimidine (<b>60</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.08 g, 62.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.49–8.40 (m, 2H), 7.49–7.43 (m, 3H), 6.46 (s, 1H), 4.62 (t, <i>J</i> = 6.0 Hz, 2H), 3.58 (t, <i>J</i> = 6.5 Hz, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.42–2.31 (m, 2H), 1.33 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 336.4 (calcd 336.2 for C<sub>16</sub>H<sub>19</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 4-(3-Bromopropoxy)-6-isopropyl-2-phenylpyrimidine (<b>61</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.03 g, 60.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.53–8.36 (m, 2H), 7.49–7.42 (m, 3H), 6.46 (s, 1H), 4.61 (t, <i>J</i> = 6.0 Hz, 2H), 3.57 (t, <i>J</i> = 6.5 Hz, 2H), 3.05–2.89 (m, 1H), 2.43–2.27 (m, 2H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 336.7 (calcd 336.2 for C<sub>16</sub>H<sub>19</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 4-(3-Bromopropoxy)-6-methoxy-2-phenylpyrimidine (<b>62</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.88 g, 58.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.36 (m, 2H), 7.48–7.42 (m, 3H), 6.75 (s, 1H), 4.62 (t, <i>J</i> = 6.0 Hz, 2H), 3.57 (t, <i>J</i> = 6.5 Hz, 2H), 3.50 (s, 3H), 2.39–2.31 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 324.5 (calcd 324.2 for C<sub>14</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 4-(3-Bromopropoxy)-2-phenyl-6-(trifluoromethyl)pyrimidine (<b>63</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.22 g, 61.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.40 (m, 2H), 7.55–7.38 (m, 3H), 6.88 (s, 1H), 4.66 (t, <i>J</i> = 6.0 Hz, 2H), 3.56 (t, <i>J</i> = 6.4 Hz, 2H), 2.42–2.31 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 362.6 (calcd 362.2 for C<sub>14</sub>H<sub>12</sub>BrF<sub>3</sub>N<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 4-(3-Bromopropoxy)-6-cyclopropyl-2-phenylpyrimidine (<b>64</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.13 g, 63.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.31 (m, 2H), 7.48–7.41 (m, 3H), 6.46 (s, 1H), 4.61 (t, <i>J</i> = 6.0 Hz, 2H), 3.59 (t, <i>J</i> = 6.5 Hz, 2H), 2.43–2.30 (m, 2H), 2.02–1.91 (m, 1H), 1.24–1.21 (m, 2H), 1.05–1.01 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 334.1 (calcd 334.2 for C<sub>16</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 4-(3-Bromopropoxy)-2,6-diphenylpyrimidine (<b>65</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.44 g, 66.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.64–8.51 (m, 2H), 8.22–8.14 (m, 2H), 7.53–7.47 (m, 6H), 7.02 (s, 1H), 4.70 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.5 Hz, 2H), 2.47–2.37 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 370.2 (calcd 370.3 for C<sub>19</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 4-(3-Bromopropoxy)-5,6-dimethyl-2-phenylpyrimidine (<b>66</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.90 g, 59.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.34 (m, 2H), 7.52–7.36 (m, 3H), 4.62 (t, <i>J</i> = 6.0 Hz, 2H), 3.59 (t, <i>J</i> = 6.6 Hz, 2H), 2.49 (s, 3H), 2.43–2.34 (m, 2H), 2.13 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 322.6 (calcd 322.2 for C<sub>15</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 4-(3-Bromopropoxy)-5-fluoro-6-methyl-2-phenylpyrimidine (<b>67</b>)</h5><div class="NLM_p last">A pale-yellow oil (1.95 g, 60.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.42–8.26 (m, 2H), 7.51–7.40 (m, 3H), 4.70 (t, <i>J</i> = 6.0 Hz, 2H), 3.61 (t, <i>J</i> = 6.4 Hz, 2H), 2.52 (s, 3H), 2.45–2.36 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 326.1 (calcd 326.2 for C<sub>14</sub>H<sub>14</sub>BrFN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 4-(3-Bromopropoxy)-5-chloro-6-methyl-2-phenylpyrimidine (<b>68</b>)</h5><div class="NLM_p last">A pale-yellow oil (2.12 g, 62.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.33 (m, 2H), 7.51–7.41 (m, 3H), 4.69 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.5 Hz, 2H), 2.62 (s, 3H), 2.47–2.35 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 342.8 (calcd 342.6 for C<sub>14</sub>H<sub>14</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 4-Ethyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>69</b>)</h5><div class="NLM_p last">A mixture of <b>59</b> (5 mmol) and piperidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 4-ethyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine, <b>69</b>, as a yellow oil (1.41 g, 86.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.49–8.41 (m, 2H), 7.49–7.43 (m, 3H), 6.45 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.52–2.33 (m, 6H), 2.06–1.97 (m, 2H), 1.64–1.57 (m, 4H), 1.50–1.38 (m, 2H), 1.33 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 326.5 (calcd 326.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 2-Phenyl-4-(3-(piperidin-1-yl)propoxy)-6-propylpyrimidine (<b>70</b>)</h5><div class="NLM_p last">A yellow oil (1.50 g, 88.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.51–8.44 (m, 2H), 7.50–7.42 (m, 3H), 6.45 (s, 1H), 4.53 (t, <i>J</i> = 6.5 Hz, 2H), 2.75–2.69 (m, 2H), 2.55–2.29 (m, 6H), 2.08–1.99 (m, 2H), 1.87–1.77 (m, 2H), 1.65–1.58 (m, 4H), 1.51–1.40 (m, 2H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 340.8 (calcd 340.5 for C<sub>21</sub>H<sub>29</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 4-Isopropyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>71</b>)</h5><div class="NLM_p last">A yellow oil (1.51 g, 89.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.52–8.46 (m, 2H), 7.50–7.44 (m, 3H), 6.48 (s, 1H), 4.54 (t, <i>J</i> = 6.5 Hz, 2H), 3.00 (dt, <i>J</i> = 13.8, 6.9 Hz, 1H), 2.54–2.36 (m, 6H), 2.09–2.01 (m, 2H), 1.66–1.59 (m, 4H), 1.51–1.42 (m, 2H), 1.35 (d, <i>J</i> = 6.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 340.2 (calcd 340.5 for C<sub>21</sub>H<sub>29</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 4-Methoxy-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>72</b>)</h5><div class="NLM_p last">A yellow oil (1.37 g, 84.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.39 (m, 2H), 7.46–7.40 (m, 3H), 6.74 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 3.50 (s, 3H), 2.51–2.38 (m, 6H), 2.07–1.97 (m, 2H), 1.65–1.55 (m, 4H), 1.45–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 328.5 (calcd 328.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 2-Phenyl-4-(3-(piperidin-1-yl)propoxy)-6-(trifluoromethyl)pyrimidine (<b>73</b>)</h5><div class="NLM_p last">A yellow oil (1.57 g, 86.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.52–8.42 (m, 2H), 7.52–7.44 (m, 3H), 6.90 (s, 1H), 4.59 (t, <i>J</i> = 6.5 Hz, 2H), 2.52–2.36 (m, 6H), 2.09–2.00 (m, 2H), 1.66–1.55 (m, 4H), 1.48–1.42 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 366.4 (calcd 366.4 for C<sub>19</sub>H<sub>22</sub>F<sub>3</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 4-Cyclopropyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>74</b>)</h5><div class="NLM_p last">A yellow oil (1.53 g, 90.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.37 (m, 2H), 7.61–7.48 (m, 3H), 6.39 (s, 1H), 4.51 (t, <i>J</i> = 6.5 Hz, 2H), 2.53–2.34 (m, 6H), 2.04–1.84 (m, 3H), 1.66–1.53 (m, 4H), 1.46–1.41 (m, 2H), 1.29–1.14 (m, 2H), 1.08–0.95 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 338.2 (calcd 338.5 for C<sub>21</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 2,4-Diphenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>75</b>)</h5><div class="NLM_p last">A yellow oil (1.71 g, 91.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.62–8.54 (m, 2H), 8.22–8.15 (m, 2H), 7.54–7.46 (m, 6H), 7.02 (s, 1H), 4.58 (t, <i>J</i> = 6.5 Hz, 2H), 2.56–2.37 (m, 6H), 2.06–1.96 (m, 2H), 1.66–1.58 (m, 4H), 1.45–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 374.8 (calcd 374.5 for C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 4,5-Dimethyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>76</b>)</h5><div class="NLM_p last">A yellow oil (1.42 g, 87.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.36 (m, 2H), 7.48–7.37 (m, 3H), 4.51 (t, <i>J</i> = 6.4 Hz, 2H), 2.56–2.30 (m, 9H), 2.12 (s, 3H), 2.06–1.97 (m, 2H), 1.64–1.55 (m, 4H), 1.47–1.41 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 326.6 (calcd 326.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 5-Fluoro-4-methyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>77</b>)</h5><div class="NLM_p last">A yellow oil (1.36 g, 82.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.38–8.28 (m, 2H), 7.48–7.39 (m, 3H), 4.58 (t, <i>J</i> = 6.6 Hz, 2H), 2.62–2.26 (m, 9H), 2.12–1.98 (m, 2H), 1.66–1.52 (m, 4H), 1.46–1.41 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 330.2 (calcd 330.4 for C<sub>19</sub>H<sub>24</sub>FN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_4_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> 5-Chloro-4-methyl-2-phenyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>78</b>)</h5><div class="NLM_p last">A yellow oil (1.41 g, 81.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.33 (m, 2H), 7.49–7.40 (m, 3H), 4.61 (t, <i>J</i> = 6.5 Hz, 2H), 2.72–2.65 (m, 2H), 2.64–2.51 (m, 7H), 2.14–2.06 (m, 2H), 1.85–1.75 (m, 4H), 1.44–1.39 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 346.9 (calcd 346.9 for C<sub>19</sub>H<sub>24</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> General Procedures for the Synthesis of 2-Phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine Derivatives (<b>79</b>–<b>88</b>)</h4><div id="sec6_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 4-Ethyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>79</b>)</h5><div class="NLM_p last">A mixture of <b>59</b> (5 mmol) and pyrrolidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 4-ethyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine, <b>79</b>, as a pale-red oil (1.37 g, 88.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48–8.41 (m, 2H), 7.48–7.43 (m, 3H), 6.46 (s, 1H), 4.54 (t, <i>J</i> = 6.5 Hz, 2H), 2.77 (q, <i>J</i> = 7.6 Hz, 2H), 2.67–2.62 (m, 2H), 2.58–2.50 (m, 4H), 2.09–2.01 (m, 2H), 1.84–1.75 (m, 4H), 1.33 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 312.8 (calcd 312.4 for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> 2-Phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-6-propylpyrimidine (<b>80</b>)</h5><div class="NLM_p last">A pale-red oil (1.40 g, 86.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.40 (m, 2H), 7.47–7.43 (m, 3H), 6.44 (s, 1H), 4.53 (t, <i>J</i> = 6.5 Hz, 2H), 2.73–2.68 (m, 2H), 2.67–2.61 (m, 2H), 2.58–2.51 (m, 4H), 2.08–2.02 (m, 2H), 1.83–1.77 (m, 6H), 1.00 (t, <i>J</i> = 7.4 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 326.6 (calcd 326.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> 4-Isopropyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>81</b>)</h5><div class="NLM_p last">A pale-red oil (1.38 g, 84.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.44 (m, 2H), 7.50–7.41 (m, 3H), 6.46 (s, 1H), 4.54 (t, <i>J</i> = 6.5 Hz, 2H), 3.03–2.93 (m, 1H), 2.69–2.61 (m, 2H), 2.60–2.57 (m, 4H), 2.09–2.02 (m, 2H), 1.85–1.76 (m, 4H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> 326.3 (calcd 326.4 for C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> 4-Methoxy-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>82</b>)</h5><div class="NLM_p last">A pale-red oil (1.28 g, 81.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.38 (m, 2H), 7.48–7.44 (m, 3H), 6.75 (s, 1H), 4.56 (t, <i>J</i> = 6.5 Hz, 2H), 3.51 (s, 3H), 2.70–2.62 (m, 2H), 2.60–2.53 (m, 4H), 2.12–2.02 (m, 2H), 1.84–1.76 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 314.8 (calcd 314.4 for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> 2-Phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-6-(trifluoromethyl)pyrimidine (<b>83</b>)</h5><div class="NLM_p last">A pale-red oil (1.57 g, 89.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50–8.42 (m, 2H), 7.53–7.43 (m, 3H), 6.91 (s, 1H), 4.62 (t, <i>J</i> = 6.5 Hz, 2H), 2.69–2.62 (m, 2H), 2.59–2.52 (m, 4H), 2.12–2.04 (m, 2H), 1.84–1.77 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 352.5 (calcd 352.4 for C<sub>18</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> 4-Cyclopropyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>84</b>)</h5><div class="NLM_p last">A pale-red oil (1.42 g, 88.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.37 (m, 2H), 7.59–7.47 (m, 3H), 6.41 (s, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 2.54–2.34 (m, 6H), 2.03–1.82 (m, 3H), 1.86–1.73 (m, 4H), 1.30–1.14 (m, 2H), 1.12–1.02 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 324.6 (calcd 324.4 for C<sub>20</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i100" class="anchor-spacer"></div><h5 class="article-section__title" id="_i100"> 2,4-Diphenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>85</b>)</h5><div class="NLM_p last">A pale-red oil (1.66 g, 92.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.64–8.55 (m, 2H), 8.23–8.18 (m, 2H), 7.58–7.47 (m, 6H), 7.03 (s, 1H), 4.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.56–2.37 (m, 6H), 2.08–1.99 (m, 2H), 1.82–1.70 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 360.3 (calcd 360.5 for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i101" class="anchor-spacer"></div><h5 class="article-section__title" id="_i101"> 4,5-Dimethyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>86</b>)</h5><div class="NLM_p last">A pale-red oil (1.33 g, 85.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.43–8.37 (m, 2H), 7.48–7.39 (m, 3H), 4.53 (t, <i>J</i> = 6.4 Hz, 2H), 2.66–2.60 (m, 2H), 2.57–2.50 (m, 4H), 2.47 (s, 3H), 2.13 (s, 3H), 2.08–2.01 (m, 2H), 1.85–1.73 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 312.8 (calcd 312.4 for C<sub>20</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i102" class="anchor-spacer"></div><h5 class="article-section__title" id="_i102"> 5-Fluoro-4-methyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>87</b>)</h5><div class="NLM_p last">A pale-red oil (1.31 g, 83.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.39–8.29 (m, 2H), 7.49–7.40 (m, 3H), 4.61 (t, <i>J</i> = 6.5 Hz, 2H), 2.69–2.63 (m, 2H), 2.59–2.47 (m, 7H), 2.13–2.03 (m, 2H), 1.85–1.75 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 316.7 (calcd 316.4 for C<sub>18</sub>H<sub>22</sub>FN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i103" class="anchor-spacer"></div><h5 class="article-section__title" id="_i103"> 5-Chloro-4-methyl-2-phenyl-6-(3-(pyrrolidin-1-yl)propoxy)pyrimidine (<b>88</b>)</h5><div class="NLM_p last">A pale-red oil (1.37 g, 82.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.42–8.33 (m, 2H), 7.49–7.42 (m, 3H), 4.61 (t, <i>J</i> = 6.5 Hz, 2H), 2.71–2.65 (m, 2H), 2.63–2.52 (m, 7H), 2.14–2.06 (m, 2H), 1.86–1.75 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 332.9 (calcd 332.8 for C<sub>18</sub>H<sub>22</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div></div><div id="sec6_1_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 2-Phenyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-ol (<b>91</b>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></h4><div class="NLM_p last">To a suspension of benzimidamide hydrochloride (<b>5</b>, 50 mmol) and ethyl 2-oxocyclopentanecarboxylate (<b>89</b>, 55 mmol) in MeOH (200 mL) was added <i>t</i>-BuOK (10 mmol) portionwise, with stirring, at 0 °C for 30 min. The resulting mixture was heated to reflux for 4 h and then cooled down to room temperature. After that, ice–water (200 mL) was added and neutralized with citric acid. The precipitate thus formed was filtered and washed with water. The crude residue obtained was recrystallized from <i>i</i>-PrOH to give 2-phenyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-ol, <b>91</b>, as a white solid (8.6 g, 81.0%), mp 232–235 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.61 (s, 1H), 8.26–8.07 (m, 2H), 7.60–7.44 (m, 3H), 2.97 (t, <i>J</i> = 7.8 Hz, 2H), 2.88 (t, <i>J</i> = 7.5 Hz, 2H), 2.24–2.05 (m, 2H).</div></div><div id="sec6_1_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 2-Phenyl-5,6,7,8-tetrahydroquinazolin-4-ol (<b>92</b>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></h4><div class="NLM_p last">To a suspension of benzimidamide hydrochloride (<b>5</b>, 50 mmol) and ethyl 2-oxocyclohexanecarboxylate (<b>90</b>, 55 mmol) in MeOH (200 mL) was added <i>t</i>-BuOK (10 mmol) portionwise, with stirring, at 0 °C for 30 min. The resulting mixture was heated to reflux for 4 h and then cooled down to room temperature. After that, ice–water (200 mL) was added and neutralized with citric acid. The precipitate thus formed was filtered and washed with water. The crude residue obtained was recrystallized from <i>i</i>-PrOH to give 2-phenyl-5,6,7,8-tetrahydroquinazolin-4-ol, <b>92</b>, as a white solid (8.9 g, 78.7%), mp 246–249 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.90 (s, 1H), 8.32–8.09 (m, 2H), 7.70–7.36 (m, 3H), 2.74 (t, <i>J</i> = 6.1 Hz, 2H), 2.59 (t, <i>J</i> = 6.0 Hz, 2H), 1.93–1.71 (m, 4H).</div></div><div id="sec6_1_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 2-Phenyl-4-(3-(piperidin-1-yl)propoxy)-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine (<b>94</b>)</h4><div class="NLM_p">To a solution of <b>91</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 100/1 to 50/1) to yield 4-(3-bromopropoxy)-2-phenyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine, <b>93</b>, as a pale-yellow oil (2.17 g, 65.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47–8.36 (m, 2H), 7.52–7.40 (m, 3H), 4.67 (t, <i>J</i> = 6.0 Hz, 2H), 3.59 (t, <i>J</i> = 6.6 Hz, 2H), 3.03 (t, <i>J</i> = 7.8 Hz, 2H), 2.87 (t, <i>J</i> = 7.5 Hz, 2H), 2.45–2.35 (m, 2H), 2.20–2.10 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 334.3 (calcd 334.2 for C<sub>16</sub>H<sub>17</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div><div class="NLM_p last">A mixture of <b>93</b> (5 mmol) and piperidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 2-phenyl-4-(3-(piperidin-1-yl)propoxy)-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine, <b>94</b>, as a yellow oil (1.27 g, 75.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.31 (m, 2H), 7.53–7.40 (m, 3H), 4.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.87 (t, <i>J</i> = 6.2 Hz, 2H), 2.68–2.63 (m, 2H), 2.61–2.48 (m, 6H), 2.41–2.36 (m, 2H), 2.08–2.00 (m, 2H), 1.67–1.54 (m, 4H), 1.47–1.41 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 338.6 (calcd 338.5 for C<sub>21</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 2-Phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine (<b>95</b>)</h4><div class="NLM_p last">A mixture of <b>93</b> (5 mmol) and pyrrolidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 2-phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine, <b>95</b>, as a pale-red oil (1.13 g, 70.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.29 (m, 2H), 7.52–7.40 (m, 3H), 4.57 (t, <i>J</i> = 6.5 Hz, 2H), 2.88 (t, <i>J</i> = 6.2 Hz, 2H), 2.69–2.64 (m, 2H), 2.63–2.51 (m, 6H), 2.42–2.35 (m, 2H), 2.06–2.00 (m, 2H), 1.85–1.73 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 324.5 (calcd 324.4 for C<sub>20</sub>H<sub>25</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 2-Phenyl-4-(3-(piperidin-1-yl)propoxy)-5,6,7,8-tetrahydroquinazoline (<b>97</b>)</h4><div class="NLM_p">To a solution of <b>92</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 100/1 to 50/1) to yield 4-(3-bromopropoxy)-2-phenyl-5,6,7,8-tetrahydroquinazoline, <b>96</b>, as a pale-yellow oil (1.90 g, 54.9%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.42–8.34 (m, 2H), 7.47–7.41 (m, 3H), 4.64 (t, <i>J</i> = 5.9 Hz, 2H), 3.59 (t, <i>J</i> = 6.6 Hz, 2H), 2.86 (t, <i>J</i> = 6.2 Hz, 2H), 2.60 (t, <i>J</i> = 6.2 Hz, 2H), 2.43–2.34 (m, 2H), 1.94–1.77 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 348.8 (calcd 348.2 for C<sub>17</sub>H<sub>19</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>).</div><div class="NLM_p last">A mixture of <b>96</b> (5 mmol) and piperidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 2-phenyl-4-(3-(piperidin-1-yl)propoxy)-5,6,7,8-tetrahydroquinazoline, <b>97</b>, as a yellow oil (1.47 g, 84.0%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.46–8.32 (m, 2H), 7.51–7.38 (m, 3H), 4.57 (t, <i>J</i> = 6.5 Hz, 2H), 2.86 (t, <i>J</i> = 6.2 Hz, 2H), 2.68–2.64 (m, 2H), 2.63–2.50 (m, 6H), 2.08–2.00 (m, 2H), 1.92–1.84 (m, 4H), 1.65–1.52 (m, 4H), 1.46–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 352.7 (calcd 352.5 for C<sub>22</sub>H<sub>29</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 2-Phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-5,6,7,8-tetrahydroquinazoline (<b>98</b>)</h4><div class="NLM_p last">A mixture of <b>96</b> (5 mmol) and pyrrolidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 2-phenyl-4-(3-(pyrrolidin-1-yl)propoxy)-5,6,7,8-tetrahydroquinazoline, <b>98</b>, as a pale-red oil (1.30 g, 77.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.32 (m, 2H), 7.49–7.36 (m, 3H), 4.55 (t, <i>J</i> = 6.4 Hz, 2H), 2.85 (t, <i>J</i> = 6.2 Hz, 2H), 2.68–2.62 (m, 2H), 2.60–2.48 (m, 6H), 2.10–2.01 (m, 2H), 1.92–1.73 (m, 8H). MS (ESI) <i>m</i>/<i>z</i> 338.7 (calcd 338.5 for C<sub>21</sub>H<sub>27</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> General Procedures for the Synthesis of 5-Chloro-6-methylpyrimidin-4-ol Derivatives (<b>110</b>–<b>120</b>)</h4><div id="sec6_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> 5-Chloro-6-methyl-2-(<i>p</i>-tolyl)pyrimidin-4-ol (<b>110</b>)</h5><div class="NLM_p last">To a suspension of 4-methylbenzimidamide (<b>99</b>, 50 mmol) and ethyl 2-chloro-3-oxobutanoate (<b>48</b>, 55 mmol) in MeOH (200 mL) was added <i>t</i>-BuOK (10 mmol) portionwise, with stirring, at 0 °C for 30 min. The resulting mixture was heated to reflux for 4 h and then cooled down to room temperature. After that, ice–water (200 mL) was added and neutralized with citric acid. The precipitate thus formed was filtered and washed with water. The crude residue obtained was recrystallized from <i>i</i>-PrOH to give 5-chloro-6-methyl-2-(<i>p</i>-tolyl)pyrimidin-4-ol, <b>110</b>, as a white solid (9.60 g, 81.8%), mp 175–178 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.60 (s, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 2.58 (s, 3H), 2.40 (s, 3H).</div></div><div id="sec6_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> 5-Chloro-2-(4-methoxyphenyl)-6-methylpyrimidin-4-ol (<b>111</b>)</h5><div class="NLM_p last">A white solid (10.12 g, 80.8%), mp 143–146 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.58 (s, 1H), 8.33 (d, <i>J</i> = 8.8 Hz, 2H), 6.95 (d, <i>J</i> = 8.9 Hz, 2H), 3.87 (s, 3H), 2.58 (s, 3H).</div></div><div id="sec6_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> 5-Chloro-6-methyl-2-(4-(trifluoromethyl)phenyl)pyrimidin-4-ol (<b>112</b>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></h5><div class="NLM_p last">A white solid (12.87 g, 89.2%), mp 157–161 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.60 (s, 1H), 8.50 (d, <i>J</i> = 8.2 Hz, 2H), 7.69 (d, <i>J</i> = 8.3 Hz, 2H), 2.60 (s, 3H).</div></div><div id="sec6_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> 5-Chloro-2-(4-fluorophenyl)-6-methylpyrimidin-4-ol (<b>113</b>)</h5><div class="NLM_p last">A white solid (10.07 g, 84.4%), mp 164–167 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.05 (s, 1H), 8.25–7.98 (m, 2H), 7.24–7.12 (m, 2H), 2.51 (s, 3H).</div></div><div id="sec6_1_6_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> 5-Chloro-2-(3,4-difluorophenyl)-6-methylpyrimidin-4-ol (<b>114</b>)</h5><div class="NLM_p last">A white solid (11.04 g, 86.1%), mp 170–173 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.78 (s, 1H), 8.25–8.20 (m, 1H), 8.19–8.13 (m, 1H), 7.30–7.15 (m, 1H), 2.58 (s, 3H).</div></div><div id="sec6_1_6_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> 5-Chloro-2-(4-chlorophenyl)-6-methylpyrimidin-4-ol (<b>115</b>)</h5><div class="NLM_p last">A white solid (10.66 g, 83.6%), mp 171–174 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.84 (s, 1H), 8.44–8.30 (m, 2H), 7.48–7.35 (m, 2H), 2.60 (s, 3H).</div></div><div id="sec6_1_6_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> 5-Chloro-2-(3,4-dichlorophenyl)-6-methylpyrimidin-4-ol (<b>116</b>)</h5><div class="NLM_p last">A white solid (12.87 g, 88.9%), mp 177–180 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 11.92 (s, 1H), 8.50–8.45 (m, 1H), 8.27–8.20 (m, 1H), 7.56–7.48 (m, 1H), 2.59 (s, 3H).</div></div><div id="sec6_1_6_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> 5-Chloro-6-methyl-2-(naphthalen-2-yl)pyrimidin-4-ol (<b>117</b>)</h5><div class="NLM_p last">A white solid (12.41 g, 91.7%), mp 204–207 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 12.08 (s, 1H), 8.92 (s, 1H), 8.52–8.42 (m, 1H), 8.05–7.95 (m, 1H), 7.93–7.88 (m, 1H), 7.86–7.82 (m, 1H), 7.57–7.49 (m, 2H), 2.63 (s, 3H).</div></div><div id="sec6_1_6_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> 5-Chloro-6-methylpyrimidin-4-ol (<b>118</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></h5><div class="NLM_p last">To a suspension of formimidamide hydrochloride (<b>107</b>, 100 mmol) and ethyl 2-chloro-3-oxobutanoate (<b>48</b>, 110 mmol) in MeOH (300 mL) was added <i>t</i>-BuOK (20 mmol) portionwise, with stirring, at 0 °C for 30 min. The resulting mixture was heated to reflux for and then cooled down to room temperature. After that, ice–water (500 mL) was added and neutralized with citric acid. The mixture was extracted with EtOH (3 × 150 mL), and the combined organic layers were dried with anhydrous magnesium sulfate. The filtrate was evaporated under reduced pressure, and the crude product was purified by means of chromatography (petroleum ether/EtOAc = 20/1 to 2/1) to yield 5-chloro-6-methylpyrimidin-4-ol, <b>118</b>, as a pale-yellow solid (7.56 g, 53.2%), mp 211–213 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.34 (s, 1H), 8.11 (s, 1H), 2.52 (s, 3H).</div></div><div id="sec6_1_6_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> 5-Chloro-2,6-dimethylpyrimidin-4-ol (<b>119</b>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h5><div class="NLM_p last">A white solid (9.32 g, 58.8%), mp 121–124 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.31 (s, 1H), 2.50 (s, 3H), 2.45 (s, 3H).</div></div><div id="sec6_1_6_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i121" class="anchor-spacer"></div><h5 class="article-section__title" id="_i121"> 5-Chloro-2-cyclopropyl-6-methylpyrimidin-4-ol (<b>120</b>)</h5><div class="NLM_p last">A white solid (11.50 g, 62.3%), mp 133–136 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 13.45 (s, 1H), 2.39 (s, 3H), 2.00–1.91 (m, 1H), 1.24–1.18 (m, 2H), 1.14–1.09 (m, 2H).</div></div></div><div id="sec6_1_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 4-(3-Bromopropoxy)-5-chloro-6-methyl-2-(p-tolyl)pyrimidine (<b>121</b>)</h4><div class="NLM_p last">To a solution of <b>110</b> (10 mmol) and 1,3-dibromopropane (20 mmol) in acetone (100 mL), potassium carbonate (20 mmol) was added and the mixture was refluxed for 4–6 h. The progress of the reaction was monitored by TLC. After cooling to room temperature, the mixture was filtered and the solvent was evaporated under reduced pressure. The crude product was purified by means of chromatography (petroleum ether/EtOAc = 100/1 to 50/1) to yield 4-(3-bromopropoxy)-5-chloro-6-methyl-2-(<i>p</i>-tolyl)pyrimidine, <b>121</b>, as a pale-yellow oil (1.66 g, 46.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 4.65 (t, <i>J</i> = 6.0 Hz, 2H), 3.60 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.46–2.33 (m, 5H). MS (ESI) <i>m</i>/<i>z</i> 356.8 (calcd 356.7 for C<sub>15</sub>H<sub>16</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 4-(3-Bromopropoxy)-5-chloro-2-(4-methoxyphenyl)-6-methylpyrimidine (<b>122</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.64 g, 44.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 8.8 Hz, 2H), 6.95 (d, <i>J</i> = 8.9 Hz, 2H), 4.65 (t, <i>J</i> = 6.0 Hz, 2H), 3.86 (s, 3H), 3.61 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.44–2.35 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 372.4 (calcd 372.7 for C<sub>15</sub>H<sub>16</sub>BrClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 4-(3-Bromopropoxy)-5-chloro-6-methyl-2-(4-(trifluoromethyl)phenyl)pyrimidine (<b>123</b>)</h4><div class="NLM_p last">A pale-yellow oil (2.15 g, 52.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.50 (d, <i>J</i> = 8.2 Hz, 2H), 7.70 (d, <i>J</i> = 8.3 Hz, 2H), 4.69 (t, <i>J</i> = 6.0 Hz, 2H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 2.62 (s, 3H), 2.50–2.35 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 410.7 (calcd 410.6 for C<sub>15</sub>H<sub>13</sub>BrClF<sub>3</sub>N<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 4-(3-Bromopropoxy)-5-chloro-2-(4-fluorophenyl)-6-methylpyrimidine (<b>124</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.75 g, 48.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.34 (m, 2H), 7.18–7.06 (m, 2H), 4.66 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.4 Hz, 2H), 2.59 (s, 3H), 2.44–2.35 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 360.6 (calcd 360.6 for C<sub>14</sub>H<sub>13</sub>BrClFN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 4-(3-Bromopropoxy)-5-chloro-2-(3,4-difluorophenyl)-6-methylpyrimidine (<b>125</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.95 g, 51.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.25–8.19 (m, 1H), 8.19–8.14 (m, 1H), 7.30–7.16 (m, 1H), 4.67 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.4 Hz, 2H), 2.60 (s, 3H), 2.46–2.36 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 378.8 (calcd 378.6 for C<sub>14</sub>H<sub>12</sub>BrClF<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 5-Chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>126</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.85 g, 49.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.42–8.29 (m, 2H), 7.50–7.36 (m, 2H), 4.69 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.4 Hz, 2H), 2.61 (s, 3H), 2.47–2.33 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 377.2 (calcd 377.1 for C<sub>14</sub>H<sub>13</sub>BrCl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 4-(3-Bromopropoxy)-5-chloro-2-(3,4-dichlorophenyl)-6-methylpyrimidine (<b>127</b>)</h4><div class="NLM_p last">A pale-yellow oil (2.19 g, 53.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.51–8.45 (m, 1H), 8.26–8.19 (m, 1H), 7.55–7.48 (m, 1H), 4.68 (t, <i>J</i> = 6.0 Hz, 2H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 2.61 (s, 3H), 2.46–2.39 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 411.7 (calcd 411.5 for C<sub>14</sub>H<sub>12</sub>BrCl<sub>3</sub>N<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 4-(3-Bromopropoxy)-5-chloro-6-methyl-2-(naphthalen-2-yl)pyrimidine (<b>128</b>)</h4><div class="NLM_p last">A pale-yellow oil (2.20 g, 56.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.92 (s, 1H), 8.53–8.42 (m, 1H), 8.03–7.95 (m, 1H), 7.93–7.89 (m, 1H), 7.88–7.84 (m, 1H), 7.57–7.47 (m, 2H), 4.75 (t, <i>J</i> = 6.0 Hz, 2H), 3.65 (t, <i>J</i> = 6.4 Hz, 2H), 2.65 (s, 3H), 2.51–2.39 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 392.9 (calcd 392.7 for C<sub>18</sub>H<sub>16</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 4-(3-Bromopropoxy)-5-chloro-6-methylpyrimidine (<b>129</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.07 g, 40.2%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.33 (s, 1H), 4.24 (t, <i>J</i> = 6.0 Hz, 2H), 3.62 (t, <i>J</i> = 6.4 Hz, 2H), 2.48 (s, 3H), 2.34–2.25 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 267.1 (calcd 266.5 for C<sub>8</sub>H<sub>10</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 4-(3-Bromopropoxy)-5-chloro-2,6-dimethylpyrimidine (<b>130</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.20 g, 42.9%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 4.18 (t, <i>J</i> = 6.0 Hz, 2H), 3.51 (t, <i>J</i> = 6.1 Hz, 2H), 2.60 (s, 3H), 2.39 (s, 3H), 2.34–2.25 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 280.8 (calcd 280.6 for C<sub>9</sub>H<sub>12</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 4-(3-Bromopropoxy)-5-chloro-2-cyclopropyl-6-methylpyrimidine (<b>131</b>)</h4><div class="NLM_p last">A pale-yellow oil (1.35 g, 44.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 4.20 (t, <i>J</i> = 6.0 Hz, 2H), 3.55 (t, <i>J</i> = 6.2 Hz, 2H), 2.46 (s, 3H), 2.43–2.32 (m, 2H), 1.76–1.70 (m, 1H), 1.26–1.20 (m, 2H), 1.15–1.10 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 306.9 (calcd 306.6 for C<sub>11</sub>H<sub>14</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 5-Chloro-4-methyl-6-(3-(piperidin-1-yl)propoxy)-2-(<i>p</i>-tolyl)pyrimidine (<b>132</b>)</h4><div class="NLM_p last">A mixture of <b>121</b> (5 mmol) and piperidine (5.5 mmol) in acetonitrile (100 mL) and cesium carbonate (10 mmol) was heated and refluxed for 6–8 h. After filtering, the resulting filtrate was evaporated to dryness under reduced pressure. The residue was suspended in water (50 mL) and extracted with dichloromethane (3 × 25 mL). The combined organic layers were dried with anhydrous magnesium sulfate, the filtrate evaporated under reduced pressure, and the crude product purified by means of chromatography (10% MeOH/CHCl<sub>3</sub>) to yield 5-chloro-4-methyl-6-(3-(piperidin-1-yl)propoxy)-2-(<i>p</i>-tolyl)pyrimidine, <b>132</b>, as a yellow oil (1.52 g, 84.8%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 4.57 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.54–2.49 (m, 2H), 2.49–2.32 (m, 7H), 2.09–2.01 (m, 2H), 1.63–1.54 (m, 2H), 1.49–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 361.2 (calcd 360.9 for C<sub>20</sub>H<sub>26</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> 5-Chloro-2-(4-methoxyphenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>133</b>)</h4><div class="NLM_p last">A yellow oil (1.54 g, 82.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 8.9 Hz, 2H), 6.95 (d, <i>J</i> = 8.9 Hz, 2H), 4.57 (t, <i>J</i> = 6.5 Hz, 2H), 3.86 (s, 3H), 2.57 (s, 3H), 2.54–2.49 (m, 2H), 2.48–2.32 (m, 4H), 2.10–2.00 (m, 2H), 1.66–1.52 (m, 4H), 1.50–1.39 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 377.1 (calcd 375.9 for C<sub>20</sub>H<sub>26</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 5-Chloro-4-methyl-6-(3-(piperidin-1-yl)propoxy)-2-(4-(trifluoromethyl)phenyl)pyrimidine (<b>134</b>)</h4><div class="NLM_p last">A yellow oil (1.83 g, 88.7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.48 (d, <i>J</i> = 8.2 Hz, 2H), 7.68 (d, <i>J</i> = 8.3 Hz, 2H), 4.59 (t, <i>J</i> = 6.5 Hz, 2H), 2.60 (s, 3H), 2.55–2.50 (m, 2H), 2.50–2.32 (m, 4H), 2.11–2.04 (m, 2H), 1.65–1.55 (m, 4H), 1.50–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 414.9 (calcd 414.9 for C<sub>20</sub>H<sub>23</sub>ClF<sub>3</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 5-Chloro-2-(4-fluorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>135</b>)</h4><div class="NLM_p last">A yellow oil (1.46 g, 80.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44–8.31 (m, 2H), 7.19–7.01 (m, 2H), 4.57 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.55–2.48 (m, 2H), 2.47–2.28 (m, 4H), 2.09–2.02 (m, 2H), 1.65–1.54 (m, 4H), 1.51–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 365.1 (calcd 364.9 for C<sub>19</sub>H<sub>23</sub>ClFN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 5-Chloro-2-(3,4-difluorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>136</b>)</h4><div class="NLM_p last">A yellow oil (1.65 g, 86.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.21–8.16 (m, 1H), 8.15–8.10 (m, 1H), 7.23–7.16 (m, 1H), 4.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.57 (s, 3H), 2.53–2.48 (m, 2H), 2.47–2.36 (m, 4H), 2.11–1.99 (m, 2H), 1.64–1.55 (m, 4H), 1.49–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 383.3 (calcd 382.8 for C<sub>19</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> 5-Chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>137</b>)</h4><div class="NLM_p last">A yellow oil (1.55 g, 81.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.38–8.26 (m, 2H), 7.45–7.36 (m, 2H), 4.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.57 (s, 3H), 2.52–2.47 (m, 2H), 2.46–2.34 (m, 4H), 2.09–1.99 (m, 2H), 1.64–1.53 (m, 4H), 1.48–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 381.4 (calcd 381.3 for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> 5-Chloro-2-(3,4-dichlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>138</b>)</h4><div class="NLM_p last">A yellow oil (1.81 g, 87.5%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45–8.43 (m, 1H), 8.21–8.17 (m, 1H), 7.51–7.46 (m, 1H), 4.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.55–2.49 (m, 2H), 2.48–2.36 (m, 4H), 2.10–2.02 (m, 2H), 1.65–1.54 (m, 4H), 1.51–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 416.3 (calcd 414.8 for C<sub>19</sub>H<sub>22</sub>Cl<sub>3</sub>N<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 5-Chloro-4-methyl-2-(naphthalen-2-yl)-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>139</b>)</h4><div class="NLM_p last">A yellow oil (1.71 g, 86.4%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.89 (s, 1H), 8.54–8.41 (m, 1H), 8.02–7.93 (m, 1H), 7.95–7.90 (m, 1H), 7.86–7.82 (m, 1H), 7.56–7.45 (m, 2H), 4.62 (t, <i>J</i> = 6.5 Hz, 2H), 2.62 (s, 3H), 2.58–2.51 (m, 2H), 2.50–2.28 (m, 4H), 2.13–2.04 (m, 2H), 1.64–1.56 (m, 4H), 1.50–1.41 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 397.2 (calcd 396.9 for C<sub>23</sub>H<sub>26</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> 5-Chloro-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>140</b>)</h4><div class="NLM_p last">A yellow oil (1.04 g, 77.3%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 4.28 (t, <i>J</i> = 6.5 Hz, 2H), 2.58 (s, 3H), 2.51–2.45 (m, 2H), 2.47–2.34 (m, 4H), 2.08–1.99 (m, 2H), 1.62–1.55 (m, 4H), 1.47–1.40 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 271.1 (calcd 270.8 for C<sub>13</sub>H<sub>20</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> 5-Chloro-2,4-dimethyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>141</b>)</h4><div class="NLM_p last">A yellow oil (1.12 g, 79.6%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 4.22 (t, <i>J</i> = 6.5 Hz, 2H), 2.54 (s, 3H), 2.47–2.39 (m, 2H), 2.36–2.28 (m, 7H), 2.03–1.95 (m, 2H), 1.61–1.53 (m, 4H), 1.45–1.38 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 284.8 (calcd 284.8 for C<sub>14</sub>H<sub>22</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div><div id="sec6_1_6_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> 5-Chloro-2-cyclopropyl-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (<b>142</b>)</h4><div class="NLM_p last">A yellow oil (1.24 g, 80.1%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 4.31 (t, <i>J</i> = 6.5 Hz, 2H), 2.56 (s, 3H), 2.48–2.38 (m, 2H), 2.38–2.27 (m, 7H), 2.02–1.94 (m, 2H), 1.75–1.69 (m, 1H), 1.60–1.53 (m, 4H), 1.44–1.36 (m, 2H), 1.25–1.19 (m, 2H), 1.16–1.10 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 310.5 (calcd 310.8 for C<sub>16</sub>H<sub>24</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>).</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> In Vitro Binding Assays</h3><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> Materials</h4><div class="NLM_p last">The following specific radioligands and tissue sources were used: (a) σ<sub>1</sub> receptor, [<sup>3</sup>H]-(+)-pentazocine (250 μCi, PerkinElmer, NET-1056250UC), and male Dunkin Hartley guinea pig brain membrane; (b) σ<sub>2</sub> receptor, [<sup>3</sup>H]-di-<i>o</i>-tolylguanidine ([<sup>3</sup>H]-DTG, 250 μCi, PerkinElmer, NET-986250UC), and male Dunkin Hartley guinea pig brain membrane. Chemicals and reagents were purchased from different commercial sources and of analytical grade.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> Membrane Preparation</h4><div class="NLM_p last">Membrane preparation was performed by previously reported method.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Crude P2 membranes were prepared from frozen guinea pig brains minus cerebellum. Tissues were homogenized in ice-cold 10 mM Tris-sucrose buffer (0.32 mol sucrose in 10 mM Tris-HCl, pH 7.4) using an ULTRA TURAX homogenizer. The homogenates were centrifuged at 4 °C at 1000<i>g</i> for 10 min, and the supernatant was saved. The resulting pellet was then resuspended in the same buffer, incubated for 10 min at 4 °C, and centrifuged at 1000<i>g</i> for 10 min. After that, the pellet was discarded and the supernatants were combined and centrifuging at 31000<i>g</i> for 15 min. The pellets were resuspended in 10 mL of Tris-HCl, pH 7.4, in a volume of 3 mL/g, and the suspension was allowed to incubate at 25 °C for 30 min. Following centrifuging at 31000<i>g</i> for 15 min, the pellet was resuspended by gentle homogenization in 10 mM Tris-HCl, pH 7.4, in a final volume of 1.53 mL/g tissue, and aliquots were stored at −80 °C until used. The protein concentration of the suspension was determined by the method of Bradford.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Subsequently, the preparation contained 4 mg protein/mL.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> General Procedures for the Binding Assays</h4><div class="NLM_p">All the test compounds were prepared by dissolving in 5% DMSO. The filter mats were presoaked in 0.5% polyethylenimine solution for 2 h at room temperature before use. The following specific radioligands and tissue sources were used: (a) σ<sub>1</sub> receptor, [<sup>3</sup>H]-(+)-pentazocine, guinea pig brain membranes; (b) σ<sub>2</sub> receptor, [<sup>3</sup>H]-DTG, guinea pig brain membranes.</div><div class="NLM_p">The total binding (TB) was determined in the absence of nonspecific binding and compounds while specific binding (SB) was determined in the presence of compounds. Nonspecific binding (NB) was determined as the difference between total and specific binding. Nonspecific binding was determined in the presence of 10 μmol of haloperidol. Percentage of inhibition (%) was calculated as the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/jm-2014-01207r_m001.gif" alt="" /></img></span></div><div class="NLM_p last">Blank experiments were carried out to determine the effect of 5% DMSO on the binding, and no effects were observed. Compounds were tested at least three times over a six concentration range (10<sup>–5</sup> M to 10<sup>–10</sup> M), and IC<sub>50</sub> values were determined by nonlinear regression analysis using Hill equation curve fitting. <i>K</i><sub>i</sub> values were calculated based on the Cheng and Prusoff equation: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + <i>C</i>/<i>K</i><sub>d</sub>). In the equation, <i>C</i> represents the concentration of the hot ligand used and <i>K</i><sub>d</sub> its receptor dissociation constant calculated for each labeled ligand. Mean <i>K</i><sub>i</sub> values and SEM are reported for at least three independent experiments.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> σ<sub>1</sub> Receptor Binding Assays</h4><div class="NLM_p">Binding of [<sup>3</sup>H]-(+)-pentazocine at σ<sub>1</sub> receptor was performed according to D. L. Dehaven-Hudkins et al.,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with minor modifications. The binding properties of the test compounds to guinea pig σ<sub>1</sub> receptor were studied in guinea pig brain membranes using [<sup>3</sup>H]-(+)-pentazocine as the radioligand.</div><div class="NLM_p last">To each total binding assay tube was added 900 μL of the tissue suspension, 50 μL of 4.0 nM [<sup>3</sup>H]-(+)-pentazocine, 50 μL of Tris-HCl buffer, pH 8.0. Nonspecific binding each assay tube was added 900 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-(+)-pentazocine, and 50 μL of 10 μM haloperidol. To each specific binding assay tube was added 900 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-(+)-pentazocine, and 50 μL of reference drug or test compounds solution in various concentrations (10<sup>–5</sup> M to 10<sup>–10</sup> M). The tubes were incubated at 25 °C for 180 min. The incubation was followed by a rapid vacuum filtration through Whatman GF/B glass filters, and the filtrates were washed twice with 5 mL of cold buffer and transferred to scintillation vials. Scintillation fluid (2.0 mL) was added, and the radioactivity bound was measured using a Beckman LS 6500 liquid scintillation counter.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> σ<sub>2</sub> Receptor Binding Assays</h4><div class="NLM_p">Binding assays were performed as described by Ronsisvalle et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> with minor modifications.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The binding properties of the test compounds to guinea pig σ<sub>2</sub> receptor were studied in guinea pig brain membranes using [<sup>3</sup>H]-DTG.</div><div class="NLM_p last">The membranes were incubated with 3 nM [<sup>3</sup>H]-DTG in the presence of 400 nM (+)-SKF10047 to block σ<sub>1</sub> sites. To each total binding assay tube was added 850 μL of the tissue suspension, 50 μL of 3.0 nM [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF10047, and 50 μL of Tris-HCl buffer, pH 8.0. For nonspecific binding, to each assay tube was added 850 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF10047, and 50 μL of 10 μM DTG. Each specific binding assay tube was added 850 μL of the tissue suspension, 50 μL of [<sup>3</sup>H]-DTG, 50 μL of 400 nM (+)-SKF10047, and 50 μL of reference drug or test compounds solution in various concentrations (10<sup>–5</sup> M to 10<sup>–10</sup> M). The tubes were incubated at 25 °C for 120 min. The incubation was followed by a rapid vacuum filtration through Whatman GF/B glass filters, and the filtrates were washed twice with 5 mL of cold buffer and transferred to scintillation vials. Scintillation fluid (2.0 mL) was added, and the radioactivity bound was measured using a Beckman LS 6500 liquid scintillation counter.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> Functional Profile on σ<sub>1</sub> Receptor</h4><div class="NLM_p last">The functional activity of compound <b>137</b> was evaluated by using guinea pig brain membranes binding assays for σ<sub>1</sub> receptor. The binding affinities either in the absence or presence of 1 mM phenytoin were measured to identify the functional (agonistic or antagonistic) nature.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> hERG Affinity</h4><div class="NLM_p">Ability to block hERG potassium channels was determined using the whole-cell patch clamp method and cloned hERG potassium channels (expressed in HEK 293 cells) as biological material.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> For this purpose, the patch clamp amplifier (Axopatch 200B, Molecular Devices) and digital converter (Digidata 1440A, Molecular Devices) were used. Recording electrodes were made from borosilicate glass with filament (BF120-94-15, Sutter Instrument Company). Creation of voltage-clamp command pulse protocols and data acquisition were controlled by pCLAMP software (version 10.1, Molecular Devices).</div><div class="NLM_p">The bath solution consisted of 137 mM NaCl, 5.4 mM KCl, 10 mM glucose, 10 mM HEPES, and 2 mM CaCl<sub>2</sub>. The pH was adjusted to 7.5 by addition of NaOH. The pipet filling solution consisted of 140 mM KCl, 1 mM MgCl<sub>2</sub>, 5 mM EGTA, 10 mM HEPES, and 5 mM Na<sub>2</sub>ATP. The pH was adjusted to 7.2 by addition of KOH.</div><div class="NLM_p">To study voltage dependence of steady-state block of hERG channels on different drug concentrations (0.3, 1, 3, and 10 μM) in HEK cells, the holding membrane potential was switched from −80 to +50 mV for 2 s following return to −50 mV for 3s (sampling rate of 4 kHz, low-pass filtered at 1 kHz) in intervals of 30s. Tail currents were measured at −50 mV in control and in the presence of the drug at concentrations determined empirically.</div><div class="NLM_p last">All raw measurements were performed using Clampfit (version 10.2), a part of pCLAMP software (version 10.1). Results were transferred to the program Statistical Package for the Social Sciences (SPSS) spreadsheets for further analysis.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i152" class="anchor-spacer"></div><h3 class="article-section__title" id="_i152"> In Vivo Test</h3><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> Animals</h4><div class="NLM_p last">Chinese Kun Ming (KM) mice (20 ± 2.0 g) and Sprague–Dawley (SD) rats (250 ± 5.0 g) were used as experimental animals in this study. All the animals were housed under standardized conditions for light, temperature, and humidity and received standard rat chow and tap water and libitum. Animals were assigned to different experimental groups randomly, each kept in a separate cage. All research involving animals in this study follow the guidelines of the Bylaws of Experiments on Animals and have been approved by the Ethics and Experimental Animal Committee of Jiangsu Nhwa Pharmaceutical Co., Ltd.</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> Acute Toxicity</h4><div class="NLM_p last">Mice (10 mice for each group) were orally dosed with po administration of a 10 mL/kg volume of vehicle 0.5% methylcellulose (Sigma-Aldrich) or increasing dose of test compounds (200, 500, 1000, 1500, and 2000 mg/kg). The number of surviving animals was recorded after 24 h of drug administration. The percent mortality in each group was calculated. The LD<sub>50</sub> values were calculated by using Statistical Package for Social Sciences (SPSS) program.</div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> Formalin Test<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></h4><div class="NLM_p last">Mice were randomly separated into different groups: vehicle, vehicle + formalin, and drug-treated group, and each group contained 10 mice. A diluted formalin solution (20 μL of a 2.5% formalin solution, 0.92% formaldehyde) was injected into the dorsal surface of the right hind paw of the mouse. Immediately thereafter, the mouse was put into a glass cylinder and the observation period started. A mirror was placed behind the glass cylinder to allow clear observation of the paws. Nociceptive behavior induced by formalin was quantified as the time spent licking or biting the injected paw during two different periods individually recorded: the first period was recorded 0–5 min after the injection of formalin and was considered indicative of formalin-evoked nociception phase I; the second period was recorded 15–45 min after formalin injection and was considered indicative of formalin-evoked nociception phase II.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The mice (<i>n</i> = 10–12 per group) received ip administration of a 10 mL/kg volume of vehicle 30% PEG 400 (Sigma-Aldrich) or test compound 15 min before intraplantar (ipl) formalin injection. The antinociceptive effect induced by the different treatments in the formalin test was calculated by the following formula: antinociceptive effect (%) = (LT<sub>V</sub> – LT<sub>D</sub>)/LT<sub>V</sub> × 100%, where LT<sub>V</sub> represents the licking time in vehicle injected animals and LT<sub>D</sub> means licking time in drug-injected animals.</div></div><div id="sec6_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> CCI Model<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></h4><div class="NLM_p">The CCI of the sciatic nerve as an animal model was used to study the efficacy of treatments in neuropathic pain.</div><div class="NLM_p">Rats were randomly separated into several groups: sham control and vehicle- and drug-treated groups, and each group contained 10 rats. Pain threshold base values of each group were measured 1–2 days before surgery and those with the value of 2 days were picked. The pain thresholds were measured again 14 days after surgery to check whether the model was successful. Drugs were dose orally with po administration of a 10 mL/kg volume of vehicle 0.5% methylcellulose (Sigma-Aldrich) or increasing dose of test compounds twice a day for 4 days (15th, 16th, 17th, and 18th day). Each group was measured after first administration on the 15th day and the last administration on the 18th day, which result in the single administration and repeated administration, respectively.</div><div class="NLM_p">The CCI of the sciatic nerve surgery was performed as described by Bennett and Xie<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> with minor modification. Briefly, the SD rats were anesthetized with chloral hydrate (5%) and the right common sciatic nerve was exposed at the level of the midthigh of the right hind paw. At about 1 cm proximal to the nerve trifurcation, about 7 mm of the nerve was freed and four ligatures (4–0 silk tread) were tight loosely with a distance of ca. 1.0 mm. The nerve was only barely constricted. The muscle was than stitched and the skin incision closed with wound clips. The rats with sciatic nerve exposure without ligation served as the sham control group.</div><div class="NLM_p">Two tests were performed: the von Frey test and the plantar test. Allodynia to mechanical stimuli and hyperalgesia to noxious thermal stimulus were used as outcome measures of neuropathic pain by using the von Frey and plantar tests, respectively.</div><div class="NLM_p">In the von Frey test, briefly, animals were placed in a transparent test chamber with a wire-mesh grid floor through which von Frey monofilaments were applied. The monofilaments were applied in increasing force until the rats withdrew the ipsilateral, nerve injury paw using an up–down paradigm. Clear paw withdrawal, sharking, or licking was considered as nociceptive-lick response to determine the mechanical withdrawal threshold (MWT). Animals were adapted to the testing situation for at least 30 min before the sessions started. For each measurement, the paw was sampled four times and a mean calculated. At least 3 min elapsed between.</div><div class="NLM_p last">Thermal hyperalgesia was assessed through the plantar test by measuring hind paw latency in response to radiant heat. Briefly, rats were placed in a clear plastic chamber with a glass floor and allowed to acclimate to the environment for 30 min. A radiant heat source (BMC-410A) was then positioned under the plantar surface of the hind paw. The latency for the withdrawal reflex was recorded as thermal withdraw latency (TWL). A cutoff time of 30 s was imposed to prevent tissue damage in the absence of response. For each measurement, the paw was sampled four times and a mean calculated. At least 3 min elapsed between.</div></div><div id="sec6_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> Motor Coordination (Rotarod Test)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></h4><div class="NLM_p last">The motor performance of mice was assessed by means of an automated rotarod (YLS-4C, China). Mice were trained, and those which could not stay moving on the rod for 300 s in 10 rpm were discarded from the study before drug treatment. In the test, mice were required to walk against the motion of an elevated rotating drum at 10 rpm and the latencies to fall-down were recorded. With the selected animals, rotarod latencies were measured 30, 60, 90, and 120 min after ip administration of drugs.</div></div><div id="sec6_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> Pharmacokinetics Study in Rats</h4><div class="NLM_p">The HPLC conditions were as follows: column, ZORBAX BP-C18 5.0 μm × 150 mm × 4.6 mm I.D. (Agilent, USA); mobile phase, 30 mmol of NH<sub>4</sub>COOH (Roe Scientific Inc., USA) aq/acetonitrile (Merck Company, Germany) 30/70; flow rate, 1.0 mL/min; column temperature, 40 °C.</div><div class="NLM_p last">For routine compound <b>137</b> screening, rats (<i>n</i> = 8/group) were dosed via the lateral tail vein at the indicated dose for iv administration (16 mg/kg, 100% saline) or via oral gavage (320 mg/kg, suspension in 0.5% methylcellulose). At 30 min, 1, 2, 3, 4, 5, 6, 7, and 24 h after administration, serial blood samples were collected from the lateral tail vein into heparinized collection tubes (approximately 0.25 mL). The plasma was separated by centrifugation, and the sample was prepared for HPLC/MS analysis by protein precipitation with acetonitrile. The plasma samples were analyzed for drug and internal standard via the HPLC-MS/MS protocol.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i159"><a href="/doi/suppl/10.1021/jm501207r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of computational procedures, selectivity of compound <b>137</b> for additional receptors and ion channels, inhibition curves figure of functional profile of σ<sub>1</sub> receptor, <sup>13</sup>C NMR and HR-MS of partially new compounds, and <sup>1</sup>H NMR, <sup>13</sup>C NMR, HR-MS, LC-MS, and elemental analyses of compound <b>137</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501207r/suppl_file/jm501207r_si_001.pdf">jm501207r_si_001.pdf (1.28 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501207r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guisen Zhang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6106121b09000f06210c00080d4f091412154f0405144f020f"><span class="__cf_email__" data-cfemail="3e594d44565f50597e535f575210564b4d4a105b5a4b105d50">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Lan</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yin Chen</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xudong Cao</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juecheng Zhang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Wang</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangqing Xu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinli Qiu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tan Zhang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd., 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Liu</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bi-Feng Liu</span> - <span class="hlFld-Affiliation affiliation">Systems
Biology Theme, Department of Biomedical Engineering, College of Life
Science and Technology, Huazhong University
of Science and Technology, Wuhan 430074, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.L. and Y.C. contributed equally to this work;</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1002e8503-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i161">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Liangren Zhang, Zhenming Liu, and Hongwei Jin of the State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, for guiding computational works of 3D Pharmacophore Model Generation, molecular design, and performing HR-MS and elemental analyses for partially new compounds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i162" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i162"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i163" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i163"> Abbreviations Used</h2><tr><td class="NLM_term">σ<sub>1</sub>R</td><td class="NLM_def"><p class="first last">sigma-1 receptor</p></td></tr><tr><td class="NLM_term">σ<sub>2</sub>R</td><td class="NLM_def"><p class="first last">sigma-2 receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">3D</td><td class="NLM_def"><p class="first last">three-dimensional</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective dose</p></td></tr><tr><td class="NLM_term">LD<sub>50</sub></td><td class="NLM_def"><p class="first last">median lethal dose</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i164">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 67 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hecke, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, N.</span><span> </span><span class="NLM_article-title">Neuropathic Pain in the General Population: A Systematic Review of Epidemiological Studies</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=654-662&author=O.+V.+Heckeauthor=S.+K.+Austinauthor=R.+A.+Khanauthor=B.+H.+Smithauthor=N.+Torrance&title=Neuropathic+Pain+in+the+General+Population%3A+A+Systematic+Review+of+Epidemiological+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHecke%26aufirst%3DO.%2BV.%26aulast%3DAustin%26aufirst%3DS.%2BK.%26aulast%3DKhan%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DTorrance%26aufirst%3DN.%26atitle%3DNeuropathic%2520Pain%2520in%2520the%2520General%2520Population%253A%2520A%2520Systematic%2520Review%2520of%2520Epidemiological%2520Studies%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D654%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Emerging Drugs for Neuropathic Pain</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1517%2F14728214.2014.915025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=24344917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1-13&author=I.+Gilronauthor=A.+H.+Dickenson&title=Emerging+Drugs+for+Neuropathic+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728214.2014.915025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2014.915025%26sid%3Dliteratum%253Aachs%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DEmerging%2520Drugs%2520for%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2014%26volume%3D19%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jongen Joost, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartrick, C. T.</span><span> </span><span class="NLM_article-title">Neruopathic Pain and Pharmacological Treatment</span> <span class="citation_source-journal">Pain Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fpapr.12085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23750502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=283-295&author=L.+M.+Jongen+Joostauthor=G.+Hansauthor=H.+T.+Benzonauthor=F.+Huygenauthor=C.+T.+Hartrick&title=Neruopathic+Pain+and+Pharmacological+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain and pharmacological treatment</span></div><div class="casAuthors">Jongen Joost L M; Hans Guy; Benzon Honorio T; Huygen Frank; Hartrick Craig T</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is a serious chronic condition strongly affecting quality of life, which can be relieved but cannot be cured.  Apart from symptomatic management, treatment should focus on the underlying disorder.  The estimated prevalence is at least 1% to 5% of the general population.  Neuropathic pain is characterized both by spontaneous and evoked pain.  A diagnosis of neuropathic pain can usually be established based solely on history and neurological examination.  Ancillary investigations may include EMG and computerized tomography/magnetic resonance imaging scans, depending on the localization of the suspected lesion.  A limited number of agents, primarily directed at symptom control, are currently approved for use in neuropathic pain.  A mechanism-based approach to pharmacological intervention supports the use of polypharmacy in neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCgdyy7ehY67qxQ2mb9Pu8fW6udTcc2eYY5n4bCjfqhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D&md5=66f491a169f5c3b2fe5b6078346d31da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12085%26sid%3Dliteratum%253Aachs%26aulast%3DJongen%2BJoost%26aufirst%3DL.%2BM.%26aulast%3DHans%26aufirst%3DG.%26aulast%3DBenzon%26aufirst%3DH.%2BT.%26aulast%3DHuygen%26aufirst%3DF.%26aulast%3DHartrick%26aufirst%3DC.%2BT.%26atitle%3DNeruopathic%2520Pain%2520and%2520Pharmacological%2520Treatment%26jtitle%3DPain%2520Pract.%26date%3D2014%26volume%3D14%26spage%3D283%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dwokin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backonja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnerup, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portenoy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. S.</span><span> </span><span class="NLM_article-title">Pharmacologic Management of Neuropathic Pain: Evidence-Based Recommendations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dwokinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+Management+of+Neuropathic+Pain%3A+Evidence-Based+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDwokin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520Management%2520of%2520Neuropathic%2520Pain%253A%2520Evidence-Based%2520Recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Attal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruccu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T.</span><span> </span><span class="NLM_article-title">EFNS Guidelines on Pharmacological Treatment of Neuropathic Pain: 2010 Revision</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fj.1468-1331.2006.01511.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=17038030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BD28ngs1Smug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1153-1169&author=N.+Attalauthor=G.+Cruccuauthor=R.+Baronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=T.+Nurmikko&title=EFNS+Guidelines+on+Pharmacological+Treatment+of+Neuropathic+Pain%3A+2010+Revision"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">EFNS guidelines on pharmacological treatment of neuropathic pain</span></div><div class="casAuthors">Attal N; Cruccu G; Haanpaa M; Hansson P; Jensen T S; Nurmikko T; Sampaio C; Sindrup S; Wiffen P</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1153-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain treatment remains unsatisfactory despite a substantial increase in the number of trials.  This EFNS Task Force aimed at evaluating the existing evidence about the pharmacological treatment of neuropathic pain.  Studies were identified using first the Cochrane Database then Medline.  Trials were classified according to the aetiological condition.  All class I and II controlled trials (according to EFNS classification of evidence) were assessed, but lower-class studies were considered in conditions that had no top level studies.  Only treatments feasible in an outpatient setting were evaluated.  Effects on pain symptoms/signs, quality of life and comorbidities were particularly searched for.  Most of the randomized controlled trials included patients with postherpetic neuralgia (PHN) and painful polyneuropathies (PPN) mainly caused by diabetes.  These trials provide level A evidence for the efficacy of tricyclic antidepressants, gabapentin, pregabalin and opioids, with a large number of class I trials, followed by topical lidocaine (in PHN) and the newer antidepressants venlafaxine and duloxetine (in PPN).  A small number of controlled trials were performed in central pain, trigeminal neuralgia, other peripheral neuropathic pain states and multiple-aetiology neuropathic pains.  The main peripheral pain conditions respond similarly well to tricyclic antidepressants, gabapentin, and pregabalin, but some conditions, such as HIV-associated polyneuropathy, are more refractory.  There are too few studies on central pain, combination therapy, and head-to-head comparison.  For future trials, we recommend to assess quality of life and pain symptoms or signs with standardized tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuZr20ZHxIwXELvajU9pjPfW6udTcc2eY1ybNwGsyNyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28ngs1Smug%253D%253D&md5=3a7ad3adf11b9000e0b27afaa1e5c447</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2006.01511.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2006.01511.x%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DCruccu%26aufirst%3DG.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DNurmikko%26aufirst%3DT.%26atitle%3DEFNS%2520Guidelines%2520on%2520Pharmacological%2520Treatment%2520of%2520Neuropathic%2520Pain%253A%25202010%2520Revision%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2006%26volume%3D13%26spage%3D1153%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Moulin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coderre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley-Forster, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taenzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholkan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailis-Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panju, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollman, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, A.</span><span> </span><span class="NLM_article-title">Pharmacological Management of Chronic Neuropathic Pain—Consensus Statement and Guidelines from the Canadian Pain Society</span> <span class="citation_source-journal">Pain Res. Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1155%2F2007%2F730785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=17372630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BD2s7nsVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=13-21&author=D.+E.+Moulinauthor=A.+J.+Clarkauthor=I.+Gilronauthor=M.+A.+Wareauthor=C.+P.+Watsonauthor=B.+J.+Sessleauthor=T.+Coderreauthor=P.+K.+Morley-Forsterauthor=J.+Stinsonauthor=A.+Boulangerauthor=P.+Pengauthor=G.+A.+Finleyauthor=P.+Taenzerauthor=P.+Squireauthor=D.+Dionauthor=A.+Cholkanauthor=A.+Gilaniauthor=A.+Gordonauthor=J.+Henryauthor=R.+Joveyauthor=M.+Lynchauthor=A.+Mailis-Gagnonauthor=A.+Panjuauthor=G.+B.+Rollmanauthor=A.+Velly&title=Pharmacological+Management+of+Chronic+Neuropathic+Pain%E2%80%94Consensus+Statement+and+Guidelines+from+the+Canadian+Pain+Society"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society</span></div><div class="casAuthors">Moulin D E; Clark A J; Gilron I; Ware M A; Watson C P N; Sessle B J; Coderre T; Morley-Forster P K; Stinson J; Boulanger A; Peng P; Finley G A; Taenzer P; Squire P; Dion D; Cholkan A; Gilani A; Gordon A; Henry J; Jovey R; Lynch M; Mailis-Gagnon A; Panju A; Rollman G B; Velly A</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management : the journal of the Canadian Pain Society = journal de la societe canadienne pour le traitement de la douleur</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>
        ISSN:<span class="NLM_cas:issn">1203-6765</span>.
    </div><div class="casAbstract">Neuropathic pain (NeP), generated by disorders of the peripheral and central nervous system, can be particularly severe and disabling.  Prevalence estimates indicate that 2% to 3% of the population in the developed world suffer from NeP, which suggests that up to one million Canadians have this disabling condition.  Evidence-based guidelines for the pharmacological management of NeP are therefore urgently needed.  Randomized, controlled trials, systematic reviews and existing guidelines focusing on the pharmacological management of NeP were evaluated at a consensus meeting.  Medications are recommended in the guidelines if their analgesic efficacy was supported by at least one methodologically sound, randomized, controlled trial showing significant benefit relative to placebo or another relevant control group.  Recommendations for treatment are based on degree of evidence of analgesic efficacy, safety, ease of use and cost-effectiveness.  Analgesic agents recommended for first-line treatments are certain antidepressants (tricyclics) and anticonvulsants (gabapentin and pregabalin).  Second-line treatments recommended are serotonin noradrenaline reuptake inhibitors and topical lidocaine.  Tramadol and controlled-release opioid analgesics are recommended as third-line treatments for moderate to severe pain.  Recommended fourth-line treatments include cannabinoids, methadone and anticonvulsants with lesser evidence of efficacy, such as lamotrigine, topiramate and valproic acid.  Treatment must be individualized for each patient based on efficacy, side-effect profile and drug accessibility, including cost.  Further studies are required to examine head-to-head comparisons among analgesics, combinations of analgesics, long-term outcomes, and treatment of pediatric and central NeP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVR3Wisn7iNb5oR8RchjrrfW6udTcc2eY1ybNwGsyNyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7nsVahtg%253D%253D&md5=2890a7b51c560054982d89d5dfd35170</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1155%2F2007%2F730785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2007%252F730785%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DD.%2BE.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DWare%26aufirst%3DM.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BP.%26aulast%3DSessle%26aufirst%3DB.%2BJ.%26aulast%3DCoderre%26aufirst%3DT.%26aulast%3DMorley-Forster%26aufirst%3DP.%2BK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DBoulanger%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DFinley%26aufirst%3DG.%2BA.%26aulast%3DTaenzer%26aufirst%3DP.%26aulast%3DSquire%26aufirst%3DP.%26aulast%3DDion%26aufirst%3DD.%26aulast%3DCholkan%26aufirst%3DA.%26aulast%3DGilani%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DJ.%26aulast%3DJovey%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DMailis-Gagnon%26aufirst%3DA.%26aulast%3DPanju%26aufirst%3DA.%26aulast%3DRollman%26aufirst%3DG.%2BB.%26aulast%3DVelly%26aufirst%3DA.%26atitle%3DPharmacological%2520Management%2520of%2520Chronic%2520Neuropathic%2520Pain%25E2%2580%2594Consensus%2520Statement%2520and%2520Guidelines%2520from%2520the%2520Canadian%2520Pain%2520Society%26jtitle%3DPain%2520Res.%2520Manage.%26date%3D2007%26volume%3D12%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwokin, R. H.</span><span> </span><span class="NLM_article-title">Treatment of Neuropathic Pain: An Overview of Recent Guidelines</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">s22</span><span class="NLM_x">–</span> <span class="NLM_lpage">s32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=s22-s32&author=A.+B.+O%E2%80%99Connorauthor=R.+H.+Dwokin&title=Treatment+of+Neuropathic+Pain%3A+An+Overview+of+Recent+Guidelines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DDwokin%26aufirst%3DR.%2BH.%26atitle%3DTreatment%2520of%2520Neuropathic%2520Pain%253A%2520An%2520Overview%2520of%2520Recent%2520Guidelines%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2009%26volume%3D122%26spage%3Ds22%26epage%3Ds32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cohen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J. R.</span><span> </span><span class="NLM_article-title">Neuropathic Pain: Mechanisms and Their Clinical Implications</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">f7656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1136%2Fbmj.f7656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=f7656&author=S.+P.+Cohenauthor=J.+R.+Mao&title=Neuropathic+Pain%3A+Mechanisms+and+Their+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f7656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f7656%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BP.%26aulast%3DMao%26aufirst%3DJ.%2BR.%26atitle%3DNeuropathic%2520Pain%253A%2520Mechanisms%2520and%2520Their%2520Clinical%2520Implications%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2014%26volume%3D348%26spage%3Df7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vranken, J. H.</span><span> </span><span class="NLM_article-title">Elucidation of Pathophysiology and Treatment of Neuropathic Pain</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F187152412803760645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=304-314&author=J.+H.+Vranken&title=Elucidation+of+Pathophysiology+and+Treatment+of+Neuropathic+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of pathophysiology and treatment of neuropathic pain</span></div><div class="casAuthors">Vranken, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain, pain arising as a direct consequence of a lesion or disease affecting the somatosensory system, is relatively common, occurring in about 1% of the population.  Studies in animal models describe a no. of peripheral and central pathophysiol. processes after nerve injury that would be the basis of underlying neuropathic pain mechanism.  Addnl., neuro-imaging (positron emission tomog. and functional magnetic resonance imaging) provides insights in brain mechanisms corresponding with mechanistic processes including allodynia, hyperalgesia, altered sensation, and spontaneous pain.  A change in function, chem., and structures of neurons (neural plasticity) underlie the prodn. of the altered sensitivity characteristics of neuropathic pain.  Peripheral processes in neuropathic pain involve prodn. of mediators (cytokines, protons, nerve growth factor), alterations in calcium channels, sodium channels, hyperpolarisation-activated nucleotide-gated ion channels, and potassium channels, phenotypic switches and sprouting of nerves endings, and involvement of the sympathetic nervous system.  Stimulation of the N-Methyl-D-Aspartate receptor, activation of microglia, oligodendrocytes, and astrocytes, increased prodn. of nerve growth factor and brain-derived neurotrophic factor together with loss of spinal inhibitory control are responsible for central neuron hyperexcitability and maintenance of neuropathic pain.  Recent advances, including functional imaging techniques, in identification of peripheral and central sensitization mechanisms related to nervous system injury have increased potential for affecting pain research from both diagnostic as well as therapeutic view.  Key brain regions involved in generating pharmacol. induced analgesia may be identified.  Despite the progress in pain research, neuropathic pain is challenge to manage.  Although numerous treatment options are available for relieving neuropathic pain, there is no consensus on the most appropriate treatment.  However, recommendations can be proposed for first-line, second-line, and third-line pharmacol. treatments based on the level of evidence for the different treatment strategies.  Available therapies shown to be effective in managing neuropathic pain include opioids and tramadol, anticonvulsants, antidepressants, topical treatments (lidocaine patch, capsaicin), and ketamine.  Tricyclic antidepressants are often the first drugs selected to alleviate neuropathic pain (first-line pharmacol. treatment).  Although they are very effective in reducing pain in several neuropathic pain disorders, treatment may be compromised (and outweighed) by their side effects.  In patients with a history of cardiovascular disorders, glaucoma, and urine retention, pregabalin and gabapentine are emerging as first-line treatment for neuropathic pain.  In addn. these anti-epileptic drugs have a favorable safety profile with minimal concerns regarding drug interactions and showing no interference with hepatic enzymes.  Alternatively, opioids (oxycodone and methadone) and tramadol may alleviate nociceptive and neuropathic pain.  Despite the numerous treatment options available for relieving neuropathic pain, no more than half of patients experience clin. meaningful pain relief, which is almost always partial but not complete relief.  In addn., patients frequently experience burdensome adverse effects and as a consequence are often unable to tolerate the treatment.  In the remaining patients, combination therapies using two or more analgesics with different mechanisms of action may also offer adequate pain relief.  Although combination treatment is clin. practice and may result in greater pain relief, trials regarding different combinations of analgesics (which combination to use, occurrence of additive or supra-additive effects, sequential or concurrent treatment, adverse-event profiles of these analgesics, alone and in combination) are scarce.  If medical treatments have failed, invasive therapies such as intrathecal drug administration and neurosurgical stimulation techniques (spinal cord stimulation, deep brain stimulation, and motor cortex stimulation) may be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV4fUWGo1P_rVg90H21EOLACvtfcHk0lj1P2boPY4oUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFSitg%253D%253D&md5=d4544bc635b30fc12447c75a6cc829d0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F187152412803760645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152412803760645%26sid%3Dliteratum%253Aachs%26aulast%3DVranken%26aufirst%3DJ.%2BH.%26atitle%3DElucidation%2520of%2520Pathophysiology%2520and%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D304%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">s3</span><span class="NLM_x">–</span> <span class="NLM_lpage">s14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=s3-s14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanp%C3%A4%C3%A4author=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+Pharmacological+Management+of+Neuropathic+Pain%3A+An+Overview+and+Literature+Update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0lj1P2boPY4oUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520Pharmacological%2520Management%2520of%2520Neuropathic%2520Pain%253A%2520An%2520Overview%2520and%2520Literature%2520Update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3Ds3%26epage%3Ds14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Martin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eades, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppler, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. E.</span><span> </span><span class="NLM_article-title">The Effects of Morphine- and Nalorphine-Like Drugs in the Nondependent and Morphine-Dependent Chronic Spinal Dog</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+Effects+of+Morphine-+and+Nalorphine-Like+Drugs+in+the+Nondependent+and+Morphine-Dependent+Chronic+Spinal+Dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0liDpGbT0yOOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Effects%2520of%2520Morphine-%2520and%2520Nalorphine-Like%2520Drugs%2520in%2520the%2520Nondependent%2520and%2520Morphine-Dependent%2520Chronic%2520Spinal%2520Dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zukin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Behavioral and Biochemical Stereoselectivity of Sigma Opiate/PCP Receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0006-8993%2884%2991326-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=6199090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1984&pages=174-177&author=S.+R.+Zukinauthor=K.+T.+Bradyauthor=B.+L.+Sliferauthor=R.+L.+Balster&title=Behavioral+and+Biochemical+Stereoselectivity+of+Sigma+Opiate%2FPCP+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span></div><div class="casAuthors">Zukin, Stephen R.; Brady, Kathleen T.; Slifer, Barbara L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-7</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The relative potencies of (±)-ketamine [(±)-I]  [6740-88-1], (+)-I  [33643-49-1], (-)-I  [33643-46-8], (±)-N-allylnormetazocine [(±)-II]  [7313-95-3], (+)-II  [58640-82-7], (-)-II  [14198-28-8], (±)-cyclazocine [(±)-III]  [7346-09-0], (+)-III  [7313-87-3], and (-)-III  [7313-86-2] at μ opiate receptors and at σ opiate/phencyclidine (PCP)  [77-10-1] receptors were detd. in vitro in rat brain homogenates (displacement of labeled dihydromorphine  [509-60-4] and PCP for the μ and PCP receptors, resp.) and in a discriminative stimulus behavioral paradigm in rats (PCP vs. saline).  In all cases the in vitro and in vivo data were in agreement.  (+)-II and (+)-III were highly specific σ opiate/PCP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7YsmwYzvSm7Vg90H21EOLACvtfcHk0liDpGbT0yOOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D&md5=06d1ca0c2d406f214ea9fd43b1e9c7c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2991326-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252991326-X%26sid%3Dliteratum%253Aachs%26aulast%3DZukin%26aufirst%3DS.%2BR.%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DSlifer%26aufirst%3DB.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DBehavioral%2520and%2520Biochemical%2520Stereoselectivity%2520of%2520Sigma%2520Opiate%252FPCP%2520Receptors%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D294%26spage%3D174%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerchner, G. A.</span><span> </span><span class="NLM_article-title">Sigma Opioid Receptor: Characterization and Co-identity with the Phencyclidine Receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2989489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=597-602&author=L.+G.+Mendelsohnauthor=V.+Kalraauthor=B.+G.+Johnsonauthor=G.+A.+Kerchner&title=Sigma+Opioid+Receptor%3A+Characterization+and+Co-identity+with+the+Phencyclidine+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma opioid receptor:  characterization and co-identity with the phencyclidine receptor</span></div><div class="casAuthors">Mendelsohn, Laurane G.; Kalra, Vin; Johnson, Bryan G.; Kerchner, Gail A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The properties of the σ opioid receptor of rat brain cortex were characterized using the prototypic ligand 3H-labeled (+)-SKF 10,047  [58640-82-7].  Binding to this receptor was rapid, and equil. was obtained within 30 min at 37°.  Specific binding was linear with protein concn. up to 500 μg/2 mL and was dependent upon protein integrity.  Denaturation by boiling destroyed >95% of the specific binding.  A high-affinity binding site with a dissocn. const. of 150 nM and a max. binding of 2.91 pmol/mg of protein was detd. from a Scatchard plot of the binding data.  The addn. of NaCl or CaCl2 to the buffers markedly decreased binding, with CaCl2 being more potent than NaCl.  A broad pH optimum for specific binding was obsd.; max. binding was at pH 9.0.  The affinity of a no. of ligands for the site and the phencyclidine  [77-10-1] receptor were compared.  The binding (IC50) of 13 ligands to the sigma site showed a correlation of 0.86 with binding to the phencyclidine site.  Thus, the biochem. properties of the σ and phencyclidine receptors are similar, and these receptors may be one and the same site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyw4zOY5vN17Vg90H21EOLACvtfcHk0liDpGbT0yOOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D&md5=20db7f5ed4690c03d95050799953f992</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DKalra%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26atitle%3DSigma%2520Opioid%2520Receptor%253A%2520Characterization%2520and%2520Co-identity%2520with%2520the%2520Phencyclidine%2520Receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma Receptor: Advances and New Clinical Potentials</span> <span class="citation_source-journal">Pharm. Acta Helv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=211-218&author=W.+D.+Bowen&title=Sigma+Receptor%3A+Advances+and+New+Clinical+Potentials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma%2520Receptor%253A%2520Advances%2520and%2520New%2520Clinical%2520Potentials%26jtitle%3DPharm.%2520Acta%2520Helv.%26date%3D2000%26volume%3D74%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hellewell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">A Sigma-like Binding Site in Rat Pheochromocytoma (PC12) Cells: Decreased Affinity for (+)-Benzomorphans and Lower Molecular Weight Suggest a Different Sigma Receptor Form from that in Guinea Pig Brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0006-8993%2890%2991143-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2174717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=1990&pages=244-253&author=S.+B.+Hellewellauthor=W.+D.+Bowen&title=A+Sigma-like+Binding+Site+in+Rat+Pheochromocytoma+%28PC12%29+Cells%3A+Decreased+Affinity+for+%28%2B%29-Benzomorphans+and+Lower+Molecular+Weight+Suggest+a+Different+Sigma+Receptor+Form+from+that+in+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A sigma-like binding site in rat pheochromocytoma (PC12) cells:  decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span></div><div class="casAuthors">Hellewell, Susan B.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Two highly selective radiolabeled probes for sigma receptors were found to bind with high affinity and capacity to membranes from undifferentiated PC12 cells 1,3-di-o-[3H]tolylguanidine ([1H]DTG) bound with Kd = 23.7 nM and Bmax = 2025 fmol/mg protein.  The Kd and Bmax for 3H-labeled (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) were 86.3 nM and 1539 fmol/mg protein, resp.  These binding parameters were comparable to those obsd. in guinea pig brain sites exhibited high affinity for haloperidol, moderate affinity for phencyclidine (PCP), and negligible affinity for MK-801, apomorphine, and (-)-sulpiride.  These data suggest a relationship of the PC12 site to sigma receptors.  However, all (+)-opiates ((+)-benzomorphans and (+)-morphinans) tested bound with markedly lower affinity to the PC12 site compared to guinea pig brain.  These include (+)-N-allylnormetazocine ((+)-SKF 10,047), (+)-pentazocine, and dextrallorphan.  In fact, PC12 sites exhibited preference for (-)-benzomorphans, the reverse stereoselectivity of guinea pig brain sites.  Binding of 3H-labeled N-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) could not be detected, demonstrating absence of PCP receptors on this cell line.  Differentiation of cells by treatment with nerve growth factor had no effect on sigma binding parameters.  Membranes from guinea pig brain and PC12 cells were photoaffinity-labeled using azido-di-o [3H]tolylguanidine.  In guinea pig brain, a polypeptide of 25 kDa was specifically labeled.  However, label was incorporated into polypeptides of 18 kDa and 21 kDa in membranes from PC12 cells.  In view of the otherwise similar binding characteristics, the marked differences in affinity for (+)-benzomorphans and mol. wt. suggest that PC12 cells contain a mol. form of sigma receptor distinct from that predominant in guinea pig brain.  This raises the possibility of multiple sigma receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSWLms51RjbVg90H21EOLACvtfcHk0lgbiCUGBJpM0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D&md5=cdb78ce18d40ae20a42e7215a3cbd0a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2890%2991143-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252890%252991143-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DA%2520Sigma-like%2520Binding%2520Site%2520in%2520Rat%2520Pheochromocytoma%2520%2528PC12%2529%2520Cells%253A%2520Decreased%2520Affinity%2520for%2520%2528%252B%2529-Benzomorphans%2520and%2520Lower%2520Molecular%2520Weight%2520Suggest%2520a%2520Different%2520Sigma%2520Receptor%2520Form%2520from%2520that%2520in%2520Guinea%2520Pig%2520Brain%26jtitle%3DBrain%2520Res.%26date%3D1990%26volume%3D527%26spage%3D244%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Quirion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzhak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarm, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+M.+Musacchioauthor=R.+B.+Rothmanauthor=T.+P.+Suauthor=S.+W.+Tarmauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2eYWmbFmzOWPIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DTarm%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span> </span><span class="NLM_article-title">Understanding the Molecular Mechanism of Sigma-1 Receptor: Towards a Hypothesis that Sigma-1 Receptor Are Intracellular Amplifiers for Signal Transduction</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F0929867033456783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=12871086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=2073-2080&author=T.+P.+Suauthor=T.+Hayashi&title=Understanding+the+Molecular+Mechanism+of+Sigma-1+Receptor%3A+Towards+a+Hypothesis+that+Sigma-1+Receptor+Are+Intracellular+Amplifiers+for+Signal+Transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the molecular mechanism of sigma-1 receptors: Towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction</span></div><div class="casAuthors">Su, Tsung-Ping; Hayashi, Teruo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2073-2080</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although sigma receptors were discovered in 1982, the biochem. and physiol. roles of sigma receptors have just begun to unveil.  Sigma receptors are non-opioid, non-phencyclidine receptors that contain two subtypes: Sigma-1 and Sigma-2 receptors.  The sigma-1 receptor has been cloned and its sequence does not resemble that of any mammalian protein.  Sigma-2 receptors have not been cloned.  Sigma-1 receptors contain 223 amino acids and reside primarily at the endoplasmic reticulum.  Sigma-1 receptors exist mainly in the central nervous system, but also in the periphery.  Sigma-1 receptor ligands include cocaine, (+)-benzomorphans like (+)-pentazocine and (+)N-allyl-normetazocine (or (+)SKF-10047), and endogenous neurosteroids like progesterone and pregnenolone sulfate.  Many pharmacol. and physiol. actions have been attributed to sigma-1 receptors.  These include the regulation of IP3 receptors and calcium signaling at the endoplasmic reticulum, mobilization of cytoskeletal adaptor proteins, modulation of nerve growth factor-induced neurite sprouting, modulation of neurotransmitter release and neuronal firing, modulation of potassium channels as a regulatory subunit, alteration of psychostimulant-induced gene expression, and blockade of spreading depression.  Behaviorally, sigma-1 receptors are involved in learning and memory, psychostimulant-induced sensitization, cocaine-induced conditioned place preference, and pain perception.  Notably, in almost all the aforementioned biochem. and behavioral tests, sigma-1 agonists, while having no effects by themselves, caused the amplification of signal transductions incurred upon the stimulation of the glutamatergic, dopaminergic, IP3-related metabotropic, or nerve growth factor-related systems.  Thus, it is hypothesized that sigma-1 receptors, at least in part, are intracellular amplifiers creating a supersensitized state for signal transduction in the biol. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6DJ73APuq7Vg90H21EOLACvtfcHk0lgbiCUGBJpM0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslyqtrY%253D&md5=771f615ddf6b87b9b17f564c5e7ad162</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F0929867033456783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033456783%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DHayashi%26aufirst%3DT.%26atitle%3DUnderstanding%2520the%2520Molecular%2520Mechanism%2520of%2520Sigma-1%2520Receptor%253A%2520Towards%2520a%2520Hypothesis%2520that%2520Sigma-1%2520Receptor%2520Are%2520Intracellular%2520Amplifiers%2520for%2520Signal%2520Transduction%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D2073%26epage%3D2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Pharmacology and Therapeutic Potential of Sigma-1 Receptor Ligands</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F157015908787386113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=19587856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=344-366&author=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=C.+M.+Cend%C3%A1nauthor=E.+Del+Pozo&title=Pharmacology+and+Therapeutic+Potential+of+Sigma-1+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and therapeutic potential of sigma1 receptor ligands</span></div><div class="casAuthors">Cobos, E. J.; Entrena, J. M.; Nieto, F. R.; Cendan, C. M.; del Pozo, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">344-366</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, initially described as a subtype of opioid receptors, are now considered unique receptors.  Pharmacol. studies have distinguished two types of σ receptors, termed σ1 and σ2.  Of these two subtypes, the σ1 receptor has been cloned in humans and rodents, and its amino acid sequence shows no homol. with other mammalian proteins.  Several psychoactive drugs show high to moderate affinity for σ1 receptors, including the antipsychotic haloperidol, the antidepressant drugs fluvoxamine and sertraline, and the psychostimulants cocaine and methamphetamine; in addn., the anticonvulsant drug phenytoin allosterically modulates σ1 receptors.  Certain neurosteroids are known to interact with σ1 receptors, and have been proposed to be their endogenous ligands.  These receptors are located in the plasma membrane and in subcellular membranes, particularly in the endoplasmic reticulum, where they play a modulatory role in intracellular Ca2+ signaling.  Sigma1 receptors also play a modulatory role in the activity of some ion channels and in several neurotransmitter systems, mainly in glutamatergic neurotransmission.  In accordance with their widespread modulatory role, σ1 receptor ligands have been proposed to be useful in several therapeutic fields such as amnesic and cognitive deficits, depression and anxiety, schizophrenia, analgesia, and against some effects of drugs of abuse (such as cocaine and methamphetamine).  In this review we provide an overview of the present knowledge of σ1 receptors, focusing on σ1 ligand neuropharmacol. and the role of σ1 receptors in behavioral animal studies, which have contributed greatly to the potential therapeutic applications of σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTkDMnDR6uN7Vg90H21EOLACvtfcHk0lhjV1rAlECXDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSqu7w%253D&md5=37895c10c7ef1bb7077d0782f73d5776</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157015908787386113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015908787386113%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPharmacology%2520and%2520Therapeutic%2520Potential%2520of%2520Sigma-1%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2008%26volume%3D6%26spage%3D344%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Monnet, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced neuronal activation is selectively modulated by sigma receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0014-2999%2890%2990186-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2163857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1990&pages=441-455&author=F.+P.+Monnetauthor=G.+Debonnelauthor=J.+L.+Junienauthor=C.+De+Montigny&title=N-Methyl-d-aspartate-induced+neuronal+activation+is+selectively+modulated+by+sigma+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors</span></div><div class="casAuthors">Monnet, Francois P.; Debonnel, Guy; Junien, Jean Louis; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of 2 high-affinity σ ligands, DTG (1,3-di(2-tolyl)guanidine) and haloperidol, on the activation of dorsal hippocampus pyramidal neurons induced by microiontophoretic application of N-methyl-D-aspartate (NMDA) were assessed electrophysiol.  Low doses of DTG (0.5-3 μg/kg, i.v.) potentiated the NMDA response.  This effect of DTG was blocked by haloperidol (10 μg/kg i.v.), but not by spiperone, a potent dopamine antagonist with low affinity for σ receptors.  Apparently, σ receptors modulate the NMDA-induced neuronal activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAVkVDgk_ebVg90H21EOLACvtfcHk0lhjV1rAlECXDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D&md5=415aeb364969efa07c6149f19404209f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2890%2990186-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252890%252990186-A%26sid%3Dliteratum%253Aachs%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DN-Methyl-d-aspartate-induced%2520neuronal%2520activation%2520is%2520selectively%2520modulated%2520by%2520sigma%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D179%26spage%3D441%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cheng, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">zheng, P.</span><span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2010&pages=128-136&author=Z.+X.+Chengauthor=M.+D.+Lanauthor=P.+X.+Wuauthor=Y.+H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%2BX.%26aulast%3DLan%26aufirst%3DM.%2BD.%26aulast%3DWu%26aufirst%3DP.%2BX.%26aulast%3DZhu%26aufirst%3DY.%2BH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3Dzheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D210%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ayder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span> </span><span class="NLM_article-title">The Sigma Receptor as A Ligand-Regulated Auxiliary Potassium Channel Subunit</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=399-410&author=E.+Ayderauthor=C.+P.+Palmerauthor=V.+A.+Klyachkoauthor=M.+B.+Jackson&title=The+Sigma+Receptor+as+A+Ligand-Regulated+Auxiliary+Potassium+Channel+Subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyder%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DC.%2BP.%26aulast%3DKlyachko%26aufirst%3DV.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Sigma%2520Receptor%2520as%2520A%2520Ligand-Regulated%2520Auxiliary%2520Potassium%2520Channel%2520Subunit%26jtitle%3DNeuron%26date%3D2002%26volume%3D34%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> Signaling via σ<sub>1</sub> Receptor: Novel Regulatory Mechanism Affecting Intracellular Ca<sup>2+</sup> Concentration</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=10869377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=788-798&author=T.+Hayashiauthor=T.+Mauriceauthor=T.+P.+Su&title=Ca2%2B+Signaling+via+%CF%831+Receptor%3A+Novel+Regulatory+Mechanism+Affecting+Intracellular+Ca2%2B+Concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ signaling via σ1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration</span></div><div class="casAuthors">Hayashi, Teruo; Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-798</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ1-receptor is a one-transmembrane endoplasmic reticulum protein that binds neurosteroids and dextrorotatory benzomorphans.  The roles of σ1-receptors in regulating intracellular Ca2+ in NG108 cells were examd. in this study.  σ1-Ligands pregnenolone sulfate, (+)-pentazocine, and 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride modulate Ca2+ signaling in NG 108 cells via two modes of action.  First, nanomolar concns. of the ligands, without effect by themselves, potentiated the bradykinin-induced increase of the cytosolic free Ca2+ concn. in a bell-shaped manner.  This effect of σ1-ligands was unaffected by depletion of Ca2+ from perfusion buffer and was blocked by a 21-mer antisense oligodeoxynucleotide against the cloned σ1-receptors.  Second, after the cells were depleted of the endoplasmic reticulum Ca2+ stores, the depolarization (75 mM KCl)-induced increase in cytosolic free Ca2+ was potentiated by 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride, whereas it was inhibited by pregnenolone sulfate and (+)-pentazocine.  These effects, albeit opposite in direction, were blocked by both the 21-mer antisense oligodeoxynucleotide and pertussis toxin.  Western blotting indicates that σ1-receptors are increased on the plasma membrane and the nuclear membrane in the presence of σ1-ligand.  These results suggest that Ca2+ signaling via σ1-receptors may represent a novel mechanism that affects intracellular Ca2+ concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5UrPmwIQdrVg90H21EOLACvtfcHk0lhjV1rAlECXDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D&md5=de8007846ac5a0a4292c2f501a049a7c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DCa2%252B%2520Signaling%2520via%2520%25CF%25831%2520Receptor%253A%2520Novel%2520Regulatory%2520Mechanism%2520Affecting%2520Intracellular%2520Ca2%252B%2520Concentration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Crawford, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-2 Receptor Agonists Activate A Novel Apoptotic Pathway and Potentiate Antineoplastic Drugs in Breast Tumor Cell Lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=313-322&author=K.+W.+Crawfordauthor=W.+D.+Bowen&title=Sigma-2+Receptor+Agonists+Activate+A+Novel+Apoptotic+Pathway+and+Potentiate+Antineoplastic+Drugs+in+Breast+Tumor+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DK.%2BW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-2%2520Receptor%2520Agonists%2520Activate%2520A%2520Novel%2520Apoptotic%2520Pathway%2520and%2520Potentiate%2520Antineoplastic%2520Drugs%2520in%2520Breast%2520Tumor%2520Cell%2520Lines%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D1%26spage%3D313%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The Sigma-2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+B.+Zengauthor=W.+G.+Hawkins&title=The+Sigma-2+Receptor%3A+A+Novel+Protein+for+the+Imaging+and+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%2BB.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Sigma-2%2520Receptor%253A%2520A%2520Novel%2520Protein%2520for%2520the%2520Imaging%2520and%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bermack, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span> </span><span class="NLM_article-title">The Role of Sigma Receptors in Depression</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1254%2Fjphs.CRJ04005X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15750289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=317-336&author=J.+E.+Bermackauthor=G.+Debonnel&title=The+Role+of+Sigma+Receptors+in+Depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sigma receptors in depression</span></div><div class="casAuthors">Bermack, Jordanna E.; Debonnel, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-336</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Behavioral models used to test potential antidepressants have shown that ligands that bind to sigma receptors possess "antidepressant-like" properties.  The focus of this review is to discuss the literature concerning sigma receptors and their ligands, with respect to their antidepressants properties.  In addn. to the behavioral data, we discuss electrophysiol. and biochem. models demonstrating sigma receptors' ability to modulate important factors in the pathophysiol. of depression and/or the mechanisms of action of antidepressants such as the serotonergic neurotransmission in the dorsal raphe nucleus (DRN) and the glutamatergic transmission in the hippocampus.  We also discuss the significance of these two systems in the mechanism of action of antidepressants.  Sigma ligands have potential as antidepressant medications with a fast onset of action as they produce a rapid modulation of the serotonergic system in the DRN and the glutamatergic transmission in the hippocampus.  As these effects of sigma ligands may produce antidepressant properties by completely novel mechanisms of action, they may provide an alternative to the antidepressants currently available and may prove to be beneficial for treatment-resistant depressed patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc8adYlmpSrVg90H21EOLACvtfcHk0liDM728K5OSNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D&md5=1cdda174b9b1e5087118ae49526b3eb0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CRJ04005X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CRJ04005X%26sid%3Dliteratum%253Aachs%26aulast%3DBermack%26aufirst%3DJ.%2BE.%26aulast%3DDebonnel%26aufirst%3DG.%26atitle%3DThe%2520Role%2520of%2520Sigma%2520Receptors%2520in%2520Depression%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D97%26spage%3D317%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span> </span><span class="NLM_article-title">Effect of the Novel Sigma 1 Receptor Ligand and Putative Atypical Antipsychotic E-5842 on BDNF mRNA Expression in the Rat Brain</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=2345-2348&author=S.+Ovalleauthor=F.+Andreuauthor=M.+P.+P%C3%A9rezauthor=D.+Zamanilloauthor=X.+Guitart&title=Effect+of+the+Novel+Sigma+1+Receptor+Ligand+and+Putative+Atypical+Antipsychotic+E-5842+on+BDNF+mRNA+Expression+in+the+Rat+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DAndreu%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%2BP.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DGuitart%26aufirst%3DX.%26atitle%3DEffect%2520of%2520the%2520Novel%2520Sigma%25201%2520Receptor%2520Ligand%2520and%2520Putative%2520Atypical%2520Antipsychotic%2520E-5842%2520on%2520BDNF%2520mRNA%2520Expression%2520in%2520the%2520Rat%2520Brain%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D2345%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The Potential Role of Sigma-1 Receptor in Lipid Transport and Lipid Raft Reconstitution in the Brain: Implication for Drug Abuse</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1612-1624&author=T.+Hayashiauthor=T.+P.+Su&title=The+Potential+Role+of+Sigma-1+Receptor+in+Lipid+Transport+and+Lipid+Raft+Reconstitution+in+the+Brain%3A+Implication+for+Drug+Abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520Potential%2520Role%2520of%2520Sigma-1%2520Receptor%2520in%2520Lipid%2520Transport%2520and%2520Lipid%2520Raft%2520Reconstitution%2520in%2520the%2520Brain%253A%2520Implication%2520for%2520Drug%2520Abuse%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1612%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Attenuation by A Sigma<sub>1</sub> (σ<sub>1</sub>) Receptor Agonist of the Learning and Memory Deficits Induced by a Prenatal Restraint Stress in Juvenile Rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1038%2Fsj.bjp.0705835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15205309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2004&pages=689-700&author=J.+Meunierauthor=M.+Gueauthor=M.+Recasensauthor=T.+Maurice&title=Attenuation+by+A+Sigma1+%28%CF%831%29+Receptor+Agonist+of+the+Learning+and+Memory+Deficits+Induced+by+a+Prenatal+Restraint+Stress+in+Juvenile+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation by a sigma1 (σ1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span></div><div class="casAuthors">Meunier, Johann; Gue, Michele; Recasens, Max; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1: Stress during pregnancy results in complex neurochem. and behavioral alterations throughout the offspring lifetime.  We here examd. the impact of prenatal stress (PS) on memory functions in male and female offspring and report the efficacy of a selective sigma1 (σ1) receptor agonist, igmesine, in alleviating the obsd. deficits.  2: Dams received an unpredictable 90-min duration restraint stress from gestational day E17 to E20.  Learning was examd. in offspring between day P24 and P36 using spontaneous alternation in the Y-maze, delayed alternation in the T-maze, water-maze learning and passive avoidance.  3: Both male and female PS rats showed impairments of spontaneous and delayed alternation performances.  Acquisition of a fixed platform position in the water-maze was unchanged in PS rats, but the probe test revealed a diminution of time spent in the training quadrant.  Acquisition of a daily changing platform position demonstrated impaired working memory for male and female PS rats.  Finally, passive avoidance deficits were obsd.  4: Pretreatment with the selective σ1 agonist igmesine (1-10 mg kg-1 i.p.) reversed the PS-induced learning deficits in offspring rats for each test.  The σ1 antagonist BD1063 failed to affect performances alone but blocked the igmesine effect, confirming the involvement of the σ1 receptor.  5: PS thus induces delayed memory deficits, affecting spatial and nonspatial, short- and long-term memories in juvenile male and female offspring rats.  Activation of the σ1 neuromodulatory receptor allows a significant recovery of the memory functions in PS rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhtHAjlawprVg90H21EOLACvtfcHk0liqXynIGcpCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D&md5=cc7f51d2bef3acb88732499642b49a77</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705835%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DGue%26aufirst%3DM.%26aulast%3DRecasens%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAttenuation%2520by%2520A%2520Sigma1%2520%2528%25CF%25831%2529%2520Receptor%2520Agonist%2520of%2520the%2520Learning%2520and%2520Memory%2520Deficits%2520Induced%2520by%2520a%2520Prenatal%2520Restraint%2520Stress%2520in%2520Juvenile%2520Rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D142%26spage%3D689%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma 1 Receptor: A New Therapeutic Target for Pain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">716</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+Receptor%3A+A+New+Therapeutic+Target+for+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0liqXynIGcpCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520Receptor%253A%2520A%2520New%2520Therapeutic%2520Target%2520for%2520Pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Functional Antagonism of Morphine Analgesia by (+)-Pentazocine: Evidence for an Anti-opioid Sigma 1 System</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">R7</span><span class="NLM_x">–</span> <span class="NLM_lpage">R8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1993&pages=R7-R8&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Functional+Antagonism+of+Morphine+Analgesia+by+%28%2B%29-Pentazocine%3A+Evidence+for+an+Anti-opioid+Sigma+1+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DFunctional%2520Antagonism%2520of%2520Morphine%2520Analgesia%2520by%2520%2528%252B%2529-Pentazocine%253A%2520Evidence%2520for%2520an%2520Anti-opioid%2520Sigma%25201%2520System%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D250%26spage%3DR7%26epage%3DR8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">(−)-Pentazocine Analgesia in Mice: Interactions with a Sigma Receptor System</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0014-2999%2895%2900552-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=8788445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSgsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1995&pages=303-308&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=%28%E2%88%92%29-Pentazocine+Analgesia+in+Mice%3A+Interactions+with+a+Sigma+Receptor+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-Pentazocine analgesia in mice: interactions with a σ receptor system</span></div><div class="casAuthors">Chien, C.-C.; Pasternak, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">303-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(-)-Pentazocine is active in the tail-flick assay in CD-1 mice, although it shows a biphasic dose-response curve with a peak effect of only 30%.  Co-administration of haloperidol shifts the dose-response curve to the left and elevates the maximal response to 70% through a blockade of σ1 receptors, but the curve remains biphasic. (+)-Pentazocine is inactive in all antinociceptive assays, either alone or with haloperidol.  The analgesic actions of (-)-pentazocine are readily reversed by nor-binaltorphimine, but not by the μ-selective opioid receptor antagonist β-funaltrexamine, implying a κ1-opioid receptor mechanism of action.  This conclusion is supported by the ability of antisense oligodeoxynucleotides directed against the KOR-1 clone, which encodes the κ1-opioid receptor, to block (-)-pentazocine analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44ztcW7-k47Vg90H21EOLACvtfcHk0liqXynIGcpCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSgsbrK&md5=4b298a555e0175f771326de69c996420</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900552-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900552-8%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3D%2528%25E2%2588%2592%2529-Pentazocine%2520Analgesia%2520in%2520Mice%253A%2520Interactions%2520with%2520a%2520Sigma%2520Receptor%2520System%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D294%26spage%3D303%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Sigma Antagonists Potentiate Opioid Analgesia in Rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0304-3940%2895%2911504-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=7644123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1995&pages=137-139&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Sigma+Antagonists+Potentiate+Opioid+Analgesia+in+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma antagonists potentiate opioid analgesia in rats</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-9</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In mice, activation of sigma1 receptors antagonizes opioid analgesia.  Sigma antagonists potentiate opioid analgesia, implying that the anti-opioid sigma system is tonically active.  Co-administration of haloperidol with the mu opioid morphine, the kappa1 analgesic U 50488H or the kappa3 agonist naloxone benzoylhydrazone enhances the analgesic activity of all agents.  The effect results from sigma receptor blockade since (-)sulpiride, a selective D2 antagonist which does not block sigma receptors, is inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT7Y-iEDEl3bVg90H21EOLACvtfcHk0liqXynIGcpCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D&md5=66ace8f372aca6d388626a9d9ba09728</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2911504-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252911504-P%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%2520Antagonists%2520Potentiate%2520Opioid%2520Analgesia%2520in%2520Rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D190%26spage%3D137%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kim, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovalyshyn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chein, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=695-703&author=F.+J.+Kimauthor=I.+Kovalyshynauthor=M.+Burgmanauthor=C.+Neilanauthor=C.+C.+Cheinauthor=G.+W.+Pasternak&title=Sigma-1+Receptor+Modulation+of+G-Protein-Coupled+Receptor+Signaling%3A+Potentiation+of+Opioid+Transduction+Independent+from+Receptor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DF.%2BJ.%26aulast%3DKovalyshyn%26aufirst%3DI.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DNeilan%26aufirst%3DC.%26aulast%3DChein%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma-1%2520Receptor%2520Modulation%2520of%2520G-Protein-Coupled%2520Receptor%2520Signaling%253A%2520Potentiation%2520of%2520Opioid%2520Transduction%2520Independent%2520from%2520Receptor%2520Binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D695%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">King, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Enhanced κ-Opioid Receptor-Mediated Analgesia by Antisense Targeting the Sigma-1 Receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">R5</span><span class="NLM_x">–</span> <span class="NLM_lpage">R6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1997&pages=R5-R6&author=M.+Kingauthor=Y.+X.+Panauthor=J.+Meiauthor=A.+Changauthor=J.+Xuauthor=G.+W.+Pasternak&title=Enhanced+%CE%BA-Opioid+Receptor-Mediated+Analgesia+by+Antisense+Targeting+the+Sigma-1+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DEnhanced%2520%25CE%25BA-Opioid%2520Receptor-Mediated%2520Analgesia%2520by%2520Antisense%2520Targeting%2520the%2520Sigma-1%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D331%26spage%3DR5%26epage%3DR6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Selective Antagonism of Opioid Analgesia by a Sigma Receptor System</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=7996472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=1583-1590&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Selective+Antagonism+of+Opioid+Analgesia+by+a+Sigma+Receptor+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism of opioid analgesia by a sigma system</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1583-90</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">(+)-Pentazocine antagonizes morphine analgesia as potently as its (-) isomer, ruling out an opioid receptor mechanism of action and suggesting a role for sigma1 receptors.  Systemic (+)-pentazocine also reverses supraspinal or spinal morphine analgesia.  1,3-Di(2-tolyl)guanidine, a sigma ligand with no appreciable opioid receptor affinity, antagonizes morphine analgesia.  The actions of both (+)-pentazocine and 1,3-di(2-tolyl)guanidine are reversed by haloperidol, which has high affinity for both sigma and D2 receptors, but not by the D2-selective antagonist (-)-sulpiride, which lacks activity at sigma sites.  The antiopioid sigma system is tonically active.  Haloperidol, but not (-)-sulpiride, decreases morphine ED50 almost 2-fold.  The antiopioid system modulates only mu analgesia.  Unlike analgesia, (+)-pentazocine does not influence morphine's inhibition of gastrointestinal transit or lethality.  (+)-Pentazocine also antagonizes kappa1, kappa3 and delta analgesia through sigma mechanisms in a haloperidol-sensitive manner.  (-)-Sulpiride is inactive.  Alone, haloperidol enhances kappa1, kappa3 and delta analgesia more dramatically than morphine, which indicates that the sigma system is active against all opioid analgesic systems.  Sigma systems are responsible for some strain differences in kappa receptor sensitivity.  Unlike CD-1 mice, BALB-C mice are relatively insensitive toward the kappa1 agent U50,488H and the kappa3 analgesic naloxone benzoylhydrazone.  Blockade of the sigma system with haloperidol eliminates these strain differences.  In conclusion, sigma1 systems functionally antagonize opioid analgesia without affecting morphine's effects on gastrointestinal transit or lethality.  The antiopioid sigma system is tonically active and is more active against kappa analgesia than mu.  The level of this tonic activity plays a significant role in strain differences in analgesic sensitivity toward opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPi-tKcGCFM7Vg90H21EOLACvtfcHk0lg4bihTagujIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D&md5=d1314dcf06a32a48599975aa5208c4b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSelective%2520Antagonism%2520of%2520Opioid%2520Analgesia%2520by%2520a%2520Sigma%2520Receptor%2520System%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D1583%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoliu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Formalin-Induced Pain is Reduced in Sigma 1 Receptor Knockout Mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-Induced+Pain+is+Reduced+in+Sigma+1+Receptor+Knockout+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lg4bihTagujIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-Induced%2520Pain%2520is%2520Reduced%2520in%2520Sigma%25201%2520Receptor%2520Knockout%2520Mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptors Are Essential for Capsaicin-Induced Mechanical Hypersensitivity: Studies with Selective Sigma-1 Ligands and Sigma-1 Knockout Mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+D.+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+Receptors+Are+Essential+for+Capsaicin-Induced+Mechanical+Hypersensitivity%3A+Studies+with+Selective+Sigma-1+Ligands+and+Sigma-1+Knockout+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DPozo%26aufirst%3DE.%2BD.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520Receptors%2520Are%2520Essential%2520for%2520Capsaicin-Induced%2520Mechanical%2520Hypersensitivity%253A%2520Studies%2520with%2520Selective%2520Sigma-1%2520Ligands%2520and%2520Sigma-1%2520Knockout%2520Mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Fernández, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.jpain.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23063344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1107-1121&author=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=M.+A.+Tejadaauthor=D.+Zamanilloauthor=J.+M.+Velaauthor=J.+M.+Baeyens&title=Role+of+Sigma-1+Receptors+in+Paclitaxel-Induced+Neuropathic+Pain+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span></div><div class="casAuthors">Nieto, Francisco Rafael; Cendan, Cruz Miguel; Sanchez-Fernandez, Cristina; Cobos, Enrique Jose; Entrena, Jose Manuel; Tejada, Miguel Angel; Zamanillo, Daniel; Vela, Jose Miguel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sigma-1 (σ1) receptors play a role in different types of pain and in central sensitization mechanisms; however, it is unknown whether they are involved in chemotherapy-induced neuropathic pain.  We compared the ability of paclitaxel to induce cold (acetone test) and mech. (electronic Von Frey test) allodynia in wild-type (WT) and σ1 receptor knockout (σ1-KO) mice.  We also tested the effect on paclitaxel-induced painful neuropathy of BD-1063 (16-64 mg/kg, s.c.) and S1RA (32-128 mg/kg, s.c.), 2 selective σ1 receptor antagonists that bind to the σ1 receptor with high affinity and competitively.  The responses to cold and mech. stimuli were similar in WT and σ1-KO mice not treated with paclitaxel; however, treatment with paclitaxel (2 mg/kg, i.p., once per day during 5 consecutive days) produced cold and mech. allodynia and an increase in spinal cord diphosphorylated extracellular signal-regulated kinase (pERK) in WT but not in σ1-KO mice.  The administration of BD-1063 or S1RA 30 min before each paclitaxel dose prevented the development of cold and mech. allodynia in WT mice.  Moreover, the acute administration of both σ1 receptor antagonists dose dependently reversed both types of paclitaxel-induced allodynia after they had fully developed.  These results suggest that σ1 receptors play a key role in paclitaxel-induced painful neuropathy.  Perspective: Antagonists of the σ1 receptor may have therapeutic value for the treatment and/or prevention of paclitaxel-induced neuropathic pain.  This possibility is esp. interesting in the context of chemotherapy-induced neuropathy, where the onset of nerve damage is predictable and preventive treatment could be administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHYCYBeIn__bVg90H21EOLACvtfcHk0lj_ipg8L_x9Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I&md5=798467267c69e426eae9df6cde797d6d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DTejada%26aufirst%3DM.%2BA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520Sigma-1%2520Receptors%2520in%2520Paclitaxel-Induced%2520Neuropathic%2520Pain%2520in%2520Mice%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D1107%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">De La Puente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptor Regulate Activity-Induced Spinal Sensitization and Neuropathic Pain after Peripheral Nerve Injury</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=294-303&author=B.+De+La+Puenteauthor=X.+Nadalauthor=E.+Portillo-Salidoauthor=R.+S%C3%A1nchez-Arroyosauthor=S.+Ovalleauthor=G.+Palaciosauthor=A.+Muroauthor=L.+Romeroauthor=J.+M.+Entrenaauthor=J.+M.+Baeyensauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=D.+Zamanilloauthor=J.+M.+Vela&title=Sigma-1+Receptor+Regulate+Activity-Induced+Spinal+Sensitization+and+Neuropathic+Pain+after+Peripheral+Nerve+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BPuente%26aufirst%3DB.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520Receptor%2520Regulate%2520Activity-Induced%2520Spinal%2520Sensitization%2520and%2520Neuropathic%2520Pain%2520after%2520Peripheral%2520Nerve%2520Injury%26jtitle%3DPain%26date%3D2009%26volume%3D145%26spage%3D294%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive Effects of Haloperidol and its Metabolites in the Formalin Test in Mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+Effects+of+Haloperidol+and+its+Metabolites+in+the+Formalin+Test+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520Effects%2520of%2520Haloperidol%2520and%2520its%2520Metabolites%2520in%2520the%2520Formalin%2520Test%2520in%2520Mice%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Antagonism by Haloperidol and its Metabolites of Mechanical Hypersensitivity Induced by Intraplantar Capsaicin in Mice: Role of Sigma-1 Receptors</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1007%2Fs00213-009-1513-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=19326101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=21-33&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Antagonism+by+Haloperidol+and+its+Metabolites+of+Mechanical+Hypersensitivity+Induced+by+Intraplantar+Capsaicin+in+Mice%3A+Role+of+Sigma-1+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors</span></div><div class="casAuthors">Entrena, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.; Cendan, Cruz M.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: We evaluated the effects of haloperidol and its metabolites on capsaicin-induced mech. hypersensitivity (allodynia) and on nociceptive pain induced by punctate mech. stimuli in mice.  Results: S.c. administration of haloperidol or its metabolites I or II (reduced haloperidol) dose-dependently reversed capsaicin-induced (1 μg, intraplantar) mech. hypersensitivity of the hind paw (stimulated with a nonpainful, 0.5-g force, punctate stimulus).  The order of potency of these drugs to induce antiallodynic effects was the order of their affinity for brain sigma-1 (σ1) receptor ([3H](+)-pentazocine-labeled).  Antiallodynic activity of haloperidol and its metabolites was dose-dependently prevented by the selective σ1 receptor agonist PRE-084, but not by naloxone.  These results suggest the involvement of σ1 receptors, but discard any role of the endogenous opioid system, on the antiallodynic effects.  Dopamine receptor antagonism also appears unlikely to be involved in these effects, since the D2/D3 receptor antagonist (-)-sulpiride, which had no affinity for σ1 receptors, showed no antiallodynic effect.  None of these drugs modified hind-paw withdrawal after a painful (4 g force) punctate mech. stimulus in noncapsaicin-sensitized animals.  As expected, the control drug gabapentin showed antiallodynic but not antinociceptive activity, whereas clonidine exhibited both activities and rofecoxib, used as neg. control, showed neither.  Conclusion: These results show that haloperidol and its metabolites I and II produce antiallodynic but not antinociceptive effects against punctate mech. stimuli and suggest that their antiallodynic effect may be due to blockade of σ1 receptors but not to dopamine receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0AnJHWbghLVg90H21EOLACvtfcHk0lj_ipg8L_x9Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kksbg%253D&md5=8b2077efc615a10a83b9dcaa973deeb2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1513-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1513-8%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DAntagonism%2520by%2520Haloperidol%2520and%2520its%2520Metabolites%2520of%2520Mechanical%2520Hypersensitivity%2520Induced%2520by%2520Intraplantar%2520Capsaicin%2520in%2520Mice%253A%2520Role%2520of%2520Sigma-1%2520Receptors%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2009%26volume%3D205%26spage%3D21%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ<sub>1</sub> Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1<i>H</i>-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+Biological+Evaluation+of+the+1-Arylpyrazole+Class+of+%CF%831+Receptor+Antagonists%3A+Identification+of+4-%7B2-%5B5-Methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520the%25201-Arylpyrazole%2520Class%2520of%2520%25CF%25831%2520Receptor%2520Antagonists%253A%2520Identification%2520of%25204-%257B2-%255B5-Methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Arconada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segalés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laloya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escriche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plata-Salamán, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Pharmacological Properties of S1RA, a New Sigma-1 Receptor Antagonist that Inhibits Neuropathic Pain and Activity-Induced Spinal Sensitization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+Properties+of+S1RA%2C+a+New+Sigma-1+Receptor+Antagonist+that+Inhibits+Neuropathic+Pain+and+Activity-Induced+Spinal+Sensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0liemhqbJiw-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520Properties%2520of%2520S1RA%252C%2520a%2520New%2520Sigma-1%2520Receptor%2520Antagonist%2520that%2520Inhibits%2520Neuropathic%2520Pain%2520and%2520Activity-Induced%2520Spinal%2520Sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. S.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Novel Sigma-1 Receptor Antagonist Based on 3,4-dihydro-2(1<i>H</i>)-quinolinone Scaffold As a Potential Analgesic</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejmech.2014.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=24735647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=216-230&author=Y.+Lanauthor=Y.+Chenauthor=X.+Q.+Xuauthor=Y.+L.+Qiuauthor=S.+C.+Liuauthor=X.+Liuauthor=B.-F.+Liuauthor=G.+S.+Zhang&title=Synthesis+and+Biological+Evaluation+of+a+Novel+Sigma-1+Receptor+Antagonist+Based+on+3%2C4-dihydro-2%281H%29-quinolinone+Scaffold+As+a+Potential+Analgesic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Xu, Xiangqing; Qiu, Yinli; Liu, Shicheng; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-230</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis and sigma-1 receptor (σ1R) antagonist activity of a new series of 3,4-dihydro-2(1H)-quinolinones, e.g. I [R = PhCH2, 4-MeC6H4CH2, 4-FC6H4CH2, etc.] are reported.  The new compds. were evaluated in vitro in sigma-1 and sigma-2 receptor-binding assays in guinea pig brain membranes.  The structure-activity relationship led us to the promising deriv. I [R = 4-FC6H4CH2].  The compds. with highest affinity and greatest selectivity were further profiled, and compd. I [R = 4-FC6H4CH2] had a high binding const. for sigma-1 receptor (Kiσ1 = 1.22 nM) and high sigma-1/2 selectivity (1066-fold).  Thus, this compd., which proved to be an antagonist of sigma-1 receptor, emerged as the most interesting candidate.  In addn., this compd. exerted dose-dependent antinociceptive effects in the formalin test.  These characteristics suggested that the potent and selective compd. I [R = 4-FC6H4CH2] could be a potent candidate for pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56iTGYzwCw7Vg90H21EOLACvtfcHk0liemhqbJiw-pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D&md5=04009cdd675bf12a18a5869979c2cf10</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%2BQ.%26aulast%3DQiu%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DS.%2BC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.-F.%26aulast%3DZhang%26aufirst%3DG.%2BS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Novel%2520Sigma-1%2520Receptor%2520Antagonist%2520Based%2520on%25203%252C4-dihydro-2%25281H%2529-quinolinone%2520Scaffold%2520As%2520a%2520Potential%2520Analgesic%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D216%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural Features Important for Sigma-1 Receptor Binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+El-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+Features+Important+for+Sigma-1+Receptor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3DEl-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520Features%2520Important%2520for%2520Sigma-1%2520Receptor%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore Identification for Sigma-1 Receptor Binding: Application of the “Deconstruction–Reconstruction–Elaboration” Approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+Identification+for+Sigma-1+Receptor+Binding%3A+Application+of+the+%E2%80%9CDeconstruction%E2%80%93Reconstruction%E2%80%93Elaboration%E2%80%9D+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520Identification%2520for%2520Sigma-1%2520Receptor%2520Binding%253A%2520Application%2520of%2520the%2520%25E2%2580%259CDeconstruction%25E2%2580%2593Reconstruction%25E2%2580%2593Elaboration%25E2%2580%259D%2520Approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]-Dofetilide Binding Assay Is a Predictive Screening Tool for hERG Blockade and Proarrhythmia: Comparion of Intact Cell and Membrane Preparations and Effects of Altering [K<sup>+</sup>]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5D-Dofetilide+Binding+Assay+Is+a+Predictive+Screening+Tool+for+hERG+Blockade+and+Proarrhythmia%3A+Comparion+of+Intact+Cell+and+Membrane+Preparations+and+Effects+of+Altering+%5BK%2B%5Do"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lhUIGnbqu-xpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255D-Dofetilide%2520Binding%2520Assay%2520Is%2520a%2520Predictive%2520Screening%2520Tool%2520for%2520hERG%2520Blockade%2520and%2520Proarrhythmia%253A%2520Comparion%2520of%2520Intact%2520Cell%2520and%2520Membrane%2520Preparations%2520and%2520Effects%2520of%2520Altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin Differentially Modulates the Affinity of Agonist and Antagonist Ligands for Sigma-1 Receptors of Guinea Pig Brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+Differentially+Modulates+the+Affinity+of+Agonist+and+Antagonist+Ligands+for+Sigma-1+Receptors+of+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520Differentially%2520Modulates%2520the%2520Affinity%2520of%2520Agonist%2520and%2520Antagonist%2520Ligands%2520for%2520Sigma-1%2520Receptors%2520of%2520Guinea%2520Pig%2520Brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maricel, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Víctor, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrique, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, C.</span><span> </span><span class="NLM_article-title">Predicting the Antinociceptive Efficacy of σ1 Receptor Ligands by A Novel Receptor Fluorescence Resonance Energy Transfer (FRET) Based Biosensor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=238-242&author=G.+S.+Maricelauthor=F.+D.+V%C3%ADctorauthor=P.+S.+Enriqueauthor=P.+Pilarauthor=Z.+Danielauthor=J.+M.+Velaauthor=B.+Javierauthor=C.+Francisco&title=Predicting+the+Antinociceptive+Efficacy+of+%CF%831+Receptor+Ligands+by+A+Novel+Receptor+Fluorescence+Resonance+Energy+Transfer+%28FRET%29+Based+Biosensor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaricel%26aufirst%3DG.%2BS.%26aulast%3DV%25C3%25ADctor%26aufirst%3DF.%2BD.%26aulast%3DEnrique%26aufirst%3DP.%2BS.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DZ.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DFrancisco%26aufirst%3DC.%26atitle%3DPredicting%2520the%2520Antinociceptive%2520Efficacy%2520of%2520%25CF%25831%2520Receptor%2520Ligands%2520by%2520A%2520Novel%2520Receptor%2520Fluorescence%2520Resonance%2520Energy%2520Transfer%2520%2528FRET%2529%2520Based%2520Biosensor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D238%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerón-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a New Series of Hexahydro-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolines as Novel Selective σ<sub>1</sub> Receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3665</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3665-3656&author=J.+L.+D%C3%ADazauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Cer%C3%B3n-Bertranauthor=J.+Ram%C3%ADrezauthor=R.+F.+Reinosoauthor=A.+R.+Fern%C3%A1ndez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+Biological+Evaluation+of+a+New+Series+of+Hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+Novel+Selective+%CF%831+Receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCer%25C3%25B3n-Bertran%26aufirst%3DJ.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFern%25C3%25A1ndez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520New%2520Series%2520of%2520Hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520Novel%2520Selective%2520%25CF%25831%2520Receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3665%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A Peripheral Mononeuropathy in Rat that Produces Disorders of Pain Sensation like Those Seen in Man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+Peripheral+Mononeuropathy+in+Rat+that+Produces+Disorders+of+Pain+Sensation+like+Those+Seen+in+Man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett G J; Xie Y K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2ebsOowGDzUqUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520Peripheral%2520Mononeuropathy%2520in%2520Rat%2520that%2520Produces%2520Disorders%2520of%2520Pain%2520Sensation%2520like%2520Those%2520Seen%2520in%2520Man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Caspni, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span> </span><span class="NLM_article-title">Tramadol Reduced Anxiety-Related and Depression-Associated Behaviors Presumably Induced by Pain in the Chronic Constriction Injury Model of Neuropathic Pain in Rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=290-296&author=O.+Caspniauthor=M.+C.+Reitzauthor=A.+Ceciauthor=A.+Kremerauthor=R.+D.+Treede&title=Tramadol+Reduced+Anxiety-Related+and+Depression-Associated+Behaviors+Presumably+Induced+by+Pain+in+the+Chronic+Constriction+Injury+Model+of+Neuropathic+Pain+in+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaspni%26aufirst%3DO.%26aulast%3DReitz%26aufirst%3DM.%2BC.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26atitle%3DTramadol%2520Reduced%2520Anxiety-Related%2520and%2520Depression-Associated%2520Behaviors%2520Presumably%2520Induced%2520by%2520Pain%2520in%2520the%2520Chronic%2520Constriction%2520Injury%2520Model%2520of%2520Neuropathic%2520Pain%2520in%2520Rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D124%26spage%3D290%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of <i>Plasmodium falciparum</i> Macrophage Migration Inhibitory Factor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10159</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301269s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10148-10159&author=M.+K.+Dahlgrenauthor=A.+B.+Garciaauthor=A.+A.+Hareauthor=J.+Tirado-Rivesauthor=L.+Lengauthor=R.+Bucalaauthor=W.+L.+Jorgensen&title=Virtual+Screening+and+Optimization+Yield+Low-Nanomolar+Inhibitors+of+the+Tautomerase+Activity+of+Plasmodium+falciparum+Macrophage+Migration+Inhibitory+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of Plasmodium falciparum Macrophage Migration Inhibitory Factor</span></div><div class="casAuthors">Dahlgren, Markus K.; Garcia, Alvaro Baeza; Hare, Alissa A.; Tirado-Rives, Julian; Leng, Lin; Bucala, Richard; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10148-10159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Plasmodium falciparum orthologue of the human cytokine, macrophage migratory inhibitory factor (PfMIF), is produced by the parasite during malaria infection and modulates the host's immune response.  As for other MIF orthologues, PfMIF has tautomerase activity, whose inhibition may influence the cytokine activity.  To identify small-mol. inhibitors of the tautomerase activity of PfMIF, virtual screening has been performed by docking 2.1 million compds. into the enzymic site.  Assaying of 17 compds. identified four as active.  Substructure search for the most potent of these compds., a 4-phenoxypyridine analog, identified four addnl. compds. that were purchased and also shown to be active.  Thirty-one addnl. analogs were then designed, synthesized, and assayed.  Three were found to be potent PfMIF tautomerase inhibitors with Ki of ∼40 nM; they are also highly selective with Ki > 100 μM for human MIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKwibTSCNZ_LVg90H21EOLACvtfcHk0lhpyN5Icddb2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7fE&md5=814ad5b502c4981032f893fbdba68e73</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm301269s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301269s%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGarcia%26aufirst%3DA.%2BB.%26aulast%3DHare%26aufirst%3DA.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DLeng%26aufirst%3DL.%26aulast%3DBucala%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DVirtual%2520Screening%2520and%2520Optimization%2520Yield%2520Low-Nanomolar%2520Inhibitors%2520of%2520the%2520Tautomerase%2520Activity%2520of%2520Plasmodium%2520falciparum%2520Macrophage%2520Migration%2520Inhibitory%2520Factor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10148%26epage%3D10159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zanatta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourega, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonacorso, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, M. A. P.</span><span> </span><span class="NLM_article-title">A Convenient Synthesis of 5- and 6-Substituted 2-Phenyl-3<i>H</i>-Pyrimidin-4-Ones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1055%2Fs-2008-1032032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=358-362&author=N.+Zanattaauthor=L.+Fantinelauthor=R.+V.+Louregaauthor=H.+G.+Bonacorsoauthor=M.+A.+P.+Martins&title=A+Convenient+Synthesis+of+5-+and+6-Substituted+2-Phenyl-3H-Pyrimidin-4-Ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1032032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1032032%26sid%3Dliteratum%253Aachs%26aulast%3DZanatta%26aufirst%3DN.%26aulast%3DFantinel%26aufirst%3DL.%26aulast%3DLourega%26aufirst%3DR.%2BV.%26aulast%3DBonacorso%26aufirst%3DH.%2BG.%26aulast%3DMartins%26aufirst%3DM.%2BA.%2BP.%26atitle%3DA%2520Convenient%2520Synthesis%2520of%25205-%2520and%25206-Substituted%25202-Phenyl-3H-Pyrimidin-4-Ones%26jtitle%3DSynthesis%26date%3D2008%26volume%3D3%26spage%3D358%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, S.</span><span> </span><span class="NLM_article-title">Synthesis of 3-Amino-4-methyl-2-pentenamide, 2-Amino-1-clohexene-1-carboxamide, 3-Amino-2,4-diphenyl-2-butenamide, and Synthesis of 4(3<i>H</i>)-Pyrimidone Derivatives From Them</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1971&pages=1004-1012&issue=9&author=T.+Katoauthor=H.+Yamanakaauthor=S.+Konno&title=Synthesis+of+3-Amino-4-methyl-2-pentenamide%2C+2-Amino-1-clohexene-1-carboxamide%2C+3-Amino-2%2C4-diphenyl-2-butenamide%2C+and+Synthesis+of+4%283H%29-Pyrimidone+Derivatives+From+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DKonno%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25203-Amino-4-methyl-2-pentenamide%252C%25202-Amino-1-clohexene-1-carboxamide%252C%25203-Amino-2%252C4-diphenyl-2-butenamide%252C%2520and%2520Synthesis%2520of%25204%25283H%2529-Pyrimidone%2520Derivatives%2520From%2520Them%26jtitle%3DYakugaku%2520Zasshi%26date%3D1971%26volume%3D91%26issue%3D9%26spage%3D1004%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Raboisson, P.; Jean-Marie, B.; Belfrage, A. K.; Gertrud, L.; Classon, B. O.; Lindquist, K. C.; Nilsson, K. M.; Rosenquist, A. A. K.; Samuelsson, B. B.; Waehling, H. J.</span><span> </span><span class="NLM_article-title">Preparation of Pyrimidine-Substituted Macrocyclic Peptides as Inhibitors of Hepatitis C Virus</span>. PCT Int. Appl. WO 2008095999 A1 20080814,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Raboisson&author=B.+Jean-Marie&author=A.+K.+Belfrage&author=L.+Gertrud&author=B.+O.+Classon&author=K.+C.+Lindquist&author=K.+M.+Nilsson&author=A.+A.+K.+Rosenquist&author=B.+B.+Samuelsson&author=H.+J.+Waehling&title=Preparation+of+Pyrimidine-Substituted+Macrocyclic+Peptides+as+Inhibitors+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Pyrimidine-Substituted%2520Macrocyclic%2520Peptides%2520as%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Guan, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. M.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Substituted 6-fluoroalkylpyrimidin-4(3<i>H</i>)-ones and Pyrimidines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1055%2Fs-1996-4327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=997-1001&author=H.+P.+Guanauthor=Q.+S.+Huauthor=C.+M.+Hu&title=Synthesis+of+2-Substituted+6-fluoroalkylpyrimidin-4%283H%29-ones+and+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-4327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-4327%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DHu%26aufirst%3DQ.%2BS.%26aulast%3DHu%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520of%25202-Substituted%25206-fluoroalkylpyrimidin-4%25283H%2529-ones%2520and%2520Pyrimidines%26jtitle%3DSynthesis%26date%3D1996%26volume%3D8%26spage%3D997%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Naganuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagumo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuka, Y.</span><span> </span><span class="NLM_article-title">Discovery of Selective PDE4B Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3174-3176&author=K.+Naganumaauthor=A.+Omuraauthor=N.+Maekawaraauthor=M.+Saitohauthor=N.+Ohkawaauthor=T.+Kubotaauthor=H.+Nagumoauthor=T.+Kodamaauthor=M.+Takemuraauthor=Y.+Ohtsuka&title=Discovery+of+Selective+PDE4B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaganuma%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DA.%26aulast%3DMaekawara%26aufirst%3DN.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DOhkawa%26aufirst%3DN.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DNagumo%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DOhtsuka%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Selective%2520PDE4B%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3174%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grassi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, F.</span><span> </span><span class="NLM_article-title">Ring-Enlargement of Isoxazol-3-ones to 1,3-Oxazin-4-ones</span> <span class="citation_source-journal">J. Chem. Res. Synopses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=102-103&author=G.+Grassiauthor=F.+Fotiauthor=F.+Risitano&title=Ring-Enlargement+of+Isoxazol-3-ones+to+1%2C3-Oxazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrassi%26aufirst%3DG.%26aulast%3DFoti%26aufirst%3DF.%26aulast%3DRisitano%26aufirst%3DF.%26atitle%3DRing-Enlargement%2520of%2520Isoxazol-3-ones%2520to%25201%252C3-Oxazin-4-ones%26jtitle%3DJ.%2520Chem.%2520Res.%2520Synopses%26date%3D1983%26volume%3D4%26spage%3D102%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hayashi, S.; Masui, A.; Sekiguchi, F.</span><span> </span><span class="NLM_article-title">Fluorine-Containing Phosphate Esters of Pyrimidinols as Insecticides and Acaricides</span>, <i>Jpn. Kokai Tokkyo Koho</i><span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>JP 61268694 A 19861128,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=S.+Hayashi&author=A.+Masui&author=F.+Sekiguchi&title=Fluorine-Containing+Phosphate+Esters+of+Pyrimidinols+as+Insecticides+and+Acaricides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26atitle%3DFluorine-Containing%2520Phosphate%2520Esters%2520of%2520Pyrimidinols%2520as%2520Insecticides%2520and%2520Acaricides%26date%3D1986%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Yoburn, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskaran, S.</span><span> </span><span class="NLM_article-title">Chemoselective Arylamidine Cyclizations: Mild Formation of 2-Arylimidazole-4-carboxylic Acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3801</span><span class="NLM_x">–</span> <span class="NLM_lpage">3803</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0514855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=3801-3803&author=J.+C.+Yoburnauthor=S.+Baskaran&title=Chemoselective+Arylamidine+Cyclizations%3A+Mild+Formation+of+2-Arylimidazole-4-carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fol0514855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0514855%26sid%3Dliteratum%253Aachs%26aulast%3DYoburn%26aufirst%3DJ.%2BC.%26aulast%3DBaskaran%26aufirst%3DS.%26atitle%3DChemoselective%2520Arylamidine%2520Cyclizations%253A%2520Mild%2520Formation%2520of%25202-Arylimidazole-4-carboxylic%2520Acids%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D3801%26epage%3D3803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ho, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. S.</span><span> </span><span class="NLM_article-title">Microwave-Assisted Copper-Powder-Catalyzed Synthesis of Pyrimidinones from β-Bromo α,β-Unsaturated Carboxylic Acids and Amidines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2705</span><span class="NLM_x">–</span> <span class="NLM_lpage">2708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=2705-2708&author=S.+L.+Hoauthor=C.+S.+Cho&title=Microwave-Assisted+Copper-Powder-Catalyzed+Synthesis+of+Pyrimidinones+from+%CE%B2-Bromo+%CE%B1%2C%CE%B2-Unsaturated+Carboxylic+Acids+and+Amidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BL.%26aulast%3DCho%26aufirst%3DC.%2BS.%26atitle%3DMicrowave-Assisted%2520Copper-Powder-Catalyzed%2520Synthesis%2520of%2520Pyrimidinones%2520from%2520%25CE%25B2-Bromo%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Carboxylic%2520Acids%2520and%2520Amidines%26jtitle%3DSynlett%26date%3D2013%26volume%3D24%26spage%3D2705%26epage%3D2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkaichi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span> </span><span class="NLM_article-title">Identification of the Fused Bicyclic 4-Amino-2-phenylpyrimidine Derivatives as Novel and Potent PDE4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3325</span><span class="NLM_x">–</span> <span class="NLM_lpage">3328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3325-3328&author=T.+Gotoauthor=A.+Shiinaauthor=T.+Yoshinoauthor=K.+Mizukamiauthor=K.+Hiraharaauthor=O.+Suzukiauthor=Y.+Sogawaauthor=T.+Takahashiauthor=T.+Mikkaichiauthor=N.+Nakao&title=Identification+of+the+Fused+Bicyclic+4-Amino-2-phenylpyrimidine+Derivatives+as+Novel+and+Potent+PDE4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DShiina%26aufirst%3DA.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DMizukami%26aufirst%3DK.%26aulast%3DHirahara%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DO.%26aulast%3DSogawa%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DMikkaichi%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520the%2520Fused%2520Bicyclic%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520Novel%2520and%2520Potent%2520PDE4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3325%26epage%3D3328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Sun, X. J.; Tymianski, M.; Garman, J. D.</span>, <span> </span><span class="NLM_article-title">Agents and Methods for Treating Ischemic and Other Diseases Caused by TRPM7 Gene and Protein Activity</span>. PCT Int. Appl. WO 2011072275 A2 20110616,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=X.+J.+Sun&author=M.+Tymianski&author=J.+D.+Garman&title=Agents+and+Methods+for+Treating+Ischemic+and+Other+Diseases+Caused+by+TRPM7+Gene+and+Protein+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%2BJ.%26atitle%3DAgents%2520and%2520Methods%2520for%2520Treating%2520Ischemic%2520and%2520Other%2520Diseases%2520Caused%2520by%2520TRPM7%2520Gene%2520and%2520Protein%2520Activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbaj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span> </span><span class="NLM_article-title">Xanthine Oxidase-Activated Prodrugs of Thymidine Phosphorylase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1248-1260&author=P.+Reiganauthor=A.+Gbajauthor=I.+J.+Stratfordauthor=R.+A.+Bryceauthor=S.+Freeman&title=Xanthine+Oxidase-Activated+Prodrugs+of+Thymidine+Phosphorylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DGbaj%26aufirst%3DA.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26aulast%3DFreeman%26aufirst%3DS.%26atitle%3DXanthine%2520Oxidase-Activated%2520Prodrugs%2520of%2520Thymidine%2520Phosphorylase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1248%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ataka, K.; Kono, M.</span>, <span> </span><span class="NLM_article-title">Method for The Preparation of 5-Chloro-4-hydroxy-6-methylpyrimidine by Cyclocondensation of 2-Chloro-3-oxobutanoic Ester with Formamidine</span>, <i>Jpn. Kokai Tokkyo Koho</i><span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">, </span>JP 08198858 A 19960806,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=K.+Ataka&author=M.+Kono&title=Method+for+The+Preparation+of+5-Chloro-4-hydroxy-6-methylpyrimidine+by+Cyclocondensation+of+2-Chloro-3-oxobutanoic+Ester+with+Formamidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAtaka%26aufirst%3DK.%26atitle%3DMethod%2520for%2520The%2520Preparation%2520of%25205-Chloro-4-hydroxy-6-methylpyrimidine%2520by%2520Cyclocondensation%2520of%25202-Chloro-3-oxobutanoic%2520Ester%2520with%2520Formamidine%26date%3D1996%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit62c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zurmuehlen, F.</span>, <span> </span><span class="NLM_article-title">Preparation of 5-Chloro-4-hydroxypyrimidines</span>, <i>Ger. Offen.</i><span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">, </span>DE 4323180 A1 19950119,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=F.+Zurmuehlen&title=Preparation+of+5-Chloro-4-hydroxypyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZurmuehlen%26aufirst%3DF.%26atitle%3DPreparation%2520of%25205-Chloro-4-hydroxypyrimidines%26date%3D1995%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Breslin, M. J.; Cox, C. D.; Hartingh, T. J.; Pero, J.; Raheem, I. T.; Rossi, M.; Vassallo, L.</span>, <span> </span><span class="NLM_article-title">Preparation of Aryloxymethylcyclopropane Derivatives As PDE10 Inhibitors</span>, PCT Int. Appl. WO 2012162213 A1 20121129,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+J.+Breslin&author=C.+D.+Cox&author=T.+J.+Hartingh&author=J.+Pero&author=I.+T.+Raheem&author=M.+Rossi&author=L.+Vassallo&title=Preparation+of+Aryloxymethylcyclopropane+Derivatives+As+PDE10+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Aryloxymethylcyclopropane%2520Derivatives%2520As%2520PDE10%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Chokai, S.; Aoki, T.; Kimura, K.</span>, <span> </span><span class="NLM_article-title">Preparation and Formulation of Pyrimidine Derivatives As Brain Function Improvers</span>, PCT Int. Appl.<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">, </span>WO 9204333 A1 19920319,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=S.+Chokai&author=T.+Aoki&author=K.+Kimura&title=Preparation+and+Formulation+of+Pyrimidine+Derivatives+As+Brain+Function+Improvers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChokai%26aufirst%3DS.%26atitle%3DPreparation%2520and%2520Formulation%2520of%2520Pyrimidine%2520Derivatives%2520As%2520Brain%2520Function%2520Improvers%26date%3D1992%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleissner, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Rice, F. Y.</span><span> </span><span class="NLM_article-title">Characterization of the Binding of [<sup>3</sup>H](+)-Pentazocine to Sigma Recognition Sites in Guinea Pig Brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+Binding+of+%5B3H%5D%28%2B%29-Pentazocine+to+Sigma+Recognition+Sites+in+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lgbWD1CctLlDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520Binding%2520of%2520%255B3H%255D%2528%252B%2529-Pentazocine%2520to%2520Sigma%2520Recognition%2520Sites%2520in%2520Guinea%2520Pig%2520Brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein–Dye Binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+Rapid+and+Sensitive+Method+for+the+Quantitation+of+Microgram+Quantities+of+Protein+Utilizing+the+Principle+of+Protein%E2%80%93Dye+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520Rapid%2520and%2520Sensitive%2520Method%2520for%2520the%2520Quantitation%2520of%2520Microgram%2520Quantities%2520of%2520Protein%2520Utilizing%2520the%2520Principle%2520of%2520Protein%25E2%2580%2593Dye%2520Binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezzavento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoto, G. M.</span><span> </span><span class="NLM_article-title">Opioid and Sigma Receptor Studies. New Developments in the Design of Selective Sigma Ligands</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=1499-1509&author=G.+Ronsisvalleauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Cagnottoauthor=T.+Menniniauthor=C.+Parentiauthor=G.+M.+Scoto&title=Opioid+and+Sigma+Receptor+Studies.+New+Developments+in+the+Design+of+Selective+Sigma+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DScoto%26aufirst%3DG.%2BM.%26atitle%3DOpioid%2520and%2520Sigma%2520Receptor%2520Studies.%2520New%2520Developments%2520in%2520the%2520Design%2520of%2520Selective%2520Sigma%2520Ligands%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2011%26volume%3D73%26spage%3D1499%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57a','cit57b'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60a','cit60b'],'ref61':['cit61'],'ref62':['cit62a','cit62b','cit62c'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A. Wold, Jia Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xue-Chu Zhen</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15187-15217. <a href="https://doi.org/10.1021/acs.jmedchem.0c01192" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01192%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecules%252BSelectively%252BTargeting%252BSigma-1%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurological%252BDiseases%26aulast%3DYe%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09072020%26date%3D28102020%26volume%3D63%26issue%3D24%26spage%3D15187%26epage%3D15217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna J. Kochanowska-Karamyan, Hugo C. Araujo, Xiong Zhang, Abir El-Alfy, Paulo Carvalho, Mitchell A. Avery, Stephen D. Holmbo, Jakob Magolan, <span class="NLM_string-name hlFld-ContribAuthor">Mark T. Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Isolation and Synthesis of Veranamine, an Antidepressant Lead from the Marine Sponge Verongula rigida. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (4)
                                     , 1092-1098. <a href="https://doi.org/10.1021/acs.jnatprod.9b01107" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.9b01107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.9b01107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.9b01107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DIsolation%252Band%252BSynthesis%252Bof%252BVeranamine%25252C%252Ban%252BAntidepressant%252BLead%252Bfrom%252Bthe%252BMarine%252BSponge%252BVerongula%252Brigida%26aulast%3DKochanowska-Karamyan%26aufirst%3DAnna%2BJ.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07112019%26date%3D31032020%26volume%3D83%26issue%3D4%26spage%3D1092%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youyi Peng, Hiep Dong, <span class="NLM_string-name hlFld-ContribAuthor">William J. Welsh</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 486-497. <a href="https://doi.org/10.1021/acs.jcim.8b00521" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00521%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComprehensive%252B3D-QSAR%252BModel%252BPredicts%252BBinding%252BAffinity%252Bof%252BStructurally%252BDiverse%252BSigma%252B1%252BReceptor%252BLigands%26aulast%3DPeng%26aufirst%3DYouyi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01082018%26date%3D14122018%26date%3D29112018%26volume%3D59%26issue%3D1%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Óscar M. Bautista-Aguilera, Josiane Budni, Francielle Mina, Eduarda Behenck Medeiros, Winnie Deuther-Conrad, José M. Entrena, Ignacio Moraleda, Isabel Iriepa, Francisco López-Muñoz, <span class="NLM_string-name hlFld-ContribAuthor">José Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6937-6943. <a href="https://doi.org/10.1021/acs.jmedchem.8b00848" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DContilisant%25252C%252Ba%252BTetratarget%252BSmall%252BMolecule%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%252BCombining%252BCholinesterase%25252C%252BMonoamine%252BOxidase%252BInhibition%25252C%252Band%252BH3R%252BAntagonism%252Bwith%252BS1R%252BAgonism%252BProfile%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593scar%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29052018%26date%3D18072018%26date%3D03072018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Long  Zhan</span>, <span class="hlFld-ContribAuthor ">Meng-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Fei  Chen</span>, and <span class="hlFld-ContribAuthor ">Bing  Han</span>  . </span><span class="cited-content_cbyCitation_article-title">Cu-Catalyzed [3 + 3] Annulation for the Synthesis of Pyrimidines via β-C(sp3)–H Functionalization of Saturated Ketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (23)
                                     , 11994-12000. <a href="https://doi.org/10.1021/acs.joc.6b02181" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02181%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCu-Catalyzed%252B%25255B3%252B%25252B%252B3%25255D%252BAnnulation%252Bfor%252Bthe%252BSynthesis%252Bof%252BPyrimidines%252Bvia%252B%2525CE%2525B2-C%252528sp3%252529%2525E2%252580%252593H%252BFunctionalization%252Bof%252BSaturated%252BKetones%26aulast%3DZhan%26aufirst%3DJun-Long%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05092016%26date%3D16112016%26date%3D02122016%26date%3D02112016%26volume%3D81%26issue%3D23%26spage%3D11994%26epage%3D12000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Min  Shi</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Ya-Zhou  Xu</span>, <span class="hlFld-ContribAuthor ">Jun-Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Tao  Pang</span>, <span class="hlFld-ContribAuthor ">Zhao-Bing  Gao</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, and <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6329-6343. <a href="https://doi.org/10.1021/acs.jmedchem.6b00571" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00571%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%252BAlkoxyisoxazoles%252Bas%252BSigma-1%252BReceptor%252BAntagonists%252Bwith%252BAntinociceptive%252BEfficacy%26aulast%3DSun%26aufirst%3DHao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14042016%26date%3D30062016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6329%26epage%3D6343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Fengying  Zhang</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Yan  Song</span>, <span class="hlFld-ContribAuthor ">Xintong  Wang</span>, <span class="hlFld-ContribAuthor ">Meiliang  Wang</span>, <span class="hlFld-ContribAuthor ">Zehui  Gong</span>, <span class="hlFld-ContribAuthor ">Ruibin  Su</span>, and <span class="hlFld-ContribAuthor ">Yanxing  Jia</span>  . </span><span class="cited-content_cbyCitation_article-title">Gram Scale Syntheses of (−)-Incarvillateine and Its Analogs. Discovery of Potent Analgesics for Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3953-3963. <a href="https://doi.org/10.1021/acs.jmedchem.6b00132" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGram%252BScale%252BSyntheses%252Bof%252B%252528%2525E2%252588%252592%252529-Incarvillateine%252Band%252BIts%252BAnalogs.%252BDiscovery%252Bof%252BPotent%252BAnalgesics%252Bfor%252BNeuropathic%252BPain%26aulast%3DHuang%26aufirst%3DBin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02022016%26date%3D08042016%26date%3D28042016%26date%3D29032016%26volume%3D59%26issue%3D8%26spage%3D3953%26epage%3D3963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Juecheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Song  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi-Feng  Liu</span>, and <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 2942-2961. <a href="https://doi.org/10.1021/acs.jmedchem.5b01416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B%2525CF%2525831%252BReceptor%252BLigands%252Bfor%252BTreating%252BNeuropathic%252BPain%25253A%252B6-Hydroxypyridazinones%26aulast%3DCao%26aufirst%3DXudong%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D12092015%26date%3D29032016%26date%3D14042016%26date%3D22032016%26volume%3D59%26issue%3D7%26spage%3D2942%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Du</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Bifeng  Liu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113658. <a href="https://doi.org/10.1016/j.ejmech.2021.113658" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113658%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252B%2525CE%2525BC%252Bopioid%252Band%252B%2525CF%2525831%252Breceptor%252Bligands%252Bas%252Bnovel%252Banalgesics%252Bwith%252Breduced%252Bside%252Beffects%26aulast%3DZhuang%26aufirst%3DTao%26date%3D2021%26volume%3D223%26spage%3D113658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastasija O.  Finke</span>, <span class="hlFld-ContribAuthor ">Marina Y.  Ravaeva</span>, <span class="hlFld-ContribAuthor ">Vyacheslav I.  Krasnov</span>, <span class="hlFld-ContribAuthor ">Igor V.  Cheretaev</span>, <span class="hlFld-ContribAuthor ">Elena N.  Chuyan</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Baev</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>. </span><span class="cited-content_cbyCitation_article-title">Cross‐Coupling‐Cyclocondensation Reaction Sequence to Access a Library of Ring‐C Bridged Pyrimidino‐tetrahydrothebaines and Pyrimidinotetrahydrooripavines. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (29)
                                     , 7391-7397. <a href="https://doi.org/10.1002/slct.202101790" title="DOI URL">https://doi.org/10.1002/slct.202101790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101790%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%2525E2%252580%252590Coupling%2525E2%252580%252590Cyclocondensation%252BReaction%252BSequence%252Bto%252BAccess%252Ba%252BLibrary%252Bof%252BRing%2525E2%252580%252590C%252BBridged%252BPyrimidino%2525E2%252580%252590tetrahydrothebaines%252Band%252BPyrimidinotetrahydrooripavines%26aulast%3DFinke%26aufirst%3DAnastasija%2BO.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D29%26spage%3D7391%26epage%3D7397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Daniel  Diez-Iriepa</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Francisco  López-Muñoz</span>, <span class="hlFld-ContribAuthor ">María Angeles  Martínez-Grau</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Studies on the affinity of 6-[(
              n
              -(cyclo)aminoalkyl)oxy]-4
              H
              -chromen-4-ones for sigma 1/2 receptors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 1000-1004. <a href="https://doi.org/10.1039/D1MD00105A" title="DOI URL">https://doi.org/10.1039/D1MD00105A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00105A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00105A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DStudies%252Bon%252Bthe%252Baffinity%252Bof%252B6-%25255B%252528%252Bn%252B-%252528cyclo%252529aminoalkyl%252529oxy%25255D-4%252BH%252B-chromen-4-ones%252Bfor%252Bsigma%252B1%25252F2%252Breceptors%26aulast%3DDeuther-Conrad%26aufirst%3DWinnie%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D6%26spage%3D1000%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran  Singh</span>, <span class="hlFld-ContribAuthor ">Prerna  Turk</span>, <span class="hlFld-ContribAuthor ">Raj  Kamal</span>, <span class="hlFld-ContribAuthor ">Anita  Dhanda</span>. </span><span class="cited-content_cbyCitation_article-title">New Palladium(II) complexes of 2-arylidene-1-(4-methyl-6-phenyl-pyrimidin-2-yl)hydrazines: synthesis, spectroscopic characterization, biological evaluation and protein binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>86 </em><a href="https://doi.org/10.1007/s13738-021-02272-2" title="DOI URL">https://doi.org/10.1007/s13738-021-02272-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-021-02272-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-021-02272-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DNew%252BPalladium%252528II%252529%252Bcomplexes%252Bof%252B2-arylidene-1-%2525284-methyl-6-phenyl-pyrimidin-2-yl%252529hydrazines%25253A%252Bsynthesis%25252C%252Bspectroscopic%252Bcharacterization%25252C%252Bbiological%252Bevaluation%252Band%252Bprotein%252Bbinding%26aulast%3DSingh%26aufirst%3DKiran%26date%3D2021%26date%3D2021%26volume%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laise P.A.  Chiari</span>, <span class="hlFld-ContribAuthor ">Aldineia P.  da Silva</span>, <span class="hlFld-ContribAuthor ">Aline A.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Célio F.  Lipinski</span>, <span class="hlFld-ContribAuthor ">Kathia M.  Honório</span>, <span class="hlFld-ContribAuthor ">Albérico B.F.  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Drug design of new sigma-1 antagonists against neuropathic pain: A QSAR study using partial least squares and artificial neural networks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1223 </em>, 129156. <a href="https://doi.org/10.1016/j.molstruc.2020.129156" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129156%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDrug%252Bdesign%252Bof%252Bnew%252Bsigma-1%252Bantagonists%252Bagainst%252Bneuropathic%252Bpain%25253A%252BA%252BQSAR%252Bstudy%252Busing%252Bpartial%252Bleast%252Bsquares%252Band%252Bartificial%252Bneural%252Bnetworks%26aulast%3DChiari%26aufirst%3DLaise%2BP.A.%26date%3D2021%26volume%3D1223%26spage%3D129156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Volodymyr A.  Tkachuk</span>, <span class="hlFld-ContribAuthor ">Vyacheslav O.  Shishkanu</span>, <span class="hlFld-ContribAuthor ">Tetiana M.  Tkachuk</span>, <span class="hlFld-ContribAuthor ">Svitlana V.  Shishkina</span>, <span class="hlFld-ContribAuthor ">Olga V.  Hordiyenko</span>. </span><span class="cited-content_cbyCitation_article-title">2-Carbamimidoylbenzoic Acid as a New Effective and Available Precursor for the Synthesis of Substituted 2-(Pyrimidin-2-yl)benzoic Acids. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (02)
                                     , 371-382. <a href="https://doi.org/10.1055/s-0040-1705941" title="DOI URL">https://doi.org/10.1055/s-0040-1705941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705941%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3D2-Carbamimidoylbenzoic%252BAcid%252Bas%252Ba%252BNew%252BEffective%252Band%252BAvailable%252BPrecursor%252Bfor%252Bthe%252BSynthesis%252Bof%252BSubstituted%252B2-%252528Pyrimidin-2-yl%252529benzoic%252BAcids%26aulast%3DTkachuk%26aufirst%3DVolodymyr%2BA.%26date%3D2021%26date%3D2020%26volume%3D53%26issue%3D02%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirill P.  Cheremnykh</span>, <span class="hlFld-ContribAuthor ">Victor A.  Savelyev</span>, <span class="hlFld-ContribAuthor ">Sergey A.  Borisov</span>, <span class="hlFld-ContribAuthor ">Igor D.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Baev</span>, <span class="hlFld-ContribAuthor ">Tatyana G.  Tolstikova</span>, <span class="hlFld-ContribAuthor ">Valentin A.  Vavilin</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrides of Alkaloid Lappaconitine with Pyrimidine Motif on the Anthranilic Acid Moiety: Design, Synthesis, and Investigation of Antinociceptive Potency. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5578. <a href="https://doi.org/10.3390/molecules25235578" title="DOI URL">https://doi.org/10.3390/molecules25235578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235578%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DHybrides%252Bof%252BAlkaloid%252BLappaconitine%252Bwith%252BPyrimidine%252BMotif%252Bon%252Bthe%252BAnthranilic%252BAcid%252BMoiety%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BInvestigation%252Bof%252BAntinociceptive%252BPotency%26aulast%3DCheremnykh%26aufirst%3DKirill%2BP.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastiano  Intagliata</span>, <span class="hlFld-ContribAuthor ">Abhisheak  Sharma</span>, <span class="hlFld-ContribAuthor ">Tamara I.  King</span>, <span class="hlFld-ContribAuthor ">Christophe  Mesangeau</span>, <span class="hlFld-ContribAuthor ">Michael  Seminerio</span>, <span class="hlFld-ContribAuthor ">Frederick T.  Chin</span>, <span class="hlFld-ContribAuthor ">Lisa L.  Wilson</span>, <span class="hlFld-ContribAuthor ">Rae R.  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Jay P.  McLaughlin</span>, <span class="hlFld-ContribAuthor ">Bonnie A.  Avery</span>, <span class="hlFld-ContribAuthor ">Christopher R.  McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     <a href="https://doi.org/10.1208/s12248-020-00472-x" title="DOI URL">https://doi.org/10.1208/s12248-020-00472-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-020-00472-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-020-00472-x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%252BSigma-2%252BReceptor%252BLigand%25252C%252B1-%2525284-%2525286%25252C7-Dimethoxy-3%25252C4-dihydroisoquinolin-2%2525281H%252529-yl%252529butyl%252529-3-methyl-1H-benzo%25255Bd%25255Dimidazol-2%2525283H%252529-one%252B%252528CM398%252529%25252C%252Bwith%252BDrug-Like%252BProperties%252Band%252BAntinociceptive%252BEffects%252BIn%252BVivo%26aulast%3DIntagliata%26aufirst%3DSebastiano%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Olga  Ciupak</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (6)
                                     , 111. <a href="https://doi.org/10.3390/ph13060111" title="DOI URL">https://doi.org/10.3390/ph13060111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13060111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13060111%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNovel%252B1%25252C2%25252C4-Oxadiazole%252BDerivatives%252Bin%252BDrug%252BDiscovery%26aulast%3DBiernacki%26aufirst%3DKarol%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D6%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Lanchang  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Hao</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112144. <a href="https://doi.org/10.1016/j.ejmech.2020.112144" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112144%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPiperidine%252Bpropionamide%252Bas%252Ba%252Bscaffold%252Bfor%252Bpotent%252Bsigma-1%252Breceptor%252Bantagonists%252Band%252Bmu%252Bopioid%252Breceptor%252Bagonists%252Bfor%252Btreating%252Bneuropathic%252Bpain%26aulast%3DXiong%26aufirst%3DJiaying%26date%3D2020%26volume%3D191%26spage%3D112144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Ramesh  Neelamegam</span>, <span class="hlFld-ContribAuthor ">Michael S.  Placzek</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Gengyang  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiying  Qu</span>, <span class="hlFld-ContribAuthor ">Hayden R.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jinchun  Song</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (6)
                                     , 1204-1215. <a href="https://doi.org/10.1016/j.apsb.2019.07.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DNovel%252Bradioligands%252Bfor%252Bimaging%252Bsigma-1%252Breceptor%252Bin%252Bbrain%252Busing%252Bpositron%252Bemission%252Btomography%252B%252528PET%252529%26aulast%3DLan%26aufirst%3DYu%26date%3D2019%26volume%3D9%26issue%3D6%26spage%3D1204%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Yin  Fang</span>, <span class="hlFld-ContribAuthor ">L.  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">H.M.  Manukumar</span>, <span class="hlFld-ContribAuthor ">C.S.  Shantharam</span>, <span class="hlFld-ContribAuthor ">Njud S.  Alharbi</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 117-153. <a href="https://doi.org/10.1016/j.ejmech.2019.03.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Band%252Bpharmaceutical%252Bapplications%252Bof%252Bchloro-containing%252Bmolecules%252Bfor%252Bdrug%252Bdiscovery%25253A%252BA%252Bcritical%252Breview%26aulast%3DFang%26aufirst%3DWan-Yin%26date%3D2019%26volume%3D173%26spage%3D117%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Mingming  Zhao</span>, <span class="hlFld-ContribAuthor ">Wen  Tan</span>, <span class="hlFld-ContribAuthor ">Lvyin  Zheng</span>, <span class="hlFld-ContribAuthor ">Kailiang  Tao</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Developments towards synthesis of N-heterocycles from amidines
              via
              C–N/C–C bond formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (13)
                                     , 2120-2141. <a href="https://doi.org/10.1039/C9QO00283A" title="DOI URL">https://doi.org/10.1039/C9QO00283A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00283A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00283A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DDevelopments%252Btowards%252Bsynthesis%252Bof%252BN-heterocycles%252Bfrom%252Bamidines%252Bvia%252BC%2525E2%252580%252593N%25252FC%2525E2%252580%252593C%252Bbond%252Bformation%26aulast%3DGuo%26aufirst%3DWei%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D13%26spage%3D2120%26epage%3D2141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iredia D.  Iyamu</span>, <span class="hlFld-ContribAuthor ">Wei  Lv</span>, <span class="hlFld-ContribAuthor ">Neha  Malik</span>, <span class="hlFld-ContribAuthor ">Rama K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Gary E.  Schiltz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (9)
                                     , 1824-1835. <a href="https://doi.org/10.1016/j.bmc.2019.03.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bselective%252Btetrahydroindazole-based%252Bsigma-1%252Breceptor%252Bligands%26aulast%3DIyamu%26aufirst%3DIredia%2BD.%26date%3D2019%26volume%3D27%26issue%3D9%26spage%3D1824%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Yao</span>, <span class="hlFld-ContribAuthor ">Fei  Dou</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Song  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi‐Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Sigma‐1 (σ
              1
              ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , e1800599. <a href="https://doi.org/10.1002/cbdv.201800599" title="DOI URL">https://doi.org/10.1002/cbdv.201800599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800599%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BSigma%2525E2%252580%2525901%252B%252528%2525CF%252583%252B1%252B%252529%252BReceptor%252BLigands%252BBased%252Bon%252BPhenyl%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590oxadiazole%252BDerivatives%26aulast%3DCao%26aufirst%3DXudong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3De1800599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kamal</span>, <span class="hlFld-ContribAuthor ">Ravinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>, <span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Kushal K.  Bansal</span>, <span class="hlFld-ContribAuthor ">Prabodh C.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Anthelmintic and Antimicrobial Evaluation of New 2‐Arylidene‐1‐(4‐methyl‐6‐phenylpyrimidin‐2‐yl)hydrazines. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 713-717. <a href="https://doi.org/10.1002/slct.201802822" title="DOI URL">https://doi.org/10.1002/slct.201802822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802822%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%25252C%252BAnthelmintic%252Band%252BAntimicrobial%252BEvaluation%252Bof%252BNew%252B2%2525E2%252580%252590Arylidene%2525E2%252580%2525901%2525E2%252580%252590%2525284%2525E2%252580%252590methyl%2525E2%252580%2525906%2525E2%252580%252590phenylpyrimidin%2525E2%252580%2525902%2525E2%252580%252590yl%252529hydrazines%26aulast%3DKamal%26aufirst%3DRaj%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D2%26spage%3D713%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirill P.  Cheremnykh</span>, <span class="hlFld-ContribAuthor ">Viktor А.  Savel’ev</span>, <span class="hlFld-ContribAuthor ">Oleg P.  Shkurko</span>, <span class="hlFld-ContribAuthor ">Elvira E.  Shults</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of hybrid molecules containing pyrimidine and diterpene alkaloid lappaconitine fragments. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2018,</strong> <em>54 </em>
                                    (12)
                                     , 1131-1138. <a href="https://doi.org/10.1007/s10593-019-02404-w" title="DOI URL">https://doi.org/10.1007/s10593-019-02404-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02404-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02404-w%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252Bhybrid%252Bmolecules%252Bcontaining%252Bpyrimidine%252Band%252Bditerpene%252Balkaloid%252Blappaconitine%252Bfragments%26aulast%3DCheremnykh%26aufirst%3DKirill%2BP.%26date%3D2018%26date%3D2019%26volume%3D54%26issue%3D12%26spage%3D1131%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Xu</span>, <span class="hlFld-ContribAuthor ">Shi-Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Hui  Wen</span>, <span class="hlFld-ContribAuthor ">Qin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Wen  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan-Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Feng-Cheng  Jia</span>, <span class="hlFld-ContribAuthor ">An-Xin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Dimethyl Sulfoxide Serves as a Dual Synthon: Construction of 5-Methyl Pyrimidine Derivatives via Four Component Oxidative Annulation. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (12)
                                     , 2267-2271. <a href="https://doi.org/10.1002/adsc.201800180" title="DOI URL">https://doi.org/10.1002/adsc.201800180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800180%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDimethyl%252BSulfoxide%252BServes%252Bas%252Ba%252BDual%252BSynthon%25253A%252BConstruction%252Bof%252B5-Methyl%252BPyrimidine%252BDerivatives%252Bvia%252BFour%252BComponent%252BOxidative%252BAnnulation%26aulast%3DXu%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D12%26spage%3D2267%26epage%3D2271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Arena</span>, <span class="hlFld-ContribAuthor ">Maria  Dichiara</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Floresta</span>, <span class="hlFld-ContribAuthor ">Carmela  Parenti</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>, <span class="hlFld-ContribAuthor ">Valeria  Pittalà</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 231-256. <a href="https://doi.org/10.4155/fmc-2017-0164" title="DOI URL">https://doi.org/10.4155/fmc-2017-0164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0164%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSigma-1%252Breceptor%252Bantagonists%25253A%252Bfrom%252Bopioids%252Bto%252Bsmall%252Bmolecules%25253A%252Bwhat%252Bis%252Bnew%25253F%26aulast%3DArena%26aufirst%3DEmanuela%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D231%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojun  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhichao  Lu</span>, <span class="hlFld-ContribAuthor ">Shiwen  Liu</span>, <span class="hlFld-ContribAuthor ">Gerald B.  Hammond</span>, <span class="hlFld-ContribAuthor ">Bo  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Gold-catalyzed Fluorination of Alkynyl Esters and Ketones: Efficient Access to Fluorinated 1,3-Dicarbonyl Compounds. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (22)
                                     , 4062-4066. <a href="https://doi.org/10.1002/adsc.201701179" title="DOI URL">https://doi.org/10.1002/adsc.201701179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201701179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201701179%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DGold-catalyzed%252BFluorination%252Bof%252BAlkynyl%252BEsters%252Band%252BKetones%25253A%252BEfficient%252BAccess%252Bto%252BFluorinated%252B1%25252C3-Dicarbonyl%252BCompounds%26aulast%3DZeng%26aufirst%3DXiaojun%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D22%26spage%3D4062%26epage%3D4066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Lynch</span>, <span class="hlFld-ContribAuthor ">Terry R.  Van Vleet</span>, <span class="hlFld-ContribAuthor ">Scott W.  Mittelstadt</span>, <span class="hlFld-ContribAuthor ">Eric A.G.  Blomme</span>. </span><span class="cited-content_cbyCitation_article-title">Potential functional and pathological side effects related to off-target pharmacological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological and Toxicological Methods</span><span> <strong>2017,</strong> <em>87 </em>, 108-126. <a href="https://doi.org/10.1016/j.vascn.2017.02.020" title="DOI URL">https://doi.org/10.1016/j.vascn.2017.02.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vascn.2017.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vascn.2017.02.020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520and%2520Toxicological%2520Methods%26atitle%3DPotential%252Bfunctional%252Band%252Bpathological%252Bside%252Beffects%252Brelated%252Bto%252Boff-target%252Bpharmacological%252Bactivity%26aulast%3DLynch%26aufirst%3DJames%2BJ.%26date%3D2017%26volume%3D87%26spage%3D108%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Merlos</span>, <span class="hlFld-ContribAuthor ">Luz  Romero</span>, <span class="hlFld-ContribAuthor ">Daniel  Zamanillo</span>, <span class="hlFld-ContribAuthor ">Carlos  Plata-Salamán</span>, <span class="hlFld-ContribAuthor ">José Miguel  Vela</span>. </span><span class="cited-content_cbyCitation_article-title">Sigma-1 Receptor and Pain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 131-161. <a href="https://doi.org/10.1007/164_2017_9" title="DOI URL">https://doi.org/10.1007/164_2017_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2017_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2017_9%26sid%3Dliteratum%253Aachs%26atitle%3DSigma-1%252BReceptor%252Band%252BPain%26aulast%3DMerlos%26aufirst%3DManuel%26date%3D2017%26date%3D2017%26spage%3D131%26epage%3D161%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSigma%252BProteins%25253A%252BEvolution%252Bof%252Bthe%252BConcept%252Bof%252BSigma%252BReceptors%26aulast%3DKim%26aufirst%3DFelix%2BJ.%26date%3D2017%26volume%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Yiyan  Songyang</span>, <span class="hlFld-ContribAuthor ">Lingli  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Peng</span>, <span class="hlFld-ContribAuthor ">Jinchun  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 2051-2056. <a href="https://doi.org/10.1016/j.bmcl.2016.02.077" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B6%25252C7-dihydro-5H-cyclopenta%25255Bd%25255Dpyrimidine%252Band%252B5%25252C6%25252C7%25252C8-tetrahydroquinazoline%252Bderivatives%252Bas%252Bsigma-1%252B%252528%2525CF%2525831%252529%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bpain%26aulast%3DLan%26aufirst%3DYu%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D2051%26epage%3D2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luz  Romero</span>, <span class="hlFld-ContribAuthor ">Manuel  Merlos</span>, <span class="hlFld-ContribAuthor ">José Miguel  Vela</span>. </span><span class="cited-content_cbyCitation_article-title">Antinociception by Sigma-1 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 179-215. <a href="https://doi.org/10.1016/bs.apha.2015.11.003" title="DOI URL">https://doi.org/10.1016/bs.apha.2015.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2015.11.003%26sid%3Dliteratum%253Aachs%26atitle%3DAntinociception%252Bby%252BSigma-1%252BReceptor%252BAntagonists%26aulast%3DRomero%26aufirst%3DLuz%26date%3D2016%26spage%3D179%26epage%3D215%26pub%3DElsevier%26atitle%3DPharmacological%252BMechanisms%252Band%252Bthe%252BModulation%252Bof%252BPain%26date%3D2016%26volume%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Miguel  Vela</span>, <span class="hlFld-ContribAuthor ">Manuel  Merlos</span>, <span class="hlFld-ContribAuthor ">Carmen  Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational sigma-1 receptor antagonists for the treatment of pain. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2015,</strong> <em>24 </em>
                                    (7)
                                     , 883-896. <a href="https://doi.org/10.1517/13543784.2015.1048334" title="DOI URL">https://doi.org/10.1517/13543784.2015.1048334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2015.1048334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2015.1048334%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bsigma-1%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bpain%26aulast%3DVela%26aufirst%3DJos%25C3%25A9%2BMiguel%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D7%26spage%3D883%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative σ<sub>1</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) The 3D-QSAR pharmacophore model of σ-1R antagonist. The model is constituted with four pharmacophore features: HBA, green; Hydrophob_aromatic, blue; Hydrophobic, light blue; and PosIonizable, red. (B) The virtual screening result and molecular design of pyrimidine scaffold by this 3D-QSAR model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>n</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) HNR<sub>1</sub>R<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) K<sub>2</sub>CO<sub>3</sub>, KI, acetonitrile, reflux;</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) Br(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, KI, acetone, reflux; (II) morpholine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (III) 2-(cholomethyl)oxirane, K<sub>2</sub>CO<sub>3</sub>, KI, acetone, reflux; (IV) morpholine, MeOH, reflux.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (IV) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (I) <i>t</i>-BuOK, MeOH, reflux; (II) Br(CH<sub>2</sub>)<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (III) piperidine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glennon’s pharmacophoric σ<sub>1</sub> receptor model (A) and general structure of the new pyrimidine derivative (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antinociceptive effect of S1RA and compound <b>137</b> in phase I (0–5 min) and phase II (15–45 min) of the mice formalin test at the dose of 80 mg/kg. Each column and vertical line represents mean ± SEM of the values obtained in at least 10 animals. Statistically significant differences: <sup>##</sup><i>p</i> < 0.01 vs vehicle; ** <i>p</i> < 0.01 vs vehicle + formalin (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antinociceptive effects of compound <b>137</b> on the expression of neuropathic pain in CCI and sham operated rats. Date obtained from 10 rats per group and expressed as mean ± SEM pressure threshold (g) evoking paw withdrawal or latency (s) to paw withdrawal. Statistically significant differences between the rats before surgery (basal) and surgery groups: * <i>p</i> < 0.05, ** <i>p</i> < 0.01 VS basal; <sup>#</sup><i>p</i> < 0.05; <sup>##</sup><i>p</i> < 0.01 vs vehicle treatment on day 14 (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/medium/jm-2014-01207r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0008.jpeg" id="rightTab-GRAPHIC-d1002e3524-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response effect of compound <b>137</b> and pregabalin on motor coordination (rotarod test). Date obtained from 8–10 mice per group and expressed as mean ± SEM latency (s) to fall down from rod. Statistically significant differences: * <i>p</i> < 0.05, ** <i>p</i> < 0.01 vs vehicle (Two-Way ANOVA followed by Newman–Keuls test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-24/jm501207r/20141218/images/large/jm-2014-01207r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501207r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i164">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 67 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hecke, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, N.</span><span> </span><span class="NLM_article-title">Neuropathic Pain in the General Population: A Systematic Review of Epidemiological Studies</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=654-662&author=O.+V.+Heckeauthor=S.+K.+Austinauthor=R.+A.+Khanauthor=B.+H.+Smithauthor=N.+Torrance&title=Neuropathic+Pain+in+the+General+Population%3A+A+Systematic+Review+of+Epidemiological+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHecke%26aufirst%3DO.%2BV.%26aulast%3DAustin%26aufirst%3DS.%2BK.%26aulast%3DKhan%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DTorrance%26aufirst%3DN.%26atitle%3DNeuropathic%2520Pain%2520in%2520the%2520General%2520Population%253A%2520A%2520Systematic%2520Review%2520of%2520Epidemiological%2520Studies%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D654%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Emerging Drugs for Neuropathic Pain</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1517%2F14728214.2014.915025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=24344917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1-13&author=I.+Gilronauthor=A.+H.+Dickenson&title=Emerging+Drugs+for+Neuropathic+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728214.2014.915025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.2014.915025%26sid%3Dliteratum%253Aachs%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DEmerging%2520Drugs%2520for%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2014%26volume%3D19%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jongen Joost, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartrick, C. T.</span><span> </span><span class="NLM_article-title">Neruopathic Pain and Pharmacological Treatment</span> <span class="citation_source-journal">Pain Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fpapr.12085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23750502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=283-295&author=L.+M.+Jongen+Joostauthor=G.+Hansauthor=H.+T.+Benzonauthor=F.+Huygenauthor=C.+T.+Hartrick&title=Neruopathic+Pain+and+Pharmacological+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain and pharmacological treatment</span></div><div class="casAuthors">Jongen Joost L M; Hans Guy; Benzon Honorio T; Huygen Frank; Hartrick Craig T</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is a serious chronic condition strongly affecting quality of life, which can be relieved but cannot be cured.  Apart from symptomatic management, treatment should focus on the underlying disorder.  The estimated prevalence is at least 1% to 5% of the general population.  Neuropathic pain is characterized both by spontaneous and evoked pain.  A diagnosis of neuropathic pain can usually be established based solely on history and neurological examination.  Ancillary investigations may include EMG and computerized tomography/magnetic resonance imaging scans, depending on the localization of the suspected lesion.  A limited number of agents, primarily directed at symptom control, are currently approved for use in neuropathic pain.  A mechanism-based approach to pharmacological intervention supports the use of polypharmacy in neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCgdyy7ehY67qxQ2mb9Pu8fW6udTcc2eadckS9xkguZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhslKksw%253D%253D&md5=66f491a169f5c3b2fe5b6078346d31da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12085%26sid%3Dliteratum%253Aachs%26aulast%3DJongen%2BJoost%26aufirst%3DL.%2BM.%26aulast%3DHans%26aufirst%3DG.%26aulast%3DBenzon%26aufirst%3DH.%2BT.%26aulast%3DHuygen%26aufirst%3DF.%26aulast%3DHartrick%26aufirst%3DC.%2BT.%26atitle%3DNeruopathic%2520Pain%2520and%2520Pharmacological%2520Treatment%26jtitle%3DPain%2520Pract.%26date%3D2014%26volume%3D14%26spage%3D283%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dwokin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backonja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnerup, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portenoy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. S.</span><span> </span><span class="NLM_article-title">Pharmacologic Management of Neuropathic Pain: Evidence-Based Recommendations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dwokinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+Management+of+Neuropathic+Pain%3A+Evidence-Based+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDwokin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520Management%2520of%2520Neuropathic%2520Pain%253A%2520Evidence-Based%2520Recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Attal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruccu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmikko, T.</span><span> </span><span class="NLM_article-title">EFNS Guidelines on Pharmacological Treatment of Neuropathic Pain: 2010 Revision</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fj.1468-1331.2006.01511.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=17038030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BD28ngs1Smug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1153-1169&author=N.+Attalauthor=G.+Cruccuauthor=R.+Baronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=T.+Nurmikko&title=EFNS+Guidelines+on+Pharmacological+Treatment+of+Neuropathic+Pain%3A+2010+Revision"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">EFNS guidelines on pharmacological treatment of neuropathic pain</span></div><div class="casAuthors">Attal N; Cruccu G; Haanpaa M; Hansson P; Jensen T S; Nurmikko T; Sampaio C; Sindrup S; Wiffen P</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1153-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain treatment remains unsatisfactory despite a substantial increase in the number of trials.  This EFNS Task Force aimed at evaluating the existing evidence about the pharmacological treatment of neuropathic pain.  Studies were identified using first the Cochrane Database then Medline.  Trials were classified according to the aetiological condition.  All class I and II controlled trials (according to EFNS classification of evidence) were assessed, but lower-class studies were considered in conditions that had no top level studies.  Only treatments feasible in an outpatient setting were evaluated.  Effects on pain symptoms/signs, quality of life and comorbidities were particularly searched for.  Most of the randomized controlled trials included patients with postherpetic neuralgia (PHN) and painful polyneuropathies (PPN) mainly caused by diabetes.  These trials provide level A evidence for the efficacy of tricyclic antidepressants, gabapentin, pregabalin and opioids, with a large number of class I trials, followed by topical lidocaine (in PHN) and the newer antidepressants venlafaxine and duloxetine (in PPN).  A small number of controlled trials were performed in central pain, trigeminal neuralgia, other peripheral neuropathic pain states and multiple-aetiology neuropathic pains.  The main peripheral pain conditions respond similarly well to tricyclic antidepressants, gabapentin, and pregabalin, but some conditions, such as HIV-associated polyneuropathy, are more refractory.  There are too few studies on central pain, combination therapy, and head-to-head comparison.  For future trials, we recommend to assess quality of life and pain symptoms or signs with standardized tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuZr20ZHxIwXELvajU9pjPfW6udTcc2eadckS9xkguZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28ngs1Smug%253D%253D&md5=3a7ad3adf11b9000e0b27afaa1e5c447</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2006.01511.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2006.01511.x%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DCruccu%26aufirst%3DG.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DNurmikko%26aufirst%3DT.%26atitle%3DEFNS%2520Guidelines%2520on%2520Pharmacological%2520Treatment%2520of%2520Neuropathic%2520Pain%253A%25202010%2520Revision%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2006%26volume%3D13%26spage%3D1153%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Moulin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilron, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessle, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coderre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley-Forster, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taenzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholkan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailis-Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panju, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollman, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, A.</span><span> </span><span class="NLM_article-title">Pharmacological Management of Chronic Neuropathic Pain—Consensus Statement and Guidelines from the Canadian Pain Society</span> <span class="citation_source-journal">Pain Res. Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1155%2F2007%2F730785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=17372630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADC%252BD2s7nsVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=13-21&author=D.+E.+Moulinauthor=A.+J.+Clarkauthor=I.+Gilronauthor=M.+A.+Wareauthor=C.+P.+Watsonauthor=B.+J.+Sessleauthor=T.+Coderreauthor=P.+K.+Morley-Forsterauthor=J.+Stinsonauthor=A.+Boulangerauthor=P.+Pengauthor=G.+A.+Finleyauthor=P.+Taenzerauthor=P.+Squireauthor=D.+Dionauthor=A.+Cholkanauthor=A.+Gilaniauthor=A.+Gordonauthor=J.+Henryauthor=R.+Joveyauthor=M.+Lynchauthor=A.+Mailis-Gagnonauthor=A.+Panjuauthor=G.+B.+Rollmanauthor=A.+Velly&title=Pharmacological+Management+of+Chronic+Neuropathic+Pain%E2%80%94Consensus+Statement+and+Guidelines+from+the+Canadian+Pain+Society"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society</span></div><div class="casAuthors">Moulin D E; Clark A J; Gilron I; Ware M A; Watson C P N; Sessle B J; Coderre T; Morley-Forster P K; Stinson J; Boulanger A; Peng P; Finley G A; Taenzer P; Squire P; Dion D; Cholkan A; Gilani A; Gordon A; Henry J; Jovey R; Lynch M; Mailis-Gagnon A; Panju A; Rollman G B; Velly A</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management : the journal of the Canadian Pain Society = journal de la societe canadienne pour le traitement de la douleur</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>
        ISSN:<span class="NLM_cas:issn">1203-6765</span>.
    </div><div class="casAbstract">Neuropathic pain (NeP), generated by disorders of the peripheral and central nervous system, can be particularly severe and disabling.  Prevalence estimates indicate that 2% to 3% of the population in the developed world suffer from NeP, which suggests that up to one million Canadians have this disabling condition.  Evidence-based guidelines for the pharmacological management of NeP are therefore urgently needed.  Randomized, controlled trials, systematic reviews and existing guidelines focusing on the pharmacological management of NeP were evaluated at a consensus meeting.  Medications are recommended in the guidelines if their analgesic efficacy was supported by at least one methodologically sound, randomized, controlled trial showing significant benefit relative to placebo or another relevant control group.  Recommendations for treatment are based on degree of evidence of analgesic efficacy, safety, ease of use and cost-effectiveness.  Analgesic agents recommended for first-line treatments are certain antidepressants (tricyclics) and anticonvulsants (gabapentin and pregabalin).  Second-line treatments recommended are serotonin noradrenaline reuptake inhibitors and topical lidocaine.  Tramadol and controlled-release opioid analgesics are recommended as third-line treatments for moderate to severe pain.  Recommended fourth-line treatments include cannabinoids, methadone and anticonvulsants with lesser evidence of efficacy, such as lamotrigine, topiramate and valproic acid.  Treatment must be individualized for each patient based on efficacy, side-effect profile and drug accessibility, including cost.  Further studies are required to examine head-to-head comparisons among analgesics, combinations of analgesics, long-term outcomes, and treatment of pediatric and central NeP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVR3Wisn7iNb5oR8RchjrrfW6udTcc2eYdvpm77keKqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7nsVahtg%253D%253D&md5=2890a7b51c560054982d89d5dfd35170</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1155%2F2007%2F730785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2007%252F730785%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DD.%2BE.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DWare%26aufirst%3DM.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BP.%26aulast%3DSessle%26aufirst%3DB.%2BJ.%26aulast%3DCoderre%26aufirst%3DT.%26aulast%3DMorley-Forster%26aufirst%3DP.%2BK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DBoulanger%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DFinley%26aufirst%3DG.%2BA.%26aulast%3DTaenzer%26aufirst%3DP.%26aulast%3DSquire%26aufirst%3DP.%26aulast%3DDion%26aufirst%3DD.%26aulast%3DCholkan%26aufirst%3DA.%26aulast%3DGilani%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DJ.%26aulast%3DJovey%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DMailis-Gagnon%26aufirst%3DA.%26aulast%3DPanju%26aufirst%3DA.%26aulast%3DRollman%26aufirst%3DG.%2BB.%26aulast%3DVelly%26aufirst%3DA.%26atitle%3DPharmacological%2520Management%2520of%2520Chronic%2520Neuropathic%2520Pain%25E2%2580%2594Consensus%2520Statement%2520and%2520Guidelines%2520from%2520the%2520Canadian%2520Pain%2520Society%26jtitle%3DPain%2520Res.%2520Manage.%26date%3D2007%26volume%3D12%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwokin, R. H.</span><span> </span><span class="NLM_article-title">Treatment of Neuropathic Pain: An Overview of Recent Guidelines</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">s22</span><span class="NLM_x">–</span> <span class="NLM_lpage">s32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=s22-s32&author=A.+B.+O%E2%80%99Connorauthor=R.+H.+Dwokin&title=Treatment+of+Neuropathic+Pain%3A+An+Overview+of+Recent+Guidelines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DDwokin%26aufirst%3DR.%2BH.%26atitle%3DTreatment%2520of%2520Neuropathic%2520Pain%253A%2520An%2520Overview%2520of%2520Recent%2520Guidelines%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2009%26volume%3D122%26spage%3Ds22%26epage%3Ds32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cohen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J. R.</span><span> </span><span class="NLM_article-title">Neuropathic Pain: Mechanisms and Their Clinical Implications</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">f7656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1136%2Fbmj.f7656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=f7656&author=S.+P.+Cohenauthor=J.+R.+Mao&title=Neuropathic+Pain%3A+Mechanisms+and+Their+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f7656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f7656%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BP.%26aulast%3DMao%26aufirst%3DJ.%2BR.%26atitle%3DNeuropathic%2520Pain%253A%2520Mechanisms%2520and%2520Their%2520Clinical%2520Implications%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2014%26volume%3D348%26spage%3Df7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vranken, J. H.</span><span> </span><span class="NLM_article-title">Elucidation of Pathophysiology and Treatment of Neuropathic Pain</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F187152412803760645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=304-314&author=J.+H.+Vranken&title=Elucidation+of+Pathophysiology+and+Treatment+of+Neuropathic+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of pathophysiology and treatment of neuropathic pain</span></div><div class="casAuthors">Vranken, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain, pain arising as a direct consequence of a lesion or disease affecting the somatosensory system, is relatively common, occurring in about 1% of the population.  Studies in animal models describe a no. of peripheral and central pathophysiol. processes after nerve injury that would be the basis of underlying neuropathic pain mechanism.  Addnl., neuro-imaging (positron emission tomog. and functional magnetic resonance imaging) provides insights in brain mechanisms corresponding with mechanistic processes including allodynia, hyperalgesia, altered sensation, and spontaneous pain.  A change in function, chem., and structures of neurons (neural plasticity) underlie the prodn. of the altered sensitivity characteristics of neuropathic pain.  Peripheral processes in neuropathic pain involve prodn. of mediators (cytokines, protons, nerve growth factor), alterations in calcium channels, sodium channels, hyperpolarisation-activated nucleotide-gated ion channels, and potassium channels, phenotypic switches and sprouting of nerves endings, and involvement of the sympathetic nervous system.  Stimulation of the N-Methyl-D-Aspartate receptor, activation of microglia, oligodendrocytes, and astrocytes, increased prodn. of nerve growth factor and brain-derived neurotrophic factor together with loss of spinal inhibitory control are responsible for central neuron hyperexcitability and maintenance of neuropathic pain.  Recent advances, including functional imaging techniques, in identification of peripheral and central sensitization mechanisms related to nervous system injury have increased potential for affecting pain research from both diagnostic as well as therapeutic view.  Key brain regions involved in generating pharmacol. induced analgesia may be identified.  Despite the progress in pain research, neuropathic pain is challenge to manage.  Although numerous treatment options are available for relieving neuropathic pain, there is no consensus on the most appropriate treatment.  However, recommendations can be proposed for first-line, second-line, and third-line pharmacol. treatments based on the level of evidence for the different treatment strategies.  Available therapies shown to be effective in managing neuropathic pain include opioids and tramadol, anticonvulsants, antidepressants, topical treatments (lidocaine patch, capsaicin), and ketamine.  Tricyclic antidepressants are often the first drugs selected to alleviate neuropathic pain (first-line pharmacol. treatment).  Although they are very effective in reducing pain in several neuropathic pain disorders, treatment may be compromised (and outweighed) by their side effects.  In patients with a history of cardiovascular disorders, glaucoma, and urine retention, pregabalin and gabapentine are emerging as first-line treatment for neuropathic pain.  In addn. these anti-epileptic drugs have a favorable safety profile with minimal concerns regarding drug interactions and showing no interference with hepatic enzymes.  Alternatively, opioids (oxycodone and methadone) and tramadol may alleviate nociceptive and neuropathic pain.  Despite the numerous treatment options available for relieving neuropathic pain, no more than half of patients experience clin. meaningful pain relief, which is almost always partial but not complete relief.  In addn., patients frequently experience burdensome adverse effects and as a consequence are often unable to tolerate the treatment.  In the remaining patients, combination therapies using two or more analgesics with different mechanisms of action may also offer adequate pain relief.  Although combination treatment is clin. practice and may result in greater pain relief, trials regarding different combinations of analgesics (which combination to use, occurrence of additive or supra-additive effects, sequential or concurrent treatment, adverse-event profiles of these analgesics, alone and in combination) are scarce.  If medical treatments have failed, invasive therapies such as intrathecal drug administration and neurosurgical stimulation techniques (spinal cord stimulation, deep brain stimulation, and motor cortex stimulation) may be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV4fUWGo1P_rVg90H21EOLACvtfcHk0lhKcaDt2zvsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFSitg%253D%253D&md5=d4544bc635b30fc12447c75a6cc829d0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F187152412803760645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152412803760645%26sid%3Dliteratum%253Aachs%26aulast%3DVranken%26aufirst%3DJ.%2BH.%26atitle%3DElucidation%2520of%2520Pathophysiology%2520and%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D304%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourlay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanpää, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miaskowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walco, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span> </span><span class="NLM_article-title">Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">s3</span><span class="NLM_x">–</span> <span class="NLM_lpage">s14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.4065%2Fmcp.2009.0649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=20194146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=s3-s14&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=J.+Audetteauthor=R.+Baronauthor=G.+K.+Gourlayauthor=M.+L.+Haanp%C3%A4%C3%A4author=J.+L.+Kentauthor=E.+J.+Kraneauthor=A.+A.+Lebelauthor=R.+M.+Levyauthor=S.+C.+Mackeyauthor=J.+Mayerauthor=C.+Miaskowskiauthor=S.+N.+Rajaauthor=A.+S.+Riceauthor=K.+E.+Schmaderauthor=B.+Staceyauthor=S.+Stanosauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=G.+A.+Walcoauthor=C.+D.+Wells&title=Recommendations+for+the+Pharmacological+Management+of+Neuropathic+Pain%3A+An+Overview+and+Literature+Update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C.; Walco, Gary A.; Wells, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S3-S14</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Dowden Health Media, Inc.</span>)
        </div><div class="casAbstract">A review.  The Neuropathic Pain Special Interest Group of the International Assocn. for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacol. treatment of neuropathic pain.  Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (le, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clin. trials.  Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clin. circumstances.  Results of several recent clin. trials have become available since the development of these guidelines.  These studies have examd. botulinum toxin, high-concn. capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions.  The increasing no. of neg. clin. trials of pharmacol. treatments for neuropathic pain and ambiguities in the interpretation of these neg. trials must also be considered in developing treatment guidelines.  The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacol. management of neuropathic pain and to provide a brief overview of these recent studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_qlufOfrkLVg90H21EOLACvtfcHk0ljMmROjHKMLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Sjsb0%253D&md5=749b581e00c2be99ae45dbf54de0bca3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2009.0649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2009.0649%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DAudette%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DGourlay%26aufirst%3DG.%2BK.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%2BL.%26aulast%3DKent%26aufirst%3DJ.%2BL.%26aulast%3DKrane%26aufirst%3DE.%2BJ.%26aulast%3DLebel%26aufirst%3DA.%2BA.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26aulast%3DMackey%26aufirst%3DS.%2BC.%26aulast%3DMayer%26aufirst%3DJ.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DSchmader%26aufirst%3DK.%2BE.%26aulast%3DStacey%26aufirst%3DB.%26aulast%3DStanos%26aufirst%3DS.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWalco%26aufirst%3DG.%2BA.%26aulast%3DWells%26aufirst%3DC.%2BD.%26atitle%3DRecommendations%2520for%2520the%2520Pharmacological%2520Management%2520of%2520Neuropathic%2520Pain%253A%2520An%2520Overview%2520and%2520Literature%2520Update%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26spage%3Ds3%26epage%3Ds14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Martin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eades, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppler, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. E.</span><span> </span><span class="NLM_article-title">The Effects of Morphine- and Nalorphine-Like Drugs in the Nondependent and Morphine-Dependent Chronic Spinal Dog</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=945347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1976&pages=517-532&author=W.+R.+Martinauthor=C.+G.+Eadesauthor=J.+A.+Thompsonauthor=R.+E.+Hupplerauthor=P.+E.+Gilbert&title=The+Effects+of+Morphine-+and+Nalorphine-Like+Drugs+in+the+Nondependent+and+Morphine-Dependent+Chronic+Spinal+Dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog</span></div><div class="casAuthors">Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-32</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Three different syndromes produced by congeners of morphine sulfate (I sulfate) [64-31-3] were identified in the nondependent chronic spinal dog.  These syndromes were attributed to interaction of agonists with three distinguishable receptors (μ, κ and σ).  I was the prototype agonist for the μ receptor, ketocyclazocine lactate [59985-33-0] for the κ receptor and SKF-10,047 lactate [59985-34-1] for the σ receptor.  The I syndrome (μ) in the dog was characterized by miosis, bradycardia, hypothermia, a general depression of the nociceptive responses and indifferences to environmental stimuli.  Ketocyclazocine (κ) constricted pupils, depressed the flexor reflex and produced sedation but did not markedly alter pulse rate or the skin twitch reflex.  SKF-10,047 (σ) caused mydriasis, tachypnea, tachycardia and mania.  The effects of these three drugs was antagonized by the pure antagonist naltrexone-HCl, indicating that they are agonists.  Further, chronic administration of I, ketocyclazocine and SKF-10,047 induced tolerance to their agonistic effects.  I suppressed abstinence in I-dependent dogs while ketocyclazocine did not.  Ketocyclazocine at best pptd. only a liminal abstinence syndrome in the I-dependent dog, indicating that it had little affinity for the I receptor.  Ketocyclazocine thus appears to be a selective agonist at the κ receptor.  Buprenorphine-HCl [53152-21-9] was a partial agonist of the μ type which both suppressed and pptd. abstinence in the I-dependent dog while I and d-propoxyphene-HCl [1639-60-7] were stronger agonists.  Apomorphine-HCl [314-19-2] and SKF-10,047 produced similar pharmacol. effects suggesting that σ activity may involve a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6rgyf41iRTbVg90H21EOLACvtfcHk0ljMmROjHKMLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltlOhurw%253D&md5=ca7c637f336ac9ecc2c3bb040dbcdbee</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BR.%26aulast%3DEades%26aufirst%3DC.%2BG.%26aulast%3DThompson%26aufirst%3DJ.%2BA.%26aulast%3DHuppler%26aufirst%3DR.%2BE.%26aulast%3DGilbert%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Effects%2520of%2520Morphine-%2520and%2520Nalorphine-Like%2520Drugs%2520in%2520the%2520Nondependent%2520and%2520Morphine-Dependent%2520Chronic%2520Spinal%2520Dog%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1976%26volume%3D197%26spage%3D517%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zukin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Behavioral and Biochemical Stereoselectivity of Sigma Opiate/PCP Receptors</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0006-8993%2884%2991326-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=6199090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1984&pages=174-177&author=S.+R.+Zukinauthor=K.+T.+Bradyauthor=B.+L.+Sliferauthor=R.+L.+Balster&title=Behavioral+and+Biochemical+Stereoselectivity+of+Sigma+Opiate%2FPCP+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors</span></div><div class="casAuthors">Zukin, Stephen R.; Brady, Kathleen T.; Slifer, Barbara L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-7</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The relative potencies of (±)-ketamine [(±)-I]  [6740-88-1], (+)-I  [33643-49-1], (-)-I  [33643-46-8], (±)-N-allylnormetazocine [(±)-II]  [7313-95-3], (+)-II  [58640-82-7], (-)-II  [14198-28-8], (±)-cyclazocine [(±)-III]  [7346-09-0], (+)-III  [7313-87-3], and (-)-III  [7313-86-2] at μ opiate receptors and at σ opiate/phencyclidine (PCP)  [77-10-1] receptors were detd. in vitro in rat brain homogenates (displacement of labeled dihydromorphine  [509-60-4] and PCP for the μ and PCP receptors, resp.) and in a discriminative stimulus behavioral paradigm in rats (PCP vs. saline).  In all cases the in vitro and in vivo data were in agreement.  (+)-II and (+)-III were highly specific σ opiate/PCP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7YsmwYzvSm7Vg90H21EOLACvtfcHk0ljMmROjHKMLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsbY%253D&md5=06d1ca0c2d406f214ea9fd43b1e9c7c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2991326-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252991326-X%26sid%3Dliteratum%253Aachs%26aulast%3DZukin%26aufirst%3DS.%2BR.%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DSlifer%26aufirst%3DB.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DBehavioral%2520and%2520Biochemical%2520Stereoselectivity%2520of%2520Sigma%2520Opiate%252FPCP%2520Receptors%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D294%26spage%3D174%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerchner, G. A.</span><span> </span><span class="NLM_article-title">Sigma Opioid Receptor: Characterization and Co-identity with the Phencyclidine Receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2989489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=597-602&author=L.+G.+Mendelsohnauthor=V.+Kalraauthor=B.+G.+Johnsonauthor=G.+A.+Kerchner&title=Sigma+Opioid+Receptor%3A+Characterization+and+Co-identity+with+the+Phencyclidine+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma opioid receptor:  characterization and co-identity with the phencyclidine receptor</span></div><div class="casAuthors">Mendelsohn, Laurane G.; Kalra, Vin; Johnson, Bryan G.; Kerchner, Gail A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-602</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The properties of the σ opioid receptor of rat brain cortex were characterized using the prototypic ligand 3H-labeled (+)-SKF 10,047  [58640-82-7].  Binding to this receptor was rapid, and equil. was obtained within 30 min at 37°.  Specific binding was linear with protein concn. up to 500 μg/2 mL and was dependent upon protein integrity.  Denaturation by boiling destroyed >95% of the specific binding.  A high-affinity binding site with a dissocn. const. of 150 nM and a max. binding of 2.91 pmol/mg of protein was detd. from a Scatchard plot of the binding data.  The addn. of NaCl or CaCl2 to the buffers markedly decreased binding, with CaCl2 being more potent than NaCl.  A broad pH optimum for specific binding was obsd.; max. binding was at pH 9.0.  The affinity of a no. of ligands for the site and the phencyclidine  [77-10-1] receptor were compared.  The binding (IC50) of 13 ligands to the sigma site showed a correlation of 0.86 with binding to the phencyclidine site.  Thus, the biochem. properties of the σ and phencyclidine receptors are similar, and these receptors may be one and the same site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyw4zOY5vN17Vg90H21EOLACvtfcHk0ljMmROjHKMLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXks1GgsL0%253D&md5=20db7f5ed4690c03d95050799953f992</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DKalra%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26atitle%3DSigma%2520Opioid%2520Receptor%253A%2520Characterization%2520and%2520Co-identity%2520with%2520the%2520Phencyclidine%2520Receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma Receptor: Advances and New Clinical Potentials</span> <span class="citation_source-journal">Pharm. Acta Helv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=211-218&author=W.+D.+Bowen&title=Sigma+Receptor%3A+Advances+and+New+Clinical+Potentials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma%2520Receptor%253A%2520Advances%2520and%2520New%2520Clinical%2520Potentials%26jtitle%3DPharm.%2520Acta%2520Helv.%26date%3D2000%26volume%3D74%26spage%3D211%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hellewell, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">A Sigma-like Binding Site in Rat Pheochromocytoma (PC12) Cells: Decreased Affinity for (+)-Benzomorphans and Lower Molecular Weight Suggest a Different Sigma Receptor Form from that in Guinea Pig Brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0006-8993%2890%2991143-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2174717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=1990&pages=244-253&author=S.+B.+Hellewellauthor=W.+D.+Bowen&title=A+Sigma-like+Binding+Site+in+Rat+Pheochromocytoma+%28PC12%29+Cells%3A+Decreased+Affinity+for+%28%2B%29-Benzomorphans+and+Lower+Molecular+Weight+Suggest+a+Different+Sigma+Receptor+Form+from+that+in+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A sigma-like binding site in rat pheochromocytoma (PC12) cells:  decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain</span></div><div class="casAuthors">Hellewell, Susan B.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Two highly selective radiolabeled probes for sigma receptors were found to bind with high affinity and capacity to membranes from undifferentiated PC12 cells 1,3-di-o-[3H]tolylguanidine ([1H]DTG) bound with Kd = 23.7 nM and Bmax = 2025 fmol/mg protein.  The Kd and Bmax for 3H-labeled (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ([3H](+)-3-PPP) were 86.3 nM and 1539 fmol/mg protein, resp.  These binding parameters were comparable to those obsd. in guinea pig brain sites exhibited high affinity for haloperidol, moderate affinity for phencyclidine (PCP), and negligible affinity for MK-801, apomorphine, and (-)-sulpiride.  These data suggest a relationship of the PC12 site to sigma receptors.  However, all (+)-opiates ((+)-benzomorphans and (+)-morphinans) tested bound with markedly lower affinity to the PC12 site compared to guinea pig brain.  These include (+)-N-allylnormetazocine ((+)-SKF 10,047), (+)-pentazocine, and dextrallorphan.  In fact, PC12 sites exhibited preference for (-)-benzomorphans, the reverse stereoselectivity of guinea pig brain sites.  Binding of 3H-labeled N-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) could not be detected, demonstrating absence of PCP receptors on this cell line.  Differentiation of cells by treatment with nerve growth factor had no effect on sigma binding parameters.  Membranes from guinea pig brain and PC12 cells were photoaffinity-labeled using azido-di-o [3H]tolylguanidine.  In guinea pig brain, a polypeptide of 25 kDa was specifically labeled.  However, label was incorporated into polypeptides of 18 kDa and 21 kDa in membranes from PC12 cells.  In view of the otherwise similar binding characteristics, the marked differences in affinity for (+)-benzomorphans and mol. wt. suggest that PC12 cells contain a mol. form of sigma receptor distinct from that predominant in guinea pig brain.  This raises the possibility of multiple sigma receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSWLms51RjbVg90H21EOLACvtfcHk0lhJ_wyqdFlKtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2rsw%253D%253D&md5=cdb78ce18d40ae20a42e7215a3cbd0a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2890%2991143-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252890%252991143-5%26sid%3Dliteratum%253Aachs%26aulast%3DHellewell%26aufirst%3DS.%2BB.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DA%2520Sigma-like%2520Binding%2520Site%2520in%2520Rat%2520Pheochromocytoma%2520%2528PC12%2529%2520Cells%253A%2520Decreased%2520Affinity%2520for%2520%2528%252B%2529-Benzomorphans%2520and%2520Lower%2520Molecular%2520Weight%2520Suggest%2520a%2520Different%2520Sigma%2520Receptor%2520Form%2520from%2520that%2520in%2520Guinea%2520Pig%2520Brain%26jtitle%3DBrain%2520Res.%26date%3D1990%26volume%3D527%26spage%3D244%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Quirion, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzhak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarm, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span> </span><span class="NLM_article-title">A proposal for the classification of sigma binding sites</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0165-6147%2892%2990030-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=1315463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=85-86&author=R.+Quirionauthor=W.+D.+Bowenauthor=Y.+Itzhakauthor=J.+L.+Junienauthor=J.+M.+Musacchioauthor=R.+B.+Rothmanauthor=T.+P.+Suauthor=S.+W.+Tarmauthor=D.+P.+Taylor&title=A+proposal+for+the+classification+of+sigma+binding+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A proposal for the classification of sigma binding sites</span></div><div class="casAuthors">Quirion R; Bowen W D; Itzhak Y; Junien J L; Musacchio J M; Rothman R B; Su T P; Tam S W; Taylor D P</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">85-6</span>
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9QiJWG_oOy3p3bfzSLaX5fW6udTcc2ebCsYjpNhgnQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksFGrsQ%253D%253D&md5=bdbde1d04c3c3e627e4ff512102ddf5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2892%2990030-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252892%252990030-A%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DItzhak%26aufirst%3DY.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DTarm%26aufirst%3DS.%2BW.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26atitle%3DA%2520proposal%2520for%2520the%2520classification%2520of%2520sigma%2520binding%2520sites%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1992%26volume%3D13%26spage%3D85%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Su, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span> </span><span class="NLM_article-title">Understanding the Molecular Mechanism of Sigma-1 Receptor: Towards a Hypothesis that Sigma-1 Receptor Are Intracellular Amplifiers for Signal Transduction</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F0929867033456783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=12871086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=2073-2080&author=T.+P.+Suauthor=T.+Hayashi&title=Understanding+the+Molecular+Mechanism+of+Sigma-1+Receptor%3A+Towards+a+Hypothesis+that+Sigma-1+Receptor+Are+Intracellular+Amplifiers+for+Signal+Transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the molecular mechanism of sigma-1 receptors: Towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction</span></div><div class="casAuthors">Su, Tsung-Ping; Hayashi, Teruo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2073-2080</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although sigma receptors were discovered in 1982, the biochem. and physiol. roles of sigma receptors have just begun to unveil.  Sigma receptors are non-opioid, non-phencyclidine receptors that contain two subtypes: Sigma-1 and Sigma-2 receptors.  The sigma-1 receptor has been cloned and its sequence does not resemble that of any mammalian protein.  Sigma-2 receptors have not been cloned.  Sigma-1 receptors contain 223 amino acids and reside primarily at the endoplasmic reticulum.  Sigma-1 receptors exist mainly in the central nervous system, but also in the periphery.  Sigma-1 receptor ligands include cocaine, (+)-benzomorphans like (+)-pentazocine and (+)N-allyl-normetazocine (or (+)SKF-10047), and endogenous neurosteroids like progesterone and pregnenolone sulfate.  Many pharmacol. and physiol. actions have been attributed to sigma-1 receptors.  These include the regulation of IP3 receptors and calcium signaling at the endoplasmic reticulum, mobilization of cytoskeletal adaptor proteins, modulation of nerve growth factor-induced neurite sprouting, modulation of neurotransmitter release and neuronal firing, modulation of potassium channels as a regulatory subunit, alteration of psychostimulant-induced gene expression, and blockade of spreading depression.  Behaviorally, sigma-1 receptors are involved in learning and memory, psychostimulant-induced sensitization, cocaine-induced conditioned place preference, and pain perception.  Notably, in almost all the aforementioned biochem. and behavioral tests, sigma-1 agonists, while having no effects by themselves, caused the amplification of signal transductions incurred upon the stimulation of the glutamatergic, dopaminergic, IP3-related metabotropic, or nerve growth factor-related systems.  Thus, it is hypothesized that sigma-1 receptors, at least in part, are intracellular amplifiers creating a supersensitized state for signal transduction in the biol. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6DJ73APuq7Vg90H21EOLACvtfcHk0lhJ_wyqdFlKtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslyqtrY%253D&md5=771f615ddf6b87b9b17f564c5e7ad162</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F0929867033456783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033456783%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%2BP.%26aulast%3DHayashi%26aufirst%3DT.%26atitle%3DUnderstanding%2520the%2520Molecular%2520Mechanism%2520of%2520Sigma-1%2520Receptor%253A%2520Towards%2520a%2520Hypothesis%2520that%2520Sigma-1%2520Receptor%2520Are%2520Intracellular%2520Amplifiers%2520for%2520Signal%2520Transduction%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D2073%26epage%3D2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Pharmacology and Therapeutic Potential of Sigma-1 Receptor Ligands</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.2174%2F157015908787386113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=19587856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=344-366&author=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=C.+M.+Cend%C3%A1nauthor=E.+Del+Pozo&title=Pharmacology+and+Therapeutic+Potential+of+Sigma-1+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and therapeutic potential of sigma1 receptor ligands</span></div><div class="casAuthors">Cobos, E. J.; Entrena, J. M.; Nieto, F. R.; Cendan, C. M.; del Pozo, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">344-366</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, initially described as a subtype of opioid receptors, are now considered unique receptors.  Pharmacol. studies have distinguished two types of σ receptors, termed σ1 and σ2.  Of these two subtypes, the σ1 receptor has been cloned in humans and rodents, and its amino acid sequence shows no homol. with other mammalian proteins.  Several psychoactive drugs show high to moderate affinity for σ1 receptors, including the antipsychotic haloperidol, the antidepressant drugs fluvoxamine and sertraline, and the psychostimulants cocaine and methamphetamine; in addn., the anticonvulsant drug phenytoin allosterically modulates σ1 receptors.  Certain neurosteroids are known to interact with σ1 receptors, and have been proposed to be their endogenous ligands.  These receptors are located in the plasma membrane and in subcellular membranes, particularly in the endoplasmic reticulum, where they play a modulatory role in intracellular Ca2+ signaling.  Sigma1 receptors also play a modulatory role in the activity of some ion channels and in several neurotransmitter systems, mainly in glutamatergic neurotransmission.  In accordance with their widespread modulatory role, σ1 receptor ligands have been proposed to be useful in several therapeutic fields such as amnesic and cognitive deficits, depression and anxiety, schizophrenia, analgesia, and against some effects of drugs of abuse (such as cocaine and methamphetamine).  In this review we provide an overview of the present knowledge of σ1 receptors, focusing on σ1 ligand neuropharmacol. and the role of σ1 receptors in behavioral animal studies, which have contributed greatly to the potential therapeutic applications of σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTkDMnDR6uN7Vg90H21EOLACvtfcHk0lgC207U0yySFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSqu7w%253D&md5=37895c10c7ef1bb7077d0782f73d5776</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157015908787386113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015908787386113%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPharmacology%2520and%2520Therapeutic%2520Potential%2520of%2520Sigma-1%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2008%26volume%3D6%26spage%3D344%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Monnet, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced neuronal activation is selectively modulated by sigma receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0014-2999%2890%2990186-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2163857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1990&pages=441-455&author=F.+P.+Monnetauthor=G.+Debonnelauthor=J.+L.+Junienauthor=C.+De+Montigny&title=N-Methyl-d-aspartate-induced+neuronal+activation+is+selectively+modulated+by+sigma+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors</span></div><div class="casAuthors">Monnet, Francois P.; Debonnel, Guy; Junien, Jean Louis; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of 2 high-affinity σ ligands, DTG (1,3-di(2-tolyl)guanidine) and haloperidol, on the activation of dorsal hippocampus pyramidal neurons induced by microiontophoretic application of N-methyl-D-aspartate (NMDA) were assessed electrophysiol.  Low doses of DTG (0.5-3 μg/kg, i.v.) potentiated the NMDA response.  This effect of DTG was blocked by haloperidol (10 μg/kg i.v.), but not by spiperone, a potent dopamine antagonist with low affinity for σ receptors.  Apparently, σ receptors modulate the NMDA-induced neuronal activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAVkVDgk_ebVg90H21EOLACvtfcHk0lgC207U0yySFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlGiuro%253D&md5=415aeb364969efa07c6149f19404209f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2890%2990186-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252890%252990186-A%26sid%3Dliteratum%253Aachs%26aulast%3DMonnet%26aufirst%3DF.%2BP.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DN-Methyl-d-aspartate-induced%2520neuronal%2520activation%2520is%2520selectively%2520modulated%2520by%2520sigma%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1990%26volume%3D179%26spage%3D441%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cheng, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">zheng, P.</span><span> </span><span class="NLM_article-title">Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.expneurol.2007.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2010&pages=128-136&author=Z.+X.+Chengauthor=M.+D.+Lanauthor=P.+X.+Wuauthor=Y.+H.+Zhuauthor=Y.+Dongauthor=L.+Maauthor=P.+zheng&title=Neurosteroid+dehydroepiandrosterone+sulphate+inhibits+persistent+sodium+currents+in+rat+medial+prefrontal+cortex+via+activation+of+sigma-1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DZ.%2BX.%26aulast%3DLan%26aufirst%3DM.%2BD.%26aulast%3DWu%26aufirst%3DP.%2BX.%26aulast%3DZhu%26aufirst%3DY.%2BH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3Dzheng%26aufirst%3DP.%26atitle%3DNeurosteroid%2520dehydroepiandrosterone%2520sulphate%2520inhibits%2520persistent%2520sodium%2520currents%2520in%2520rat%2520medial%2520prefrontal%2520cortex%2520via%2520activation%2520of%2520sigma-1%2520receptors%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D210%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ayder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. B.</span><span> </span><span class="NLM_article-title">The Sigma Receptor as A Ligand-Regulated Auxiliary Potassium Channel Subunit</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=399-410&author=E.+Ayderauthor=C.+P.+Palmerauthor=V.+A.+Klyachkoauthor=M.+B.+Jackson&title=The+Sigma+Receptor+as+A+Ligand-Regulated+Auxiliary+Potassium+Channel+Subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyder%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DC.%2BP.%26aulast%3DKlyachko%26aufirst%3DV.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BB.%26atitle%3DThe%2520Sigma%2520Receptor%2520as%2520A%2520Ligand-Regulated%2520Auxiliary%2520Potassium%2520Channel%2520Subunit%26jtitle%3DNeuron%26date%3D2002%26volume%3D34%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">Ca<sup>2+</sup> Signaling via σ<sub>1</sub> Receptor: Novel Regulatory Mechanism Affecting Intracellular Ca<sup>2+</sup> Concentration</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=10869377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=788-798&author=T.+Hayashiauthor=T.+Mauriceauthor=T.+P.+Su&title=Ca2%2B+Signaling+via+%CF%831+Receptor%3A+Novel+Regulatory+Mechanism+Affecting+Intracellular+Ca2%2B+Concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ signaling via σ1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration</span></div><div class="casAuthors">Hayashi, Teruo; Maurice, Tangui; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-798</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The σ1-receptor is a one-transmembrane endoplasmic reticulum protein that binds neurosteroids and dextrorotatory benzomorphans.  The roles of σ1-receptors in regulating intracellular Ca2+ in NG108 cells were examd. in this study.  σ1-Ligands pregnenolone sulfate, (+)-pentazocine, and 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride modulate Ca2+ signaling in NG 108 cells via two modes of action.  First, nanomolar concns. of the ligands, without effect by themselves, potentiated the bradykinin-induced increase of the cytosolic free Ca2+ concn. in a bell-shaped manner.  This effect of σ1-ligands was unaffected by depletion of Ca2+ from perfusion buffer and was blocked by a 21-mer antisense oligodeoxynucleotide against the cloned σ1-receptors.  Second, after the cells were depleted of the endoplasmic reticulum Ca2+ stores, the depolarization (75 mM KCl)-induced increase in cytosolic free Ca2+ was potentiated by 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride, whereas it was inhibited by pregnenolone sulfate and (+)-pentazocine.  These effects, albeit opposite in direction, were blocked by both the 21-mer antisense oligodeoxynucleotide and pertussis toxin.  Western blotting indicates that σ1-receptors are increased on the plasma membrane and the nuclear membrane in the presence of σ1-ligand.  These results suggest that Ca2+ signaling via σ1-receptors may represent a novel mechanism that affects intracellular Ca2+ concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5UrPmwIQdrVg90H21EOLACvtfcHk0lgC207U0yySFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsleks7g%253D&md5=de8007846ac5a0a4292c2f501a049a7c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DCa2%252B%2520Signaling%2520via%2520%25CF%25831%2520Receptor%253A%2520Novel%2520Regulatory%2520Mechanism%2520Affecting%2520Intracellular%2520Ca2%252B%2520Concentration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Crawford, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-2 Receptor Agonists Activate A Novel Apoptotic Pathway and Potentiate Antineoplastic Drugs in Breast Tumor Cell Lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=313-322&author=K.+W.+Crawfordauthor=W.+D.+Bowen&title=Sigma-2+Receptor+Agonists+Activate+A+Novel+Apoptotic+Pathway+and+Potentiate+Antineoplastic+Drugs+in+Breast+Tumor+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DK.%2BW.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-2%2520Receptor%2520Agonists%2520Activate%2520A%2520Novel%2520Apoptotic%2520Pathway%2520and%2520Potentiate%2520Antineoplastic%2520Drugs%2520in%2520Breast%2520Tumor%2520Cell%2520Lines%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D1%26spage%3D313%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The Sigma-2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+B.+Zengauthor=W.+G.+Hawkins&title=The+Sigma-2+Receptor%3A+A+Novel+Protein+for+the+Imaging+and+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%2BB.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Sigma-2%2520Receptor%253A%2520A%2520Novel%2520Protein%2520for%2520the%2520Imaging%2520and%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bermack, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span> </span><span class="NLM_article-title">The Role of Sigma Receptors in Depression</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1254%2Fjphs.CRJ04005X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15750289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=317-336&author=J.+E.+Bermackauthor=G.+Debonnel&title=The+Role+of+Sigma+Receptors+in+Depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sigma receptors in depression</span></div><div class="casAuthors">Bermack, Jordanna E.; Debonnel, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-336</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  Behavioral models used to test potential antidepressants have shown that ligands that bind to sigma receptors possess "antidepressant-like" properties.  The focus of this review is to discuss the literature concerning sigma receptors and their ligands, with respect to their antidepressants properties.  In addn. to the behavioral data, we discuss electrophysiol. and biochem. models demonstrating sigma receptors' ability to modulate important factors in the pathophysiol. of depression and/or the mechanisms of action of antidepressants such as the serotonergic neurotransmission in the dorsal raphe nucleus (DRN) and the glutamatergic transmission in the hippocampus.  We also discuss the significance of these two systems in the mechanism of action of antidepressants.  Sigma ligands have potential as antidepressant medications with a fast onset of action as they produce a rapid modulation of the serotonergic system in the DRN and the glutamatergic transmission in the hippocampus.  As these effects of sigma ligands may produce antidepressant properties by completely novel mechanisms of action, they may provide an alternative to the antidepressants currently available and may prove to be beneficial for treatment-resistant depressed patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc8adYlmpSrVg90H21EOLACvtfcHk0lho_yTa4UlGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGjtL4%253D&md5=1cdda174b9b1e5087118ae49526b3eb0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CRJ04005X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CRJ04005X%26sid%3Dliteratum%253Aachs%26aulast%3DBermack%26aufirst%3DJ.%2BE.%26aulast%3DDebonnel%26aufirst%3DG.%26atitle%3DThe%2520Role%2520of%2520Sigma%2520Receptors%2520in%2520Depression%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D97%26spage%3D317%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span> </span><span class="NLM_article-title">Effect of the Novel Sigma 1 Receptor Ligand and Putative Atypical Antipsychotic E-5842 on BDNF mRNA Expression in the Rat Brain</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=2345-2348&author=S.+Ovalleauthor=F.+Andreuauthor=M.+P.+P%C3%A9rezauthor=D.+Zamanilloauthor=X.+Guitart&title=Effect+of+the+Novel+Sigma+1+Receptor+Ligand+and+Putative+Atypical+Antipsychotic+E-5842+on+BDNF+mRNA+Expression+in+the+Rat+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DAndreu%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%2BP.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DGuitart%26aufirst%3DX.%26atitle%3DEffect%2520of%2520the%2520Novel%2520Sigma%25201%2520Receptor%2520Ligand%2520and%2520Putative%2520Atypical%2520Antipsychotic%2520E-5842%2520on%2520BDNF%2520mRNA%2520Expression%2520in%2520the%2520Rat%2520Brain%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D2345%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. P.</span><span> </span><span class="NLM_article-title">The Potential Role of Sigma-1 Receptor in Lipid Transport and Lipid Raft Reconstitution in the Brain: Implication for Drug Abuse</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1612-1624&author=T.+Hayashiauthor=T.+P.+Su&title=The+Potential+Role+of+Sigma-1+Receptor+in+Lipid+Transport+and+Lipid+Raft+Reconstitution+in+the+Brain%3A+Implication+for+Drug+Abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.%2BP.%26atitle%3DThe%2520Potential%2520Role%2520of%2520Sigma-1%2520Receptor%2520in%2520Lipid%2520Transport%2520and%2520Lipid%2520Raft%2520Reconstitution%2520in%2520the%2520Brain%253A%2520Implication%2520for%2520Drug%2520Abuse%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1612%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Attenuation by A Sigma<sub>1</sub> (σ<sub>1</sub>) Receptor Agonist of the Learning and Memory Deficits Induced by a Prenatal Restraint Stress in Juvenile Rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1038%2Fsj.bjp.0705835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15205309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2004&pages=689-700&author=J.+Meunierauthor=M.+Gueauthor=M.+Recasensauthor=T.+Maurice&title=Attenuation+by+A+Sigma1+%28%CF%831%29+Receptor+Agonist+of+the+Learning+and+Memory+Deficits+Induced+by+a+Prenatal+Restraint+Stress+in+Juvenile+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation by a sigma1 (σ1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats</span></div><div class="casAuthors">Meunier, Johann; Gue, Michele; Recasens, Max; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1: Stress during pregnancy results in complex neurochem. and behavioral alterations throughout the offspring lifetime.  We here examd. the impact of prenatal stress (PS) on memory functions in male and female offspring and report the efficacy of a selective sigma1 (σ1) receptor agonist, igmesine, in alleviating the obsd. deficits.  2: Dams received an unpredictable 90-min duration restraint stress from gestational day E17 to E20.  Learning was examd. in offspring between day P24 and P36 using spontaneous alternation in the Y-maze, delayed alternation in the T-maze, water-maze learning and passive avoidance.  3: Both male and female PS rats showed impairments of spontaneous and delayed alternation performances.  Acquisition of a fixed platform position in the water-maze was unchanged in PS rats, but the probe test revealed a diminution of time spent in the training quadrant.  Acquisition of a daily changing platform position demonstrated impaired working memory for male and female PS rats.  Finally, passive avoidance deficits were obsd.  4: Pretreatment with the selective σ1 agonist igmesine (1-10 mg kg-1 i.p.) reversed the PS-induced learning deficits in offspring rats for each test.  The σ1 antagonist BD1063 failed to affect performances alone but blocked the igmesine effect, confirming the involvement of the σ1 receptor.  5: PS thus induces delayed memory deficits, affecting spatial and nonspatial, short- and long-term memories in juvenile male and female offspring rats.  Activation of the σ1 neuromodulatory receptor allows a significant recovery of the memory functions in PS rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhtHAjlawprVg90H21EOLACvtfcHk0lho_yTa4UlGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlejurk%253D&md5=cc7f51d2bef3acb88732499642b49a77</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705835%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DGue%26aufirst%3DM.%26aulast%3DRecasens%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAttenuation%2520by%2520A%2520Sigma1%2520%2528%25CF%25831%2529%2520Receptor%2520Agonist%2520of%2520the%2520Learning%2520and%2520Memory%2520Deficits%2520Induced%2520by%2520a%2520Prenatal%2520Restraint%2520Stress%2520in%2520Juvenile%2520Rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D142%26spage%3D689%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma 1 Receptor: A New Therapeutic Target for Pain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">716</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+Receptor%3A+A+New+Therapeutic+Target+for+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0liF6ZF4tmIVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520Receptor%253A%2520A%2520New%2520Therapeutic%2520Target%2520for%2520Pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Functional Antagonism of Morphine Analgesia by (+)-Pentazocine: Evidence for an Anti-opioid Sigma 1 System</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">R7</span><span class="NLM_x">–</span> <span class="NLM_lpage">R8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1993&pages=R7-R8&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Functional+Antagonism+of+Morphine+Analgesia+by+%28%2B%29-Pentazocine%3A+Evidence+for+an+Anti-opioid+Sigma+1+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DFunctional%2520Antagonism%2520of%2520Morphine%2520Analgesia%2520by%2520%2528%252B%2529-Pentazocine%253A%2520Evidence%2520for%2520an%2520Anti-opioid%2520Sigma%25201%2520System%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D250%26spage%3DR7%26epage%3DR8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">(−)-Pentazocine Analgesia in Mice: Interactions with a Sigma Receptor System</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0014-2999%2895%2900552-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=8788445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSgsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=1995&pages=303-308&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=%28%E2%88%92%29-Pentazocine+Analgesia+in+Mice%3A+Interactions+with+a+Sigma+Receptor+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-Pentazocine analgesia in mice: interactions with a σ receptor system</span></div><div class="casAuthors">Chien, C.-C.; Pasternak, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">303-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(-)-Pentazocine is active in the tail-flick assay in CD-1 mice, although it shows a biphasic dose-response curve with a peak effect of only 30%.  Co-administration of haloperidol shifts the dose-response curve to the left and elevates the maximal response to 70% through a blockade of σ1 receptors, but the curve remains biphasic. (+)-Pentazocine is inactive in all antinociceptive assays, either alone or with haloperidol.  The analgesic actions of (-)-pentazocine are readily reversed by nor-binaltorphimine, but not by the μ-selective opioid receptor antagonist β-funaltrexamine, implying a κ1-opioid receptor mechanism of action.  This conclusion is supported by the ability of antisense oligodeoxynucleotides directed against the KOR-1 clone, which encodes the κ1-opioid receptor, to block (-)-pentazocine analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44ztcW7-k47Vg90H21EOLACvtfcHk0liF6ZF4tmIVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSgsbrK&md5=4b298a555e0175f771326de69c996420</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900552-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900552-8%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3D%2528%25E2%2588%2592%2529-Pentazocine%2520Analgesia%2520in%2520Mice%253A%2520Interactions%2520with%2520a%2520Sigma%2520Receptor%2520System%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D294%26spage%3D303%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Sigma Antagonists Potentiate Opioid Analgesia in Rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0304-3940%2895%2911504-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=7644123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1995&pages=137-139&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Sigma+Antagonists+Potentiate+Opioid+Analgesia+in+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma antagonists potentiate opioid analgesia in rats</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-9</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In mice, activation of sigma1 receptors antagonizes opioid analgesia.  Sigma antagonists potentiate opioid analgesia, implying that the anti-opioid sigma system is tonically active.  Co-administration of haloperidol with the mu opioid morphine, the kappa1 analgesic U 50488H or the kappa3 agonist naloxone benzoylhydrazone enhances the analgesic activity of all agents.  The effect results from sigma receptor blockade since (-)sulpiride, a selective D2 antagonist which does not block sigma receptors, is inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT7Y-iEDEl3bVg90H21EOLACvtfcHk0liF6ZF4tmIVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D&md5=66ace8f372aca6d388626a9d9ba09728</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2911504-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252911504-P%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%2520Antagonists%2520Potentiate%2520Opioid%2520Analgesia%2520in%2520Rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D190%26spage%3D137%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kim, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovalyshyn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chein, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=695-703&author=F.+J.+Kimauthor=I.+Kovalyshynauthor=M.+Burgmanauthor=C.+Neilanauthor=C.+C.+Cheinauthor=G.+W.+Pasternak&title=Sigma-1+Receptor+Modulation+of+G-Protein-Coupled+Receptor+Signaling%3A+Potentiation+of+Opioid+Transduction+Independent+from+Receptor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DF.%2BJ.%26aulast%3DKovalyshyn%26aufirst%3DI.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DNeilan%26aufirst%3DC.%26aulast%3DChein%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma-1%2520Receptor%2520Modulation%2520of%2520G-Protein-Coupled%2520Receptor%2520Signaling%253A%2520Potentiation%2520of%2520Opioid%2520Transduction%2520Independent%2520from%2520Receptor%2520Binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D695%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">King, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Enhanced κ-Opioid Receptor-Mediated Analgesia by Antisense Targeting the Sigma-1 Receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">R5</span><span class="NLM_x">–</span> <span class="NLM_lpage">R6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1997&pages=R5-R6&author=M.+Kingauthor=Y.+X.+Panauthor=J.+Meiauthor=A.+Changauthor=J.+Xuauthor=G.+W.+Pasternak&title=Enhanced+%CE%BA-Opioid+Receptor-Mediated+Analgesia+by+Antisense+Targeting+the+Sigma-1+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DEnhanced%2520%25CE%25BA-Opioid%2520Receptor-Mediated%2520Analgesia%2520by%2520Antisense%2520Targeting%2520the%2520Sigma-1%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D331%26spage%3DR5%26epage%3DR6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chien, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Selective Antagonism of Opioid Analgesia by a Sigma Receptor System</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=7996472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=1583-1590&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Selective+Antagonism+of+Opioid+Analgesia+by+a+Sigma+Receptor+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism of opioid analgesia by a sigma system</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1583-90</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">(+)-Pentazocine antagonizes morphine analgesia as potently as its (-) isomer, ruling out an opioid receptor mechanism of action and suggesting a role for sigma1 receptors.  Systemic (+)-pentazocine also reverses supraspinal or spinal morphine analgesia.  1,3-Di(2-tolyl)guanidine, a sigma ligand with no appreciable opioid receptor affinity, antagonizes morphine analgesia.  The actions of both (+)-pentazocine and 1,3-di(2-tolyl)guanidine are reversed by haloperidol, which has high affinity for both sigma and D2 receptors, but not by the D2-selective antagonist (-)-sulpiride, which lacks activity at sigma sites.  The antiopioid sigma system is tonically active.  Haloperidol, but not (-)-sulpiride, decreases morphine ED50 almost 2-fold.  The antiopioid system modulates only mu analgesia.  Unlike analgesia, (+)-pentazocine does not influence morphine's inhibition of gastrointestinal transit or lethality.  (+)-Pentazocine also antagonizes kappa1, kappa3 and delta analgesia through sigma mechanisms in a haloperidol-sensitive manner.  (-)-Sulpiride is inactive.  Alone, haloperidol enhances kappa1, kappa3 and delta analgesia more dramatically than morphine, which indicates that the sigma system is active against all opioid analgesic systems.  Sigma systems are responsible for some strain differences in kappa receptor sensitivity.  Unlike CD-1 mice, BALB-C mice are relatively insensitive toward the kappa1 agent U50,488H and the kappa3 analgesic naloxone benzoylhydrazone.  Blockade of the sigma system with haloperidol eliminates these strain differences.  In conclusion, sigma1 systems functionally antagonize opioid analgesia without affecting morphine's effects on gastrointestinal transit or lethality.  The antiopioid sigma system is tonically active and is more active against kappa analgesia than mu.  The level of this tonic activity plays a significant role in strain differences in analgesic sensitivity toward opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPi-tKcGCFM7Vg90H21EOLACvtfcHk0lhmeiv3jbOjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislelu7k%253D&md5=d1314dcf06a32a48599975aa5208c4b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSelective%2520Antagonism%2520of%2520Opioid%2520Analgesia%2520by%2520a%2520Sigma%2520Receptor%2520System%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D1583%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoliu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Formalin-Induced Pain is Reduced in Sigma 1 Receptor Knockout Mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-Induced+Pain+is+Reduced+in+Sigma+1+Receptor+Knockout+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lhmeiv3jbOjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-Induced%2520Pain%2520is%2520Reduced%2520in%2520Sigma%25201%2520Receptor%2520Knockout%2520Mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptors Are Essential for Capsaicin-Induced Mechanical Hypersensitivity: Studies with Selective Sigma-1 Ligands and Sigma-1 Knockout Mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=252-261&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=G.+Grisauthor=E.+D.+Pozoauthor=D.+Zamanilloauthor=J.+M.+Baeyens&title=Sigma-1+Receptors+Are+Essential+for+Capsaicin-Induced+Mechanical+Hypersensitivity%3A+Studies+with+Selective+Sigma-1+Ligands+and+Sigma-1+Knockout+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DGris%26aufirst%3DG.%26aulast%3DPozo%26aufirst%3DE.%2BD.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520Receptors%2520Are%2520Essential%2520for%2520Capsaicin-Induced%2520Mechanical%2520Hypersensitivity%253A%2520Studies%2520with%2520Selective%2520Sigma-1%2520Ligands%2520and%2520Sigma-1%2520Knockout%2520Mice%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Fernández, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.jpain.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=23063344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1107-1121&author=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=E.+J.+Cobosauthor=J.+M.+Entrenaauthor=M.+A.+Tejadaauthor=D.+Zamanilloauthor=J.+M.+Velaauthor=J.+M.+Baeyens&title=Role+of+Sigma-1+Receptors+in+Paclitaxel-Induced+Neuropathic+Pain+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice</span></div><div class="casAuthors">Nieto, Francisco Rafael; Cendan, Cruz Miguel; Sanchez-Fernandez, Cristina; Cobos, Enrique Jose; Entrena, Jose Manuel; Tejada, Miguel Angel; Zamanillo, Daniel; Vela, Jose Miguel; Baeyens, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sigma-1 (σ1) receptors play a role in different types of pain and in central sensitization mechanisms; however, it is unknown whether they are involved in chemotherapy-induced neuropathic pain.  We compared the ability of paclitaxel to induce cold (acetone test) and mech. (electronic Von Frey test) allodynia in wild-type (WT) and σ1 receptor knockout (σ1-KO) mice.  We also tested the effect on paclitaxel-induced painful neuropathy of BD-1063 (16-64 mg/kg, s.c.) and S1RA (32-128 mg/kg, s.c.), 2 selective σ1 receptor antagonists that bind to the σ1 receptor with high affinity and competitively.  The responses to cold and mech. stimuli were similar in WT and σ1-KO mice not treated with paclitaxel; however, treatment with paclitaxel (2 mg/kg, i.p., once per day during 5 consecutive days) produced cold and mech. allodynia and an increase in spinal cord diphosphorylated extracellular signal-regulated kinase (pERK) in WT but not in σ1-KO mice.  The administration of BD-1063 or S1RA 30 min before each paclitaxel dose prevented the development of cold and mech. allodynia in WT mice.  Moreover, the acute administration of both σ1 receptor antagonists dose dependently reversed both types of paclitaxel-induced allodynia after they had fully developed.  These results suggest that σ1 receptors play a key role in paclitaxel-induced painful neuropathy.  Perspective: Antagonists of the σ1 receptor may have therapeutic value for the treatment and/or prevention of paclitaxel-induced neuropathic pain.  This possibility is esp. interesting in the context of chemotherapy-induced neuropathy, where the onset of nerve damage is predictable and preventive treatment could be administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHYCYBeIn__bVg90H21EOLACvtfcHk0lhmeiv3jbOjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gltr7I&md5=798467267c69e426eae9df6cde797d6d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DTejada%26aufirst%3DM.%2BA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520Sigma-1%2520Receptors%2520in%2520Paclitaxel-Induced%2520Neuropathic%2520Pain%2520in%2520Mice%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D1107%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">De La Puente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Sigma-1 Receptor Regulate Activity-Induced Spinal Sensitization and Neuropathic Pain after Peripheral Nerve Injury</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=294-303&author=B.+De+La+Puenteauthor=X.+Nadalauthor=E.+Portillo-Salidoauthor=R.+S%C3%A1nchez-Arroyosauthor=S.+Ovalleauthor=G.+Palaciosauthor=A.+Muroauthor=L.+Romeroauthor=J.+M.+Entrenaauthor=J.+M.+Baeyensauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=D.+Zamanilloauthor=J.+M.+Vela&title=Sigma-1+Receptor+Regulate+Activity-Induced+Spinal+Sensitization+and+Neuropathic+Pain+after+Peripheral+Nerve+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BPuente%26aufirst%3DB.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DOvalle%26aufirst%3DS.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520Receptor%2520Regulate%2520Activity-Induced%2520Spinal%2520Sensitization%2520and%2520Neuropathic%2520Pain%2520after%2520Peripheral%2520Nerve%2520Injury%26jtitle%3DPain%26date%3D2009%26volume%3D145%26spage%3D294%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujalte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span> </span><span class="NLM_article-title">Antinociceptive Effects of Haloperidol and its Metabolites in the Formalin Test in Mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=485-493&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=J.+M.+Baeyens&title=Antinociceptive+Effects+of+Haloperidol+and+its+Metabolites+in+the+Formalin+Test+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DAntinociceptive%2520Effects%2520of%2520Haloperidol%2520and%2520its%2520Metabolites%2520in%2520the%2520Formalin%2520Test%2520in%2520Mice%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D182%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Entrena, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendán, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Antagonism by Haloperidol and its Metabolites of Mechanical Hypersensitivity Induced by Intraplantar Capsaicin in Mice: Role of Sigma-1 Receptors</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1007%2Fs00213-009-1513-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=19326101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=21-33&author=J.+M.+Entrenaauthor=E.+J.+Cobosauthor=F.+R.+Nietoauthor=C.+M.+Cend%C3%A1nauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Antagonism+by+Haloperidol+and+its+Metabolites+of+Mechanical+Hypersensitivity+Induced+by+Intraplantar+Capsaicin+in+Mice%3A+Role+of+Sigma-1+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors</span></div><div class="casAuthors">Entrena, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.; Cendan, Cruz M.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: We evaluated the effects of haloperidol and its metabolites on capsaicin-induced mech. hypersensitivity (allodynia) and on nociceptive pain induced by punctate mech. stimuli in mice.  Results: S.c. administration of haloperidol or its metabolites I or II (reduced haloperidol) dose-dependently reversed capsaicin-induced (1 μg, intraplantar) mech. hypersensitivity of the hind paw (stimulated with a nonpainful, 0.5-g force, punctate stimulus).  The order of potency of these drugs to induce antiallodynic effects was the order of their affinity for brain sigma-1 (σ1) receptor ([3H](+)-pentazocine-labeled).  Antiallodynic activity of haloperidol and its metabolites was dose-dependently prevented by the selective σ1 receptor agonist PRE-084, but not by naloxone.  These results suggest the involvement of σ1 receptors, but discard any role of the endogenous opioid system, on the antiallodynic effects.  Dopamine receptor antagonism also appears unlikely to be involved in these effects, since the D2/D3 receptor antagonist (-)-sulpiride, which had no affinity for σ1 receptors, showed no antiallodynic effect.  None of these drugs modified hind-paw withdrawal after a painful (4 g force) punctate mech. stimulus in noncapsaicin-sensitized animals.  As expected, the control drug gabapentin showed antiallodynic but not antinociceptive activity, whereas clonidine exhibited both activities and rofecoxib, used as neg. control, showed neither.  Conclusion: These results show that haloperidol and its metabolites I and II produce antiallodynic but not antinociceptive effects against punctate mech. stimuli and suggest that their antiallodynic effect may be due to blockade of σ1 receptors but not to dopamine receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0AnJHWbghLVg90H21EOLACvtfcHk0lgpPSkSbRPZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kksbg%253D&md5=8b2077efc615a10a83b9dcaa973deeb2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1513-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1513-8%26sid%3Dliteratum%253Aachs%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DAntagonism%2520by%2520Haloperidol%2520and%2520its%2520Metabolites%2520of%2520Mechanical%2520Hypersensitivity%2520Induced%2520by%2520Intraplantar%2520Capsaicin%2520in%2520Mice%253A%2520Role%2520of%2520Sigma-1%2520Receptors%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2009%26volume%3D205%26spage%3D21%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuberes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrocal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contijoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Port, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ<sub>1</sub> Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1<i>H</i>-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8211</span><span class="NLM_x">–</span> <span class="NLM_lpage">8224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+Biological+Evaluation+of+the+1-Arylpyrazole+Class+of+%CF%831+Receptor+Antagonists%3A+Identification+of+4-%7B2-%5B5-Methyl-1-%28naphthalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520the%25201-Arylpyrazole%2520Class%2520of%2520%25CF%25831%2520Receptor%2520Antagonists%253A%2520Identification%2520of%25204-%257B2-%255B5-Methyl-1-%2528naphthalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arroyos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Arconada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segalés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laloya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portillo-Salido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escriche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plata-Salamán, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">Pharmacological Properties of S1RA, a New Sigma-1 Receptor Antagonist that Inhibits Neuropathic Pain and Activity-Induced Spinal Sensitization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-2306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+Properties+of+S1RA%2C+a+New+Sigma-1+Receptor+Antagonist+that+Inhibits+Neuropathic+Pain+and+Activity-Induced+Spinal+Sensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0liTZDGdlsKqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520Properties%2520of%2520S1RA%252C%2520a%2520New%2520Sigma-1%2520Receptor%2520Antagonist%2520that%2520Inhibits%2520Neuropathic%2520Pain%2520and%2520Activity-Induced%2520Spinal%2520Sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. S.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a Novel Sigma-1 Receptor Antagonist Based on 3,4-dihydro-2(1<i>H</i>)-quinolinone Scaffold As a Potential Analgesic</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.ejmech.2014.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=24735647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=216-230&author=Y.+Lanauthor=Y.+Chenauthor=X.+Q.+Xuauthor=Y.+L.+Qiuauthor=S.+C.+Liuauthor=X.+Liuauthor=B.-F.+Liuauthor=G.+S.+Zhang&title=Synthesis+and+Biological+Evaluation+of+a+Novel+Sigma-1+Receptor+Antagonist+Based+on+3%2C4-dihydro-2%281H%29-quinolinone+Scaffold+As+a+Potential+Analgesic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic</span></div><div class="casAuthors">Lan, Yu; Chen, Yin; Xu, Xiangqing; Qiu, Yinli; Liu, Shicheng; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-230</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis and sigma-1 receptor (σ1R) antagonist activity of a new series of 3,4-dihydro-2(1H)-quinolinones, e.g. I [R = PhCH2, 4-MeC6H4CH2, 4-FC6H4CH2, etc.] are reported.  The new compds. were evaluated in vitro in sigma-1 and sigma-2 receptor-binding assays in guinea pig brain membranes.  The structure-activity relationship led us to the promising deriv. I [R = 4-FC6H4CH2].  The compds. with highest affinity and greatest selectivity were further profiled, and compd. I [R = 4-FC6H4CH2] had a high binding const. for sigma-1 receptor (Kiσ1 = 1.22 nM) and high sigma-1/2 selectivity (1066-fold).  Thus, this compd., which proved to be an antagonist of sigma-1 receptor, emerged as the most interesting candidate.  In addn., this compd. exerted dose-dependent antinociceptive effects in the formalin test.  These characteristics suggested that the potent and selective compd. I [R = 4-FC6H4CH2] could be a potent candidate for pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56iTGYzwCw7Vg90H21EOLACvtfcHk0liTZDGdlsKqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWns7o%253D&md5=04009cdd675bf12a18a5869979c2cf10</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%2BQ.%26aulast%3DQiu%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DS.%2BC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.-F.%26aulast%3DZhang%26aufirst%3DG.%2BS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Novel%2520Sigma-1%2520Receptor%2520Antagonist%2520Based%2520on%25203%252C4-dihydro-2%25281H%2529-quinolinone%2520Scaffold%2520As%2520a%2520Potential%2520Analgesic%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D216%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaiel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ashmawy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howie, K. B.</span><span> </span><span class="NLM_article-title">Structural Features Important for Sigma-1 Receptor Binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00034a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1214-1219&author=R.+A.+Glennonauthor=S.+Y.+Ablordeppeyauthor=A.+M.+Ismaielauthor=M.+B.+El-Ashmawyauthor=J.+B.+Fischerauthor=K.+B.+Howie&title=Structural+Features+Important+for+Sigma-1+Receptor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00034a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00034a020%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DIsmaiel%26aufirst%3DA.%2BM.%26aulast%3DEl-Ashmawy%26aufirst%3DM.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DHowie%26aufirst%3DK.%2BB.%26atitle%3DStructural%2520Features%2520Important%2520for%2520Sigma-1%2520Receptor%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1214%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore Identification for Sigma-1 Receptor Binding: Application of the “Deconstruction–Reconstruction–Elaboration” Approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+Identification+for+Sigma-1+Receptor+Binding%3A+Application+of+the+%E2%80%9CDeconstruction%E2%80%93Reconstruction%E2%80%93Elaboration%E2%80%9D+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520Identification%2520for%2520Sigma-1%2520Receptor%2520Binding%253A%2520Application%2520of%2520the%2520%25E2%2580%259CDeconstruction%25E2%2580%2593Reconstruction%25E2%2580%2593Elaboration%25E2%2580%259D%2520Approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]-Dofetilide Binding Assay Is a Predictive Screening Tool for hERG Blockade and Proarrhythmia: Comparion of Intact Cell and Membrane Preparations and Effects of Altering [K<sup>+</sup>]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5D-Dofetilide+Binding+Assay+Is+a+Predictive+Screening+Tool+for+hERG+Blockade+and+Proarrhythmia%3A+Comparion+of+Intact+Cell+and+Membrane+Preparations+and+Effects+of+Altering+%5BK%2B%5Do"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lgdpk09BNr9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255D-Dofetilide%2520Binding%2520Assay%2520Is%2520a%2520Predictive%2520Screening%2520Tool%2520for%2520hERG%2520Blockade%2520and%2520Proarrhythmia%253A%2520Comparion%2520of%2520Intact%2520Cell%2520and%2520Membrane%2520Preparations%2520and%2520Effects%2520of%2520Altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cobos, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo, E.</span><span> </span><span class="NLM_article-title">Phenytoin Differentially Modulates the Affinity of Agonist and Antagonist Ligands for Sigma-1 Receptors of Guinea Pig Brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+Differentially+Modulates+the+Affinity+of+Agonist+and+Antagonist+Ligands+for+Sigma-1+Receptors+of+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520Differentially%2520Modulates%2520the%2520Affinity%2520of%2520Agonist%2520and%2520Antagonist%2520Ligands%2520for%2520Sigma-1%2520Receptors%2520of%2520Guinea%2520Pig%2520Brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maricel, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Víctor, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrique, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, C.</span><span> </span><span class="NLM_article-title">Predicting the Antinociceptive Efficacy of σ1 Receptor Ligands by A Novel Receptor Fluorescence Resonance Energy Transfer (FRET) Based Biosensor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=238-242&author=G.+S.+Maricelauthor=F.+D.+V%C3%ADctorauthor=P.+S.+Enriqueauthor=P.+Pilarauthor=Z.+Danielauthor=J.+M.+Velaauthor=B.+Javierauthor=C.+Francisco&title=Predicting+the+Antinociceptive+Efficacy+of+%CF%831+Receptor+Ligands+by+A+Novel+Receptor+Fluorescence+Resonance+Energy+Transfer+%28FRET%29+Based+Biosensor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaricel%26aufirst%3DG.%2BS.%26aulast%3DV%25C3%25ADctor%26aufirst%3DF.%2BD.%26aulast%3DEnrique%26aufirst%3DP.%2BS.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DZ.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DJavier%26aufirst%3DB.%26aulast%3DFrancisco%26aufirst%3DC.%26atitle%3DPredicting%2520the%2520Antinociceptive%2520Efficacy%2520of%2520%25CF%25831%2520Receptor%2520Ligands%2520by%2520A%2520Novel%2520Receptor%2520Fluorescence%2520Resonance%2520Energy%2520Transfer%2520%2528FRET%2529%2520Based%2520Biosensor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D238%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Díaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enrech, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet-Buchholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerón-Bertran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinoso, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández de Henestrosa, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almansa, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of a New Series of Hexahydro-2<i>H</i>-pyrano[3,2-<i>c</i>]quinolines as Novel Selective σ<sub>1</sub> Receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3665</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3665-3656&author=J.+L.+D%C3%ADazauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=M.+Luengoauthor=M.+Bordasauthor=R.+Enrechauthor=M.+Carroauthor=R.+Pascualauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+Benet-Buchholzauthor=J.+Cer%C3%B3n-Bertranauthor=J.+Ram%C3%ADrezauthor=R.+F.+Reinosoauthor=A.+R.+Fern%C3%A1ndez+de+Henestrosaauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+Biological+Evaluation+of+a+New+Series+of+Hexahydro-2H-pyrano%5B3%2C2-c%5Dquinolines+as+Novel+Selective+%CF%831+Receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DLuengo%26aufirst%3DM.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DEnrech%26aufirst%3DR.%26aulast%3DCarro%26aufirst%3DM.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBenet-Buchholz%26aufirst%3DJ.%26aulast%3DCer%25C3%25B3n-Bertran%26aufirst%3DJ.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReinoso%26aufirst%3DR.%2BF.%26aulast%3DFern%25C3%25A1ndez%2Bde%2BHenestrosa%26aufirst%3DA.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520New%2520Series%2520of%2520Hexahydro-2H-pyrano%255B3%252C2-c%255Dquinolines%2520as%2520Novel%2520Selective%2520%25CF%25831%2520Receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3665%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A Peripheral Mononeuropathy in Rat that Produces Disorders of Pain Sensation like Those Seen in Man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+Peripheral+Mononeuropathy+in+Rat+that+Produces+Disorders+of+Pain+Sensation+like+Those+Seen+in+Man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett G J; Xie Y K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eYWSOlqyUE6vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520Peripheral%2520Mononeuropathy%2520in%2520Rat%2520that%2520Produces%2520Disorders%2520of%2520Pain%2520Sensation%2520like%2520Those%2520Seen%2520in%2520Man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Caspni, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treede, R. D.</span><span> </span><span class="NLM_article-title">Tramadol Reduced Anxiety-Related and Depression-Associated Behaviors Presumably Induced by Pain in the Chronic Constriction Injury Model of Neuropathic Pain in Rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=290-296&author=O.+Caspniauthor=M.+C.+Reitzauthor=A.+Ceciauthor=A.+Kremerauthor=R.+D.+Treede&title=Tramadol+Reduced+Anxiety-Related+and+Depression-Associated+Behaviors+Presumably+Induced+by+Pain+in+the+Chronic+Constriction+Injury+Model+of+Neuropathic+Pain+in+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaspni%26aufirst%3DO.%26aulast%3DReitz%26aufirst%3DM.%2BC.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26atitle%3DTramadol%2520Reduced%2520Anxiety-Related%2520and%2520Depression-Associated%2520Behaviors%2520Presumably%2520Induced%2520by%2520Pain%2520in%2520the%2520Chronic%2520Constriction%2520Injury%2520Model%2520of%2520Neuropathic%2520Pain%2520in%2520Rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D124%26spage%3D290%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span> </span><span class="NLM_article-title">Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of <i>Plasmodium falciparum</i> Macrophage Migration Inhibitory Factor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10159</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301269s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10148-10159&author=M.+K.+Dahlgrenauthor=A.+B.+Garciaauthor=A.+A.+Hareauthor=J.+Tirado-Rivesauthor=L.+Lengauthor=R.+Bucalaauthor=W.+L.+Jorgensen&title=Virtual+Screening+and+Optimization+Yield+Low-Nanomolar+Inhibitors+of+the+Tautomerase+Activity+of+Plasmodium+falciparum+Macrophage+Migration+Inhibitory+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of Plasmodium falciparum Macrophage Migration Inhibitory Factor</span></div><div class="casAuthors">Dahlgren, Markus K.; Garcia, Alvaro Baeza; Hare, Alissa A.; Tirado-Rives, Julian; Leng, Lin; Bucala, Richard; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10148-10159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Plasmodium falciparum orthologue of the human cytokine, macrophage migratory inhibitory factor (PfMIF), is produced by the parasite during malaria infection and modulates the host's immune response.  As for other MIF orthologues, PfMIF has tautomerase activity, whose inhibition may influence the cytokine activity.  To identify small-mol. inhibitors of the tautomerase activity of PfMIF, virtual screening has been performed by docking 2.1 million compds. into the enzymic site.  Assaying of 17 compds. identified four as active.  Substructure search for the most potent of these compds., a 4-phenoxypyridine analog, identified four addnl. compds. that were purchased and also shown to be active.  Thirty-one addnl. analogs were then designed, synthesized, and assayed.  Three were found to be potent PfMIF tautomerase inhibitors with Ki of ∼40 nM; they are also highly selective with Ki > 100 μM for human MIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKwibTSCNZ_LVg90H21EOLACvtfcHk0li_n9pDPQFxGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7fE&md5=814ad5b502c4981032f893fbdba68e73</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm301269s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301269s%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGarcia%26aufirst%3DA.%2BB.%26aulast%3DHare%26aufirst%3DA.%2BA.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DLeng%26aufirst%3DL.%26aulast%3DBucala%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DVirtual%2520Screening%2520and%2520Optimization%2520Yield%2520Low-Nanomolar%2520Inhibitors%2520of%2520the%2520Tautomerase%2520Activity%2520of%2520Plasmodium%2520falciparum%2520Macrophage%2520Migration%2520Inhibitory%2520Factor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10148%26epage%3D10159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zanatta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourega, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonacorso, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, M. A. P.</span><span> </span><span class="NLM_article-title">A Convenient Synthesis of 5- and 6-Substituted 2-Phenyl-3<i>H</i>-Pyrimidin-4-Ones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1055%2Fs-2008-1032032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=358-362&author=N.+Zanattaauthor=L.+Fantinelauthor=R.+V.+Louregaauthor=H.+G.+Bonacorsoauthor=M.+A.+P.+Martins&title=A+Convenient+Synthesis+of+5-+and+6-Substituted+2-Phenyl-3H-Pyrimidin-4-Ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1032032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1032032%26sid%3Dliteratum%253Aachs%26aulast%3DZanatta%26aufirst%3DN.%26aulast%3DFantinel%26aufirst%3DL.%26aulast%3DLourega%26aufirst%3DR.%2BV.%26aulast%3DBonacorso%26aufirst%3DH.%2BG.%26aulast%3DMartins%26aufirst%3DM.%2BA.%2BP.%26atitle%3DA%2520Convenient%2520Synthesis%2520of%25205-%2520and%25206-Substituted%25202-Phenyl-3H-Pyrimidin-4-Ones%26jtitle%3DSynthesis%26date%3D2008%26volume%3D3%26spage%3D358%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, S.</span><span> </span><span class="NLM_article-title">Synthesis of 3-Amino-4-methyl-2-pentenamide, 2-Amino-1-clohexene-1-carboxamide, 3-Amino-2,4-diphenyl-2-butenamide, and Synthesis of 4(3<i>H</i>)-Pyrimidone Derivatives From Them</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1971&pages=1004-1012&issue=9&author=T.+Katoauthor=H.+Yamanakaauthor=S.+Konno&title=Synthesis+of+3-Amino-4-methyl-2-pentenamide%2C+2-Amino-1-clohexene-1-carboxamide%2C+3-Amino-2%2C4-diphenyl-2-butenamide%2C+and+Synthesis+of+4%283H%29-Pyrimidone+Derivatives+From+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DKonno%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25203-Amino-4-methyl-2-pentenamide%252C%25202-Amino-1-clohexene-1-carboxamide%252C%25203-Amino-2%252C4-diphenyl-2-butenamide%252C%2520and%2520Synthesis%2520of%25204%25283H%2529-Pyrimidone%2520Derivatives%2520From%2520Them%26jtitle%3DYakugaku%2520Zasshi%26date%3D1971%26volume%3D91%26issue%3D9%26spage%3D1004%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Raboisson, P.; Jean-Marie, B.; Belfrage, A. K.; Gertrud, L.; Classon, B. O.; Lindquist, K. C.; Nilsson, K. M.; Rosenquist, A. A. K.; Samuelsson, B. B.; Waehling, H. J.</span><span> </span><span class="NLM_article-title">Preparation of Pyrimidine-Substituted Macrocyclic Peptides as Inhibitors of Hepatitis C Virus</span>. PCT Int. Appl. WO 2008095999 A1 20080814,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Raboisson&author=B.+Jean-Marie&author=A.+K.+Belfrage&author=L.+Gertrud&author=B.+O.+Classon&author=K.+C.+Lindquist&author=K.+M.+Nilsson&author=A.+A.+K.+Rosenquist&author=B.+B.+Samuelsson&author=H.+J.+Waehling&title=Preparation+of+Pyrimidine-Substituted+Macrocyclic+Peptides+as+Inhibitors+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Pyrimidine-Substituted%2520Macrocyclic%2520Peptides%2520as%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Guan, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. M.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Substituted 6-fluoroalkylpyrimidin-4(3<i>H</i>)-ones and Pyrimidines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1055%2Fs-1996-4327" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=997-1001&author=H.+P.+Guanauthor=Q.+S.+Huauthor=C.+M.+Hu&title=Synthesis+of+2-Substituted+6-fluoroalkylpyrimidin-4%283H%29-ones+and+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1055%2Fs-1996-4327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1996-4327%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DHu%26aufirst%3DQ.%2BS.%26aulast%3DHu%26aufirst%3DC.%2BM.%26atitle%3DSynthesis%2520of%25202-Substituted%25206-fluoroalkylpyrimidin-4%25283H%2529-ones%2520and%2520Pyrimidines%26jtitle%3DSynthesis%26date%3D1996%26volume%3D8%26spage%3D997%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Naganuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagumo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuka, Y.</span><span> </span><span class="NLM_article-title">Discovery of Selective PDE4B Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3174-3176&author=K.+Naganumaauthor=A.+Omuraauthor=N.+Maekawaraauthor=M.+Saitohauthor=N.+Ohkawaauthor=T.+Kubotaauthor=H.+Nagumoauthor=T.+Kodamaauthor=M.+Takemuraauthor=Y.+Ohtsuka&title=Discovery+of+Selective+PDE4B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaganuma%26aufirst%3DK.%26aulast%3DOmura%26aufirst%3DA.%26aulast%3DMaekawara%26aufirst%3DN.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DOhkawa%26aufirst%3DN.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DNagumo%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DOhtsuka%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Selective%2520PDE4B%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3174%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grassi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, F.</span><span> </span><span class="NLM_article-title">Ring-Enlargement of Isoxazol-3-ones to 1,3-Oxazin-4-ones</span> <span class="citation_source-journal">J. Chem. Res. Synopses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=102-103&author=G.+Grassiauthor=F.+Fotiauthor=F.+Risitano&title=Ring-Enlargement+of+Isoxazol-3-ones+to+1%2C3-Oxazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrassi%26aufirst%3DG.%26aulast%3DFoti%26aufirst%3DF.%26aulast%3DRisitano%26aufirst%3DF.%26atitle%3DRing-Enlargement%2520of%2520Isoxazol-3-ones%2520to%25201%252C3-Oxazin-4-ones%26jtitle%3DJ.%2520Chem.%2520Res.%2520Synopses%26date%3D1983%26volume%3D4%26spage%3D102%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hayashi, S.; Masui, A.; Sekiguchi, F.</span><span> </span><span class="NLM_article-title">Fluorine-Containing Phosphate Esters of Pyrimidinols as Insecticides and Acaricides</span>, <i>Jpn. Kokai Tokkyo Koho</i><span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>JP 61268694 A 19861128,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=S.+Hayashi&author=A.+Masui&author=F.+Sekiguchi&title=Fluorine-Containing+Phosphate+Esters+of+Pyrimidinols+as+Insecticides+and+Acaricides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26atitle%3DFluorine-Containing%2520Phosphate%2520Esters%2520of%2520Pyrimidinols%2520as%2520Insecticides%2520and%2520Acaricides%26date%3D1986%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Yoburn, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskaran, S.</span><span> </span><span class="NLM_article-title">Chemoselective Arylamidine Cyclizations: Mild Formation of 2-Arylimidazole-4-carboxylic Acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3801</span><span class="NLM_x">–</span> <span class="NLM_lpage">3803</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0514855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=3801-3803&author=J.+C.+Yoburnauthor=S.+Baskaran&title=Chemoselective+Arylamidine+Cyclizations%3A+Mild+Formation+of+2-Arylimidazole-4-carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fol0514855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0514855%26sid%3Dliteratum%253Aachs%26aulast%3DYoburn%26aufirst%3DJ.%2BC.%26aulast%3DBaskaran%26aufirst%3DS.%26atitle%3DChemoselective%2520Arylamidine%2520Cyclizations%253A%2520Mild%2520Formation%2520of%25202-Arylimidazole-4-carboxylic%2520Acids%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D3801%26epage%3D3803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ho, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. S.</span><span> </span><span class="NLM_article-title">Microwave-Assisted Copper-Powder-Catalyzed Synthesis of Pyrimidinones from β-Bromo α,β-Unsaturated Carboxylic Acids and Amidines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2705</span><span class="NLM_x">–</span> <span class="NLM_lpage">2708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=2705-2708&author=S.+L.+Hoauthor=C.+S.+Cho&title=Microwave-Assisted+Copper-Powder-Catalyzed+Synthesis+of+Pyrimidinones+from+%CE%B2-Bromo+%CE%B1%2C%CE%B2-Unsaturated+Carboxylic+Acids+and+Amidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BL.%26aulast%3DCho%26aufirst%3DC.%2BS.%26atitle%3DMicrowave-Assisted%2520Copper-Powder-Catalyzed%2520Synthesis%2520of%2520Pyrimidinones%2520from%2520%25CE%25B2-Bromo%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Carboxylic%2520Acids%2520and%2520Amidines%26jtitle%3DSynlett%26date%3D2013%26volume%3D24%26spage%3D2705%26epage%3D2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkaichi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span> </span><span class="NLM_article-title">Identification of the Fused Bicyclic 4-Amino-2-phenylpyrimidine Derivatives as Novel and Potent PDE4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3325</span><span class="NLM_x">–</span> <span class="NLM_lpage">3328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3325-3328&author=T.+Gotoauthor=A.+Shiinaauthor=T.+Yoshinoauthor=K.+Mizukamiauthor=K.+Hiraharaauthor=O.+Suzukiauthor=Y.+Sogawaauthor=T.+Takahashiauthor=T.+Mikkaichiauthor=N.+Nakao&title=Identification+of+the+Fused+Bicyclic+4-Amino-2-phenylpyrimidine+Derivatives+as+Novel+and+Potent+PDE4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DShiina%26aufirst%3DA.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DMizukami%26aufirst%3DK.%26aulast%3DHirahara%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DO.%26aulast%3DSogawa%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DMikkaichi%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520the%2520Fused%2520Bicyclic%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520Novel%2520and%2520Potent%2520PDE4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3325%26epage%3D3328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Sun, X. J.; Tymianski, M.; Garman, J. D.</span>, <span> </span><span class="NLM_article-title">Agents and Methods for Treating Ischemic and Other Diseases Caused by TRPM7 Gene and Protein Activity</span>. PCT Int. Appl. WO 2011072275 A2 20110616,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=X.+J.+Sun&author=M.+Tymianski&author=J.+D.+Garman&title=Agents+and+Methods+for+Treating+Ischemic+and+Other+Diseases+Caused+by+TRPM7+Gene+and+Protein+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%2BJ.%26atitle%3DAgents%2520and%2520Methods%2520for%2520Treating%2520Ischemic%2520and%2520Other%2520Diseases%2520Caused%2520by%2520TRPM7%2520Gene%2520and%2520Protein%2520Activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbaj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span> </span><span class="NLM_article-title">Xanthine Oxidase-Activated Prodrugs of Thymidine Phosphorylase Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1248-1260&author=P.+Reiganauthor=A.+Gbajauthor=I.+J.+Stratfordauthor=R.+A.+Bryceauthor=S.+Freeman&title=Xanthine+Oxidase-Activated+Prodrugs+of+Thymidine+Phosphorylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DGbaj%26aufirst%3DA.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26aulast%3DFreeman%26aufirst%3DS.%26atitle%3DXanthine%2520Oxidase-Activated%2520Prodrugs%2520of%2520Thymidine%2520Phosphorylase%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1248%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ataka, K.; Kono, M.</span>, <span> </span><span class="NLM_article-title">Method for The Preparation of 5-Chloro-4-hydroxy-6-methylpyrimidine by Cyclocondensation of 2-Chloro-3-oxobutanoic Ester with Formamidine</span>, <i>Jpn. Kokai Tokkyo Koho</i><span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">, </span>JP 08198858 A 19960806,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=K.+Ataka&author=M.+Kono&title=Method+for+The+Preparation+of+5-Chloro-4-hydroxy-6-methylpyrimidine+by+Cyclocondensation+of+2-Chloro-3-oxobutanoic+Ester+with+Formamidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAtaka%26aufirst%3DK.%26atitle%3DMethod%2520for%2520The%2520Preparation%2520of%25205-Chloro-4-hydroxy-6-methylpyrimidine%2520by%2520Cyclocondensation%2520of%25202-Chloro-3-oxobutanoic%2520Ester%2520with%2520Formamidine%26date%3D1996%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit62c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zurmuehlen, F.</span>, <span> </span><span class="NLM_article-title">Preparation of 5-Chloro-4-hydroxypyrimidines</span>, <i>Ger. Offen.</i><span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">, </span>DE 4323180 A1 19950119,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=F.+Zurmuehlen&title=Preparation+of+5-Chloro-4-hydroxypyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZurmuehlen%26aufirst%3DF.%26atitle%3DPreparation%2520of%25205-Chloro-4-hydroxypyrimidines%26date%3D1995%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Breslin, M. J.; Cox, C. D.; Hartingh, T. J.; Pero, J.; Raheem, I. T.; Rossi, M.; Vassallo, L.</span>, <span> </span><span class="NLM_article-title">Preparation of Aryloxymethylcyclopropane Derivatives As PDE10 Inhibitors</span>, PCT Int. Appl. WO 2012162213 A1 20121129,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+J.+Breslin&author=C.+D.+Cox&author=T.+J.+Hartingh&author=J.+Pero&author=I.+T.+Raheem&author=M.+Rossi&author=L.+Vassallo&title=Preparation+of+Aryloxymethylcyclopropane+Derivatives+As+PDE10+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Aryloxymethylcyclopropane%2520Derivatives%2520As%2520PDE10%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Chokai, S.; Aoki, T.; Kimura, K.</span>, <span> </span><span class="NLM_article-title">Preparation and Formulation of Pyrimidine Derivatives As Brain Function Improvers</span>, PCT Int. Appl.<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">, </span>WO 9204333 A1 19920319,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=S.+Chokai&author=T.+Aoki&author=K.+Kimura&title=Preparation+and+Formulation+of+Pyrimidine+Derivatives+As+Brain+Function+Improvers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChokai%26aufirst%3DS.%26atitle%3DPreparation%2520and%2520Formulation%2520of%2520Pyrimidine%2520Derivatives%2520As%2520Brain%2520Function%2520Improvers%26date%3D1992%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleissner, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Rice, F. Y.</span><span> </span><span class="NLM_article-title">Characterization of the Binding of [<sup>3</sup>H](+)-Pentazocine to Sigma Recognition Sites in Guinea Pig Brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm501207r&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm501207r&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm501207r&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+Binding+of+%5B3H%5D%28%2B%29-Pentazocine+to+Sigma+Recognition+Sites+in+Guinea+Pig+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0ljfCuCpGCS52Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520Binding%2520of%2520%255B3H%255D%2528%252B%2529-Pentazocine%2520to%2520Sigma%2520Recognition%2520Sites%2520in%2520Guinea%2520Pig%2520Brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein–Dye Binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+Rapid+and+Sensitive+Method+for+the+Quantitation+of+Microgram+Quantities+of+Protein+Utilizing+the+Principle+of+Protein%E2%80%93Dye+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520Rapid%2520and%2520Sensitive%2520Method%2520for%2520the%2520Quantitation%2520of%2520Microgram%2520Quantities%2520of%2520Protein%2520Utilizing%2520the%2520Principle%2520of%2520Protein%25E2%2580%2593Dye%2520Binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezzavento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoto, G. M.</span><span> </span><span class="NLM_article-title">Opioid and Sigma Receptor Studies. New Developments in the Design of Selective Sigma Ligands</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=1499-1509&author=G.+Ronsisvalleauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Cagnottoauthor=T.+Menniniauthor=C.+Parentiauthor=G.+M.+Scoto&title=Opioid+and+Sigma+Receptor+Studies.+New+Developments+in+the+Design+of+Selective+Sigma+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DScoto%26aufirst%3DG.%2BM.%26atitle%3DOpioid%2520and%2520Sigma%2520Receptor%2520Studies.%2520New%2520Developments%2520in%2520the%2520Design%2520of%2520Selective%2520Sigma%2520Ligands%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2011%26volume%3D73%26spage%3D1499%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i159"><a href="/doi/suppl/10.1021/jm501207r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15162"></div></div></div></div></div><hr /></hr><p class="last">Details of computational procedures, selectivity of compound <b>137</b> for additional receptors and ion channels, inhibition curves figure of functional profile of σ<sub>1</sub> receptor, <sup>13</sup>C NMR and HR-MS of partially new compounds, and <sup>1</sup>H NMR, <sup>13</sup>C NMR, HR-MS, LC-MS, and elemental analyses of compound <b>137</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501207r/suppl_file/jm501207r_si_001.pdf">jm501207r_si_001.pdf (1.28 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501207r&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm501207r%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501207r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a807b6bdc23b0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
